syndrome	score	normalized_score
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	2.0223507499999998	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	98.89481337497959
EMANUEL SYNDROME	1.26239828	62.422321152747614
OROFACIODIGITAL SYNDROME TYPE 2	1.1380690100000002	56.27456117589891
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	1.1081731	54.7962859558363
OTOSCLEROSIS 7	1.05030887	51.93504984236785
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	51.76937086704668
MOWAT-WILSON SYNDROME; MOWS	1.0341709399999999	51.13707105456361
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	50.59734568793273
PSEUDOAMINOPTERIN SYNDROME	1.0195076200000002	50.412007907134814
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	1.0106383	49.973443034053325
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	1.00892857	49.88890131941751
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	1.00196464	49.54455304056431
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	1.00190476	49.54159212985186
MIDDLE EAR NEUROENDOCRINE TUMOR	1.00150376	49.521763719770185
HORNER SYNDROME, CONGENITAL	1.0	49.447406687489796
INCONTINENTIA PIGMENTI; IP	1.0	49.447406687489796
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	49.447406687489796
CHILDHOOD DISINTEGRATIVE DISORDER	0.98879085	48.89314328881873
CLEFT LIP/PALATE	0.9234251299999999	45.660977948558134
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.7537098099999999	37.26899549942067
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.65109284	32.19485245079273
LIMB-MAMMARY SYNDROME	0.64987104	32.13443760930195
NON-DISTAL MONOSOMY 20Q	0.60250657	29.792387398674542
OROFACIAL CLEFT 15	0.58432212	28.893213504136217
ADNP SYNDROME	0.5451424500000001	26.955880427764576
DEAFNESS-HYPOGONADISM SYNDROME	0.53666649	26.536766186577676
POSTENCEPHALITIC PARKINSONISM	0.525641	25.991584298618825
OCULOPHARYNGODISTAL MYOPATHY	0.5232558	25.873642344187825
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.5208333	25.753856001487385
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5208333	25.753856001487385
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.51426644	25.429141804407575
17Q24.2 MICRODELETION SYNDROME	0.51296786	25.364930391031333
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.5106383	25.24973969030842
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.5106383	25.24973969030842
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.50816318	25.127351425068085
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.50613497	25.027061700350444
MULTIPLE SULFATASE DEFICIENCY	0.5058141	25.011195510966637
INHERITED CREUTZFELDT-JAKOB DISEASE	0.50549451	24.99539261426338
48,XXXY SYNDROME	0.5045172599999999	24.947070136078022
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.50441755	24.94213973515722
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.50196464	24.82084969681941
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.50156495	24.80108606284049
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	24.723703343744898
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	24.723703343744898
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5	24.723703343744898
DEAFNESS, UNILATERAL	0.5	24.723703343744898
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.5	24.723703343744898
ACATALASEMIA	0.5	24.723703343744898
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	24.723703343744898
ACITRETIN/ETRETINATE EMBRYOPATHY	0.49702329999999995	24.576513248258248
OROFACIAL CLEFT 10; OFC10	0.43333299999999997	21.427193082110016
BRANCHIOSKELETOGENITAL SYNDROME	0.40349734	19.951897068300344
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.385638	19.06879902015019
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.3645833	18.0276987065671
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	17.306592340621428
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.34946581	17.28017803044304
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.34156884	16.889693343254134
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	16.722488420962588
ATELOSTEOGENESIS TYPE II	0.33432212	16.531361832263766
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	16.482452413361038
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.333333	16.482452413361038
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	16.482452413361038
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.333333	16.482452413361038
PLACENTAL INSUFFICIENCY	0.333333	16.482452413361038
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	16.482452413361038
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.333333	16.482452413361038
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.482452413361038
HOLOPROSENCEPHALY	0.32763231000000004	16.20056807653173
CONGENITAL ENTEROVIRUS INFECTION	0.3269231	16.1654994812349
RING CHROMOSOME 7 SYNDROME	0.32405325999999995	16.023593335626867
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.32254094	15.948813033545244
MOHR-TRANEBJAERG SYNDROME	0.31799451	15.724003860359042
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.3125	15.452314589840563
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.30725047	15.192738945012385
ALOPECIA AREATA 2; AA2	0.2981531	14.742897590835815
INSULINOMA	0.2857143	14.127831188531465
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.28571399999999997	14.127816354309457
MARCUS GUNN PHENOMENON	0.28571399999999997	14.127816354309457
ALOPECIA AREATA 1	0.2822801	13.95801890448529
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2793044	13.810878256405326
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.26092455	12.902042338600264
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25991769000000003	12.852255722702902
MENINGIOMA	0.25854701	12.784479151304492
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.25789964	12.752468383637211
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.25665942	12.691142720915256
MOSAIC TRISOMY 1	0.25539307	12.62852499745655
8P INVERTED DUPLICATION/DELETION SYNDROME	0.25485852000000003	12.602092886211755
PGM3-CDG	0.25485437	12.601887679474
ISOLATED CLEFT LIP	0.25485437	12.601887679474
WEST SYNDROME	0.25431034	12.574986806813806
FRONTORHINY	0.25417745	12.568415740939107
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.25342843	12.531378644382041
HYPERTRICHOSIS CUBITI	0.25337	12.52848943240929
OTOMANDIBULAR SYNDROME	0.25312714	12.516480635221166
SCHIZOPHRENIA 1; SCZD1	0.25098912	12.41076109077518
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.25	12.361851671872449
HYPERPARATHYROIDISM 2	0.25	12.361851671872449
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.25	12.361851671872449
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	12.361851671872449
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.25	12.361851671872449
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.361851671872449
NARCOLEPSY TYPE 1	0.25	12.361851671872449
DYSTONIA 6, TORSION	0.25	12.361851671872449
TETRAAMELIA SYNDROME 2; TETAMS2	0.25	12.361851671872449
AUTOSOMAL DOMINANT PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.25	12.361851671872449
SCHIZOPHRENIA	0.25	12.361851671872449
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.25	12.361851671872449
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.25	12.361851671872449
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	12.361851671872449
SEVERE COMBINED IMMUNODEFICIENCY DUE TO FOXN1 DEFICIENCY	0.25	12.361851671872449
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.20976105	10.372139946544882
ALOPECIA UNIVERSALIS	0.20535699999999998	10.154371095122842
QUINQUAUD FOLLICULITIS DECALVANS	0.20202009999999998	9.989370043747357
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.20098912000000002	9.93839075640069
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.2	9.88948133749796
XQ25 MICRODUPLICATION SYNDROME	0.2	9.88948133749796
OTODENTAL SYNDROME	0.1899228	9.391189930826787
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.18953786	9.372155646096505
FRONTONASAL DYSPLASIA 1; FND1	0.18348008	9.072614134813163
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.17826979999999998	8.814979300697468
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1769231	8.748388478111426
ACROMELIC FRONTONASAL DYSPLASIA	0.17666106999999998	8.735431774137101
MYHRE SYNDROME	0.17642570000000005	8.723793338025072
AGEL AMYLOIDOSIS	0.17615042	8.710181455912137
PFAPA SYNDROME	0.17543893000000002	8.675000120528056
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.17424240000000002	8.615834815004273
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.17399251	8.603478402547134
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.16973541	8.392975847537823
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.16956088000000002	8.384345791648656
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.16862835	8.338234601490372
GRANULOMATOSIS WITH POLYANGIITIS	0.16817076	8.315607962664243
PEMPHIGUS VULGARIS	0.166667	8.241250930383863
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	8.241250930383863
FECHTNER SYNDROME	0.166667	8.241250930383863
PITYRIASIS RUBRA PILARIS	0.166667	8.241250930383863
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	8.241250930383863
FRONTOTEMPORAL DEMENTIA; FTD	0.1666667	8.241236096161856
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	8.094060834897212
SANDHOFF DISEASE	0.16034095	7.928444163308468
FOCAL DERMAL HYPOPLASIA; FDH	0.15498463	7.663588029920134
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.1549052	7.659660422406944
HOLOPROSENCEPHALY 7	0.1547619	7.652574609028628
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.15332837000000002	7.581690268119912
NEUROFIBROMATOSIS TYPE 1	0.15318146000000002	7.5744259496034525
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.15037961	7.4358817331761085
PELGER-HUET ANOMALY; PHA	0.15001895999999998	7.418048525954264
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.1495011	7.392441691927082
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14914766999999998	7.374965494981521
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.14896600000000002	7.365982384608606
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.14892465	7.363937734342077
NASU-HAKOLA DISEASE	0.14849565	7.342724796873144
NORMAL PRESSURE HYDROCEPHALUS	0.14835151	7.335597447673209
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.14761581	7.299218990573222
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14716733999999998	7.277043312096085
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.14633908999999998	7.23608849750717
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.14476176	7.1580936195167935
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.14476176	7.1580936195167935
UNILATERAL POLYMICROGYRIA	0.14476176	7.1580936195167935
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.14473239000000002	7.156641349182383
PHACE SYNDROME	0.14442195	7.141290896250317
SCHINZEL-GIEDION SYNDROME	0.14384612	7.112817596057459
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.14333073999999998	7.087333391598862
HYDRANENCEPHALY	0.14285699999999998	7.063908177154729
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	7.063908177154729
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	7.063908177154729
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.14285699999999998	7.063908177154729
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.14285699999999998	7.063908177154729
GANGLIONEUROMA	0.14285699999999998	7.063908177154729
BEHCET SYNDROME	0.14285699999999998	7.063908177154729
%109500 BASILAR IMPRESSION, PRIMARY	0.14285699999999998	7.063908177154729
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.14285699999999998	7.063908177154729
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	7.063908177154729
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	7.063908177154729
SYRINGOMYELIA, ISOLATED	0.14285699999999998	7.063908177154729
PTOSIS, HEREDITARY CONGENITAL 1	0.14285699999999998	7.063908177154729
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14285699999999998	7.063908177154729
16P12.1P12.3 TRIPLICATION SYNDROME	0.14285699999999998	7.063908177154729
SARCOSINEMIA	0.14285699999999998	7.063908177154729
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.14285699999999998	7.063908177154729
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.14285699999999998	7.063908177154729
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	7.063908177154729
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	7.063908177154729
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	7.063908177154729
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	7.063908177154729
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	7.063908177154729
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	7.063908177154729
UNCOMBABLE HAIR SYNDROME	0.14285699999999998	7.063908177154729
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.14285699999999998	7.063908177154729
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.14285699999999998	7.063908177154729
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	7.063908177154729
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.14285699999999998	7.063908177154729
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	7.063908177154729
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	7.063908177154729
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	7.063908177154729
PHACE ASSOCIATION	0.14285699999999998	7.063908177154729
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.14127644999999997	6.985754078514816
NATIVE AMERICAN MYOPATHY	0.14122899	6.983407304593429
BIFID UVULA	0.13923157	6.884640065527704
DERMATOMYOSITIS	0.13861367000000002	6.854086512935504
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.13727925000000002	6.788102904503584
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.13670342000000002	6.759629604310728
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.13599680000000003	6.724689077797215
DISTAL MONOSOMY 12Q	0.13495981	6.673412611536353
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.13398246000000003	6.625085188610336
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	6.52430346219616
HYDROLETHALUS	0.13165587	6.510041346685289
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.12648863999999999	6.254535223427489
NIJMEGEN BREAKAGE SYNDROME	0.12577478	6.219236697689558
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.12514364	6.188028461432816
CARIBBEAN PARKINSONISM	0.125	6.1809258359362245
YOUNG-ONSET PARKINSON DISEASE	0.125	6.1809258359362245
MUCKLE-WELLS SYNDROME	0.12353830000000002	6.108648561581122
PAPILLARY TUMOR OF THE PINEAL REGION	0.12327570000000002	6.095663672584987
PINEOCYTOMA	0.12327570000000002	6.095663672584987
MONILETHRIX	0.12093347999999998	5.979846967693414
ALKAPTONURIA	0.11904760000000002	5.886595092369611
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.11852605000000001	5.860805797411751
SAGLIKER SYNDROME	0.11728383999999999	5.799381734350483
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.1143549	5.654553247007227
FRYNS MICROPHTHALMIA SYNDROME	0.11274510000000001	5.574952811721707
DEAFNESS, X-LINKED 4	0.11261476	5.568507836734058
PETTIGREW SYNDROME	0.11261476	5.568507836734058
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.11112849999999999	5.49501613407071
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	5.494150804453678
ALOPECIA, FAMILIAL FOCAL	0.11111099999999999	5.494150804453678
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	5.494150804453678
CRONKHITE-CANADA SYNDROME	0.11111099999999999	5.494150804453678
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.11111099999999999	5.494150804453678
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.10980485000000001	5.429565074208815
BARTSOCAS-PAPAS SYNDROME	0.10979648	5.42915119941484
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.10892857	5.386235300676701
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.10730214	5.305812555017967
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10658909999999999	5.270554576153518
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.10653595	5.267926446488079
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.106109	5.246814876202855
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.10603616	5.243213127099739
DIPROSOPUS	0.10578998	5.231040164521413
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10457714000000001	5.171068371794558
HOLOPROSENCEPHALY 4	0.10424355	5.154573211397677
MONOSOMY 18Q	0.10330881000000001	5.108352742470614
HOLOPROSENCEPHALY 2; HPE2	0.10308447000000001	5.097259711254342
KBG SYNDROME	0.1026125	5.073922018720047
WIEDEMANN-STEINER SYNDROME	0.10207191000000002	5.047191245138858
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.10190476000000001	5.038926111111044
SCHISIS ASSOCIATION	0.10162338	5.025012599817317
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.10162338	5.025012599817317
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.10151745000000001	5.019774636026912
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.10110254	4.999258412518206
PHENOBARBITAL EMBRYOPATHY	0.10098912	4.99365008765171
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.10056135	4.972497970493002
ZLOTOGORA-OGUR SYNDROME	0.10015450000000002	4.952380293082198
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.10015065000000001	4.95218992056645
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	4.94474066874898
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.1	4.94474066874898
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.1	4.94474066874898
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	4.94474066874898
SANDHOFF DISEASE	0.1	4.94474066874898
N SYNDROME	0.09775640000000001	4.833800467104928
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.09722458	4.807503347280387
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.09704407000000001	4.798577595899229
TAY-SACHS DISEASE	0.09673689	4.783388341512965
TAY-SACHS DISEASE; TSD	0.09640361	4.766908509812159
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.09640361	4.766908509812159
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.09542781	4.718657730366506
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.0954136	4.717955082717476
SMITH-FINEMAN-MYERS SYNDROME	0.09446331000000001	4.670965706616423
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0944056	4.668112096776487
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0944056	4.668112096776487
PELIZAEUS-MERZBACHER DISEASE	0.09433131000000002	4.664438648933674
TRICHOHEPATOENTERIC SYNDROME 1	0.09229548	4.563772134977081
TRISOMY 8P	0.09169516	4.534087867794447
DDOST-CDG	0.09160508000000002	4.52963364540004
CHRISTIANSON SYNDROME	0.09114014000000001	4.506643568134757
LOCALIZED SCLERODERMA	0.0909091	4.49521923929368
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0909091	4.49521923929368
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0909091	4.49521923929368
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0909091	4.49521923929368
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	4.49521923929368
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.0909091	4.49521923929368
EROSIVE PUSTULAR DERMATOSIS OF THE SCALP	0.0909091	4.49521923929368
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.0909091	4.49521923929368
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0909091	4.49521923929368
HUNTINGTON DISEASE-LIKE 3	0.0909091	4.49521923929368
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	4.49521923929368
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0909091	4.49521923929368
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.0909091	4.49521923929368
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.09085837000000001	4.492710772352423
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09045265000000001	4.472648970511175
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.08912635000000001	4.407066875021557
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.08795031	4.348914746860801
VAN MALDERGEM SYNDROME 1; VMLDS1	0.08779994	4.341479340317203
VAN MALDERGEM SYNDROME 2; VMLDS2	0.08779994	4.341479340317203
CLASSIC MYCOSIS FUNGOIDES	0.08756257	4.3297420093917935
BECKWITH-WIEDEMANN SYNDROME	0.08709349000000001	4.306547219862827
OROFACIODIGITAL SYNDROME TYPE 3	0.08684079	4.294051860192898
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.08677085000000001	4.2905935085691755
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.08640201000000002	4.2723553270865615
SCLEROSTEOSIS	0.08640201000000002	4.2723553270865615
BARTSOCAS-PAPAS SYNDROME; BPS	0.08607155	4.256014937072612
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	4.23739699950664
POSTORGASMIC ILLNESS SYNDROME	0.08523806000000002	4.214801018072658
TETRASOMY 9P	0.08505610000000001	4.2058035679518015
ERMINE PHENOTYPE	0.08483706000000002	4.194972607990975
CEREBROFACIOARTICULAR SYNDROME	0.08473123	4.1897395889412365
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08468145	4.187278097036334
DERMOODONTODYSPLASIA	0.08462302000000001	4.1843888850635835
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08457552000000002	4.182040133245928
ANOPHTHALMIA PLUS SYNDROME	0.08432242000000001	4.169524994613324
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.08432242000000001	4.169524994613324
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.08377431	4.142422376533844
OROMANDIBULAR DYSTONIA	0.08333330000000001	4.120615575710594
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.08333330000000001	4.120615575710594
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	4.120615575710594
TELECANTHUS	0.08333330000000001	4.120615575710594
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0833333	4.120615575710594
MACS SYNDROME	0.08323265	4.115638694227498
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.08305807000000001	4.107006165967997
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08275089000000001	4.091816911581733
RIN2 SYNDROME	0.08237779	4.07336808414663
184705 STEINFELD SYNDROME	0.08187462000000001	4.0484876325236865
CLEFT VELUM	0.08177747	4.043683816963997
TUBEROUS SCLEROSIS COMPLEX	0.08166244	4.037995881772734
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.08163695	4.03673546737627
CREE MENTAL RETARDATION SYNDROME	0.08128222	4.019194988802018
ETHYLMALONIC ENCEPHALOPATHY	0.08123344	4.0167829443038015
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08057274	3.984113042705377
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.07872815000000001	3.8929028508037007
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07854648	3.8839197404307835
MARSHALL-SMITH SYNDROME; MRSHSS	0.07844055000000001	3.878681776640379
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.07727209	3.8209044598223136
ECTODERMAL DYSPLASIA SYNDROME	0.07712684	3.813722224000956
CLEFT SOFT PALATE	0.07692310000000001	3.8036478093624466
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	3.8036478093624466
PEDIATRIC-ONSET GRAVES DISEASE	0.07692310000000001	3.8036478093624466
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.07692310000000001	3.8036478093624466
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	3.8036478093624466
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.07692310000000001	3.8036478093624466
OROFACIODIGITAL SYNDROME TYPE 10	0.07692310000000001	3.8036478093624466
AMISH LETHAL MICROCEPHALY	0.07692310000000001	3.8036478093624466
%613857 OROFACIAL CLEFT 13; OFC13	0.07692310000000001	3.8036478093624466
FAMILIAL ANETODERMA	0.07692310000000001	3.8036478093624466
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.07692310000000001	3.8036478093624466
PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	0.07692310000000001	3.8036478093624466
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.07692310000000001	3.8036478093624466
CRANIOSYNOSTOSIS 2	0.07692310000000001	3.8036478093624466
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	3.8036478093624466
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.07692310000000001	3.8036478093624466
ALOPECIA-INTELLECTUAL DISABILITY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.07692310000000001	3.8036478093624466
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.07692310000000001	3.8036478093624466
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07692310000000001	3.8036478093624466
STEINERT MYOTONIC DYSTROPHY	0.07638890000000001	3.77723300470999
FLYNN-AIRD SYNDROME	0.07636931	3.7762643300129817
TRICHOTHIODYSTROPHY	0.07557639	3.7370564923023366
RETT SYNDROME; RTT	0.07480118999999999	3.6987248626381946
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.07465575	3.691533231809567
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0736111	3.63987799841348
ARTERIAL TORTUOSITY SYNDROME	0.07241772	3.5808684522207637
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.07241772	3.5808684522207637
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.07226812	3.573471120180315
KLEEFSTRA SYNDROME	0.07165067	3.5429398189211243
PSEUDOTRISOMY 13 SYNDROME	0.07142860000000001	3.531959033318034
HOLOPROSENCEPHALY 1; HPE1	0.07142860000000001	3.531959033318034
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.07142860000000001	3.531959033318034
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.07142860000000001	3.531959033318034
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406	3.47190317999981
CLASSIC PHENYLKETONURIA	0.0694618	3.4347058738450795
FRONTOMETAPHYSEAL DYSPLASIA	0.06876257	3.400130763666985
OROFACIODIGITAL SYNDROME TYPE 4	0.06874936	3.399477563424644
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	3.39754614771943
CHAR SYNDROME	0.06837657	3.3810440646856144
SATOYOSHI SYNDROME	0.0670045	3.31319876139191
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.0670045	3.31319876139191
GERMAN SYNDROME	0.06654950000000001	3.290700191349103
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	3.2777598050189862
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.06606427	3.2667068262021317
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.06534021000000001	3.230903936915988
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.06511249999999999	3.219644267939179
KRABBE DISEASE	0.06465129	3.196838629500842
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.06431801	3.1803587978000354
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.06406495	3.1678456370636994
OSTEOPETROSIS AND RELATED DISORDERS	0.06401745	3.165496885246044
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.06348912	3.139372336870842
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.06348912	3.139372336870842
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.063328	3.1314053707053535
ANE SYNDROME	0.063328	3.1314053707053535
DISTAL TRISOMY 6P	0.06325552000000001	3.1278214226686454
AMISH INFANTILE EPILEPSY SYNDROME	0.0627294	3.101806153062223
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	3.1001496649381917
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	3.0904629179681122
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.0625	3.0904629179681122
COFFIN-SIRIS SYNDROME 10; CSS10	0.0625	3.0904629179681122
DENTAL NONERUPTION	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	3.0904629179681122
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0625	3.0904629179681122
SATOYOSHI SYNDROME	0.0625	3.0904629179681122
%613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	3.0904629179681122
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	3.0904629179681122
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	3.0904629179681122
PYCNODYSOSTOSIS	0.0625	3.0904629179681122
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	3.0904629179681122
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	3.0904629179681122
%203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;AMR SYNDROME	0.0625	3.0904629179681122
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.0625	3.0904629179681122
INCONTINENTIA PIGMENTI	0.06238694000000001	3.084872394168025
OROFACIODIGITAL SYNDROME TYPE 5	0.06200099	3.0657881675569882
NOONAN SYNDROME	0.061418480000000004	3.036984558687459
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.06121051000000001	3.026700981518662
RHIZOMELIC SYNDROME, URBACH TYPE	0.06082862	3.007817511378776
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.05994536	2.9641425949479836
OCULODENTODIGITAL DYSPLASIA	0.059550170000000006	2.9446014742991546
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.9319740900533704
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.0588235	2.9086695272815564
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0588235	2.9086695272815564
SPINOCEREBELLAR ATAXIA TYPE 4	0.0588235	2.9086695272815564
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.057360650000000006	2.836335388408762
BAMFORTH-LAZARUS SYNDROME	0.057178980000000004	2.8273522780358458
PACHYDERMOPERIOSTOSIS	0.057120550000000006	2.824463066063096
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.05704434	2.8206946791994416
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.05704434	2.8206946791994416
VELOCARDIOFACIAL SYNDROME	0.05687844	2.812491354429987
FRYNS SYNDROME	0.05666044	2.8017118197721147
X-LINKED ADRENOLEUKODYSTROPHY	0.05568835	2.7536444902052724
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.055617260000000016	2.7501292740638594
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	2.7470803469675085
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	2.7470803469675085
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	2.7470803469675085
ELLIS VAN CREVELD SYNDROME	0.055555600000000004	2.7470803469675085
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	2.7470803469675085
CHROMOSOME 1P36 DELETION SYNDROME	0.053988219999999996	2.66957747067367
TRISOMY 13	0.05274663	2.6081840650045502
WAARDENBURG SYNDROME, TYPE 1; WS1	0.05272226	2.606979031703576
MCCUNE-ALBRIGHT SYNDROME	0.0526635	2.6040735020866195
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.05251396	2.5966791368905717
PROGRESSIVE NON-FLUENT APHASIA	0.05230499999999999	2.5863466067891534
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.05230499999999999	2.5863466067891534
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.05225776	2.584010711297237
TIETZ SYNDROME	0.0520833	2.5753841167265374
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0520833	2.5753841167265374
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.05175879	2.55933793878238
PEROXISOME BIOGENESIS DISORDER 14B	0.05158947	2.5509655038820545
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.05043863	2.4940594503698237
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0502451	2.4844898937535937
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.049959	2.470342990700303
OROFACIODIGITAL SYNDROME TYPE 1	0.04978911000000002	2.461942370778166
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04958361	2.451780928703886
15Q OVERGROWTH SYNDROME	0.04940168000000001	2.4427849620052315
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.04925377	2.435471196082085
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.049183950000000004	2.4320187781471643
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.04913645	2.429670026329508
COCKAYNE SYNDROME	0.04901966000000001	2.4238950637024765
OROFACIAL CLEFT 11; OFC11	0.0488215	2.414096565593283
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.04839234000000001	2.392875716539281
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.04827935	2.3872886540576608
CHARGE SYNDROME	0.048232750000000005	2.384984404906024
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.04795168	2.371086222308371
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.04781341	2.3642491293856915
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.047619	2.3546360590515767
PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL	0.047619	2.3546360590515767
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH	0.047619	2.3546360590515767
ALOPECIA TOTALIS	0.047619	2.3546360590515767
LIPOID PROTEINOSIS	0.047619	2.3546360590515767
TRICHODYSPLASIA-AMELOGENESIS IMPERFECTA SYNDROME	0.047619	2.3546360590515767
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.047619	2.3546360590515767
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.047619	2.3546360590515767
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.047619	2.3546360590515767
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.047619	2.3546360590515767
AMYLOIDOSIS	0.047619	2.3546360590515767
ABLEPHARON-MACROSTOMIA SYNDROME	0.04749035	2.3482746501812315
PINEOBLASTOMA	0.047188030000000006	2.3333257101914695
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.047161209999999995	2.3319995307441106
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	2.321964179556885
DEAFNESS, MID-TONE NEURAL	0.04695826	2.321964179556885
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.046406039999999996	2.294658332635919
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.04559286	2.2544486904657863
PERRAULT SYNDROME 4	0.0454545	2.247607147276505
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	2.247607147276505
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	2.247607147276505
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0454545	2.247607147276505
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0454545	2.247607147276505
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	2.247607147276505
ACUTE MONOBLASTIC LEUKEMIA	0.0454545	2.247607147276505
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	2.247607147276505
MUCOPOLYSACCHARIDOSIS TYPE 2	0.04515025	2.2325627737918365
TRIOPIA	0.0449736	2.2238278894004915
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0446605	2.208345906366638
BRANCHIOOTORENAL SYNDROME 1	0.04464287	2.207474148586738
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044396500000000005	2.195291791001141
STURGE-WEBER SYNDROME	0.044261310000000005	2.1886069960910595
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	2.1800916581854066
OROFACIODIGITAL SYNDROME I; OFD1	0.043654140000000015	2.1585840141726167
PALLISTER-HALL SYNDROME	0.04359069	2.155446576218295
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.04351843	2.1518735066110564
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.043516990000000005	2.151802302345427
DISTAL MONOSOMY 10Q	0.04328717	2.140438299340508
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	2.136169504721177
PAI SYNDROME	0.04297274	2.1248905512557608
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.04297274	2.1248905512557608
WAARDENBURG SYNDROME TYPE 1	0.042938920000000005	2.1232182399615898
MUCOPOLYSACCHARIDOSIS TYPE IX	0.04276697	2.114715758381676
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.041696800000000006	2.061798627166925
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.041666699999999994	2.0603102602256307
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.041666699999999994	2.0603102602256307
ADULT-ONSET DYSTONIA-PARKINSONISM	0.041666699999999994	2.0603102602256307
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.041666699999999994	2.0603102602256307
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.041666699999999994	2.0603102602256307
PERRY SYNDROME	0.041666699999999994	2.0603102602256307
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04116769	2.0356355098145067
OROFACIODIGITAL SYNDROME V; OFD5	0.04116769	2.0356355098145067
MUCOLIPIDOSIS TYPE III	0.04098732000000001	2.026716681070285
611426 TENTED EYEBROWS	0.0408333	2.0191007914922774
INFANTILE MYOFIBROMATOSIS	0.0408333	2.0191007914922774
FRONTONASAL DYSPLASIA	0.04068151000000001	2.011595169631184
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0405229	2.0037523164564806
SHPRINTZEN OMPHALOCELE SYNDROME	0.04042614	1.9989677853853989
LEPRECHAUNISM	0.04035306000000001	1.9953541689046776
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.04033851	1.9946347091373742
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.9910764737521427
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.040244020000000005	1.9899624236794735
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.040236	1.9895658554778397
FIBROCHONDROGENESIS	0.04013185000000001	1.984415908071338
RAINE SYNDROME	0.04013185000000001	1.984415908071338
CONGENITAL HYPOTHYROIDISM	0.04003595	1.9796739017700071
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.04003534	1.979643738851928
OROFACIODIGITAL SYNDROME IX; OFD9	0.04003534	1.979643738851928
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.03989409	1.97265929265732
FETAL HYDANTOIN SYNDROME	0.03989175000000001	1.9725435857256717
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.03983056000000001	1.9695178989104642
STICKLER SYNDROME, TYPE I	0.03963737999999999	1.959965648886574
ACROCEPHALOPOLYDACTYLY	0.039450620000000006	1.9507308512136192
HOLOPROSENCEPHALY 3; HPE3	0.03923156999999999	1.939899396778724
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0390843	1.9326172771958576
ZECHI-CEIDE SYNDROME	0.038745390000000005	1.9158590565954006
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.03871687000000001	1.9144488165566735
MEHMO SYNDROME; MEHMO	0.03857048	1.9072102106916913
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.03850847000000001	1.9041439770030009
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.03847488	1.9024830386123677
MAL DE MELEDA	0.0384615	1.9018214323108893
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.9018214323108893
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.9018214323108893
JUVENILE ABSENCE EPILEPSY	0.0384615	1.9018214323108893
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.9018214323108893
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.9018214323108893
BAZEX SYNDROME; BZX	0.0384615	1.9018214323108893
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.9018214323108893
LIP, HAMARTOMATOUS	0.0384615	1.9018214323108893
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.9018214323108893
CYCLIC NEUTROPENIA	0.0384615	1.9018214323108893
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.9018214323108893
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.9018214323108893
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.9018214323108893
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.9018214323108893
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.9018214323108893
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.882695175404168
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.03796542	1.8772915628013591
OCULOAURICULOFRONTONASAL SYNDROME	0.037769870000000004	1.8676221224236205
BRANCHIO-OCULO-FACIAL SYNDROME	0.03776427	1.8673452169461706
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.03767894000000001	1.8631258697335273
ROSSELLI-GULIENETTI SYNDROME	0.037571129999999994	1.8577949448185485
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.037571129999999994	1.8577949448185485
FLYNN-AIRD SYNDROME	0.03756515	1.8574992493265572
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.03751935000000001	1.855234558100271
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.037511409999999995	1.8548419456911713
WOODHOUSE-SAKATI SYNDROME	0.037386	1.8486407464184937
HYDROXYKYNURENINURIA	0.037384970000000003	1.8485898155896057
BRANCHIOGENIC DEAFNESS SYNDROME	0.037337680000000005	1.8462514477273544
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.037337680000000005	1.8462514477273544
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.03729953999999999	1.8443655236362928
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.03727925000000001	1.8433622357546045
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.03727925000000001	1.8433622357546045
WAGR SYNDROME	0.03727925000000001	1.8433622357546045
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.03727925000000001	1.8433622357546045
PEROXISOME BIOGENESIS DISORDER 11B	0.03723175000000001	1.841013483936949
WOLFRAM-LIKE SYNDROME	0.03674451	1.8169207295025358
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.03670342000000001	1.814888935561747
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.03670342000000001	1.814888935561747
FETAL ALCOHOL SYNDROME	0.0364432	1.8020217313935283
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03639759	1.799766435174512
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.036238	1.7918751235412553
MENKES DISEASE	0.03616644	1.7883366671186987
HARLEQUIN ICHTHYOSIS	0.035714300000000004	1.765979516659017
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	1.765979516659017
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	1.765979516659017
CROSSED POLYSYNDACTYLY	0.035714300000000004	1.765979516659017
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	1.765979516659017
BENIGN SCHWANNOMA	0.035714300000000004	1.765979516659017
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.035714300000000004	1.765979516659017
OTOSCLEROSIS 4	0.035714300000000004	1.765979516659017
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.03554677	1.7576955926166618
OROFACIODIGITAL SYNDROME XIV; OFD14	0.03542288	1.7515695534021485
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.03477814	1.7196888324144566
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.03477671000000001	1.719618122622894
OROFACIODIGITAL SYNDROME XVII	0.034672209999999995	1.7144508686240505
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.03460093	1.7109262574753665
JOUBERT SYNDROME 26	0.034480449999999996	1.7049688339176576
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.03443295	1.7026200821000017
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.03437714	1.6998604223327731
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.03403459	1.6829222131719737
ALSTROM SYNDROME; ALMS	0.03393314	1.6779057737635277
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.03391277	1.6768985300893036
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.033862500000000004	1.6744128089551236
OROFACIODIGITAL SYNDROME VIII; OFD8	0.033862500000000004	1.6744128089551236
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.033831139999999996	1.6728621382814033
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.033831139999999996	1.6728621382814033
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.033831139999999996	1.6728621382814033
NEURONAL CEROID LIPOFUSCINOSIS	0.03367748	1.6652640497698041
DESMOSTEROLOSIS	0.03346092	1.6545557193775613
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.033447840000000006	1.653908947298089
ESOPHAGEAL ATRESIA	0.033443829999999994	1.6537106631972716
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.03343014	1.6530337281997203
MYOCLONIC EPILEPSY OF LAFORA	0.03327231	1.6452294440022337
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.03327231	1.6452294440022337
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.03327231	1.6452294440022337
HEART AND BRAIN MALFORMATION SYNDROME	0.03325676	1.6444605368282432
CARDIOFACIOCUTANEOUS SYNDROME	0.033221389999999996	1.6427115820537064
MARDEN-WALKER SYNDROME	0.033220820000000005	1.6426833970318953
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.033220820000000005	1.6426833970318953
ROTHMUND-THOMSON SYNDROME	0.033215800000000004	1.642435171050324
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.03318149	1.640738630526876
EAR-PATELLA-SHORT STATURE SYNDROME	0.033173320000000006	1.6403346452142396
KOSAKI OVERGROWTH SYNDROME; KOGS	0.03311244	1.6373242870951048
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.033059580000000005	1.6347104971776043
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.03303655	1.633571723401591
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.033001590000000004	1.6318430420637968
DUBOWITZ SYNDROME	0.03293379	1.6284905078903844
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0329155	1.6275861148220705
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0329155	1.6275861148220705
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0329155	1.6275861148220705
MICROPHTHALMIA, SYNDROMIC 1	0.03287619	1.6256423372651854
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.03287338	1.6255033900523936
HYDROLETHALUS SYNDROME 1	0.03287338	1.6255033900523936
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0328128	1.6225078661552654
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.03276819	1.6203020173429366
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.032767450000000004	1.6202654262619878
NEU-LAXOVA SYNDROME	0.032644990000000006	1.6142100968390378
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.032644990000000006	1.6142100968390378
GOLDENHAR SYNDROME	0.032521140000000004	1.6080860355207922
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.03246445	1.605282862035678
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.03226764	1.5955511179255133
TEMPLE-BARAITSER SYNDROME	0.03209126	1.586829584333974
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.03196587	1.5806293740094297
TRISOMY 20P	0.03194002	1.5793511585465578
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.03193167000000001	1.5789382727007177
HOLOPROSENCEPHALY 11	0.03192638	1.5786766959193406
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.03192638	1.5786766959193406
CHROMOSOME 15Q14 DELETION SYNDROME	0.03192638	1.5786766959193406
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.03192638	1.5786766959193406
WALKER-WARBURG SYNDROME	0.03165587	1.565300677936308
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.03165587	1.565300677936308
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.03165587	1.565300677936308
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.03165587	1.565300677936308
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.03165587	1.565300677936308
AYMÉ-GRIPP SYNDROME	0.03156231	1.5606743785666264
1Q41Q42 MICRODELETION SYNDROME	0.03149923	1.5575552361527796
CRYPTOCOCCOSIS	0.03145843	1.5555377819599299
MUCOLIPIDOSIS IV; ML4	0.031274300000000005	1.5464330309665626
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	1.5452314589840561
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	1.5452314589840561
USHER SYNDROME, TYPE IIC	0.03125	1.5452314589840561
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	1.5452314589840561
USHER SYNDROME, TYPE IF	0.03125	1.5452314589840561
RETINITIS PUNCTATA ALBESCENS	0.03125	1.5452314589840561
USHER SYNDROME, TYPE IE; USH1E	0.03125	1.5452314589840561
MMEP SYNDROME	0.03125	1.5452314589840561
OROFACIAL CLEFT 14	0.03125	1.5452314589840561
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	1.5452314589840561
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	1.5452314589840561
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	1.5452314589840561
WILDERVANCK SYNDROME	0.03125	1.5452314589840561
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	1.5452314589840561
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	1.5452314589840561
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03125	1.5452314589840561
DEAFNESS, X-LINKED 3	0.03125	1.5452314589840561
USHER SYNDROME, TYPE IC	0.03125	1.5452314589840561
USHER SYNDROME, TYPE IIA	0.03125	1.5452314589840561
PERRAULT SYNDROME 3	0.03125	1.5452314589840561
PENDRED SYNDROME	0.03125	1.5452314589840561
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.031233510000000003	1.5444160712477797
BARAITSER-WINTER SYNDROME 1; BRWS1	0.031076919999999997	1.5366731018345854
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.03103518	1.5346091670794495
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030976749999999997	1.5317199551066996
CRANIOFRONTONASAL DYSPLASIA	0.03095391	1.5305905763379575
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.030915559999999998	1.5286942682914921
DISTAL MONOSOMY 6P	0.03090772	1.5283066006230621
8Q22.1 MICRODELETION SYNDROME	0.030864779999999998	1.5261833289799014
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.030499520000000002	1.508122169213229
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.030400919999999998	1.5032466549138424
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.030390300000000002	1.5027215234548215
2Q23.1 MICRODUPLICATION SYNDROME	0.030380340000000006	1.5022290272842143
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.030302999999999997	1.4984047648510033
DOORS SYNDROME	0.030218140000000004	1.4942086579195033
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.030145500000000006	1.490616798297724
SMITH-MAGENIS SYNDROME; SMS	0.030078189999999998	1.4872884933535886
SPEECH-LANGUAGE DISORDER 1	0.02968256	1.4677256158458172
WHITE-SUTTON SYNDROME; WHSUS	0.02960523	1.4639018478866737
15Q13.3 MICRODELETION SYNDROME	0.02958285	1.4627952149250076
FOUNTAIN SYNDROME	0.029554040000000004	1.4613706351383413
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02954921	1.4611318041640404
BLAU SYNDROME	0.0294118	1.4543372360111124
AREDYLD	0.0294118	1.4543372360111124
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	1.4543372360111124
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.4543372360111124
OSSIFIED EAR CARTILAGES	0.0294118	1.4543372360111124
EAR WAX, WET/DRY	0.0294118	1.4543372360111124
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.4543372360111124
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.4543372360111124
DARWINIAN POINT OF PINNA	0.0294118	1.4543372360111124
EAR FOLDING	0.0294118	1.4543372360111124
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.4543372360111124
ALKAPTONURIA	0.0294118	1.4543372360111124
OTOONYCHOPERONEAL SYNDROME	0.0294118	1.4543372360111124
EAR WITHOUT HELIX	0.0294118	1.4543372360111124
EAR MALFORMATION	0.0294118	1.4543372360111124
HAIRY EARS, Y-LINKED	0.0294118	1.4543372360111124
OSTEOMA OF MIDDLE EAR	0.0294118	1.4543372360111124
MUSICAL PERFECT PITCH	0.0294118	1.4543372360111124
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.02934275	1.4509228925793414
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.02934275	1.4509228925793414
HURLER SYNDROME	0.029295250000000002	1.4485741407616857
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.02928156	1.447897205764134
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.02928156	1.447897205764134
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	1.447897205764134
NAGER SYNDROME	0.029248889999999996	1.4462817589876533
SNEDDON SYNDROME	0.02921508	1.4446099421675496
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0291161	1.4397156378536218
AGNATHIA-OTOCEPHALY COMPLEX	0.0291161	1.4397156378536218
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.029069430000000004	1.4374079273835167
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.028949810000000003	1.4314930285955592
GAUCHER DISEASE, PERINATAL LETHAL	0.02876692	1.4224495923864842
DISTAL MONOSOMY 10P	0.02873294	1.420769369507243
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.028613349999999996	1.414855954141486
MICROPHTHALMIA, LENZ TYPE	0.02858296	1.4133532474522534
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.4019575981070547
DUBOWITZ SYNDROME	0.028161649999999996	1.392520560540747
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.02815933	1.392405842557232
DEAFNESS, X-LINKED 2	0.02811017	1.3899750080444753
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.02791896	1.3805201694117601
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.3735401734837542
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.3735401734837542
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.3735401734837542
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.3735401734837542
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.3735401734837542
GRISCELLI SYNDROME, TYPE 2; GS2	0.027777800000000002	1.3735401734837542
NASAL BONES, ABSENCE OF	0.027777800000000002	1.3735401734837542
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.027777800000000002	1.3735401734837542
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.3735401734837542
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.3735401734837542
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.027777800000000002	1.3735401734837542
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.3735401734837542
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.027777800000000002	1.3735401734837542
DIMPLES, FACIAL	0.027777800000000002	1.3735401734837542
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.3735401734837542
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.027777800000000002	1.3735401734837542
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.027777800000000002	1.3735401734837542
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.027777800000000002	1.3735401734837542
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.3735401734837542
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.027777800000000002	1.3735401734837542
CYSTINOSIS, NEPHROPATHIC; CTNS	0.027777800000000002	1.3735401734837542
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.027777800000000002	1.3735401734837542
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.3735401734837542
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.027777800000000002	1.3735401734837542
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.027777800000000002	1.3735401734837542
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.027777800000000002	1.3735401734837542
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.3735401734837542
DWARFISM, LEVI TYPE	0.027777800000000002	1.3735401734837542
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.3735401734837542
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.027777800000000002	1.3735401734837542
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.3735401734837542
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.3735401734837542
MENKES DISEASE	0.027777800000000002	1.3735401734837542
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.3735401734837542
OROFACIAL CLEFT 3	0.027777800000000002	1.3735401734837542
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.027777800000000002	1.3735401734837542
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.3735401734837542
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.027777800000000002	1.3735401734837542
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.3735401734837542
GAUCHER DISEASE, TYPE II	0.027777800000000002	1.3735401734837542
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.3735401734837542
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.027777800000000002	1.3735401734837542
CLEFT CHIN	0.027777800000000002	1.3735401734837542
REVESZ SYNDROME	0.027777800000000002	1.3735401734837542
ALSTRÖM SYNDROME	0.0277603	1.3726748438667231
MATERNAL PHENYLKETONURIA	0.027605640000000004	1.365027307948436
311450 PALLISTER W SYNDROME;;W SYNDROME	0.027486109999999998	1.3591168594270802
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.02731105	1.3504605964123684
GENITOPALATOCARDIAC SYNDROME	0.02721549	1.3457354022293115
PERMANENT NEONATAL DIABETES MELLITUS	0.027158450000000004	1.3429149221518575
TRANSIENT NEONATAL DIABETES MELLITUS	0.027158450000000004	1.3429149221518575
TRISOMY 18	0.02709544	1.3397992410564785
OCULOCEREBROCUTANEOUS SYNDROME	0.027094519999999997	1.339753749442326
OSTEOGENESIS IMPERFECTA, TYPE V	0.027006139999999998	1.3353835876392857
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.02699997	1.335078497140024
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.02699997	1.335078497140024
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.02696827	1.3335110143480304
3Q29 MICRODELETION SYNDROME	0.02696765	1.3334803569558842
WAARDENBURG SYNDROME	0.02690246	1.3302568805139268
CRANDALL SYNDROME	0.02684156	1.3272455334466586
HARTSFIELD SYNDROME	0.0268158	1.325971768250389
ACROFRONTOFACIONASAL DYSOSTOSIS	0.026815799999999997	1.3259717682503889
CORNELIA DE LANGE SYNDROME 1	0.026759099999999997	1.3231681002912081
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.02667783	1.3191495095497159
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02666432	1.318481475085368
DEAFNESS-CRANIOFACIAL SYNDROME	0.02659044	1.3148283006792962
SMITH-MAGENIS SYNDROME	0.02641923	1.306362410180331
NEONATAL ADRENOLEUKODYSTROPHY	0.02629289	1.3001152248194336
XERODERMA PIGMENTOSUM	0.02627605	1.2992825304908162
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02617284	1.2941790636466004
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02613497	1.2923064903553452
FAMILIAL MELANOMA	0.02613497	1.2923064903553452
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.02610632	1.2908898221537486
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.02593877	1.2826049091632599
OCULOFACIOCARDIODENTAL SYNDROME	0.025796009999999998	1.2755457973845536
XQ21 MICRODELETION SYNDROME	0.02568767	1.270188665344031
VOCAL CORD PARALYSIS AND PTOSIS	0.025641000000000004	1.267880954873926
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.025641000000000004	1.267880954873926
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.025641000000000004	1.267880954873926
DEND SYNDROME	0.025641000000000004	1.267880954873926
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.025641000000000004	1.267880954873926
MUNGAN SYNDROME	0.025641000000000004	1.267880954873926
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.025641000000000004	1.267880954873926
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.025641000000000004	1.267880954873926
PURE MITOCHONDRIAL MYOPATHY	0.025641000000000004	1.267880954873926
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.025641000000000004	1.267880954873926
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.025641000000000004	1.267880954873926
SCLERODERMA	0.0255452	1.2631438933132644
DE BARSY SYNDROME	0.025532229999999996	1.2625025604485274
W SYNDROME	0.025521469999999997	1.2619705063525701
RESTRICTIVE DERMOPATHY	0.025521469999999997	1.2619705063525701
TRISOMY 8Q	0.02541044	1.2564803607880581
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.02541044	1.2564803607880581
PITT-HOPKINS SYNDROME	0.025185040000000002	1.2453349153206983
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.025177409999999997	1.2449576316076725
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02514364	1.243287792683836
DILATED CARDIOMYOPATHY WITH ATAXIA	0.02514364	1.243287792683836
RENPENNING SYNDROME 1; RENS1	0.02510547	1.2414003851705746
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.02508668	1.2404712683989165
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0250777	1.240027230686863
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.02505445	1.2388775784813788
FRONTOFACIONASAL DYSPLASIA	0.025010749999999998	1.2367167268091355
CORTICOBASAL SYNDROME	0.02490474	1.231474807226195
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.02490474	1.231474807226195
ABETA AMYLOIDOSIS, IOWA TYPE	0.02490474	1.231474807226195
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.02487918	1.2302109315112626
HYPERTELORISM, TEEBI TYPE	0.024842259999999998	1.2283853332563603
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.02482075	1.2273217195385124
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.02482075	1.2273217195385124
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.024775290000000002	1.2250738404304993
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	1.2249729677208565
BRANCHIOOCULOFACIAL SYNDROME	0.02476182	1.2244077838624186
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	1.2242960327233048
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	1.2242960327233048
ALZHEIMER DISEASE 10	0.02467982	1.2203530965140446
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.02465347	1.2190501573478292
CHROMOSOME 18Q DELETION SYNDROME	0.02461682	1.2172379098927326
CHROMOSOME 17Q12 DELETION SYNDROME	0.024543109999999996	1.2135931415457977
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.024532349999999998	1.2130610874498402
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0245045	1.2116839771735939
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.024482939999999998	1.2106178910854115
MEDULLOBLASTOMA	0.024482939999999998	1.2106178910854115
3MC SYNDROME	0.024395069999999998	1.2062729474597818
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.02435764	1.204422131027469
COFFIN-LOWRY SYNDROME; CLS	0.02429793	1.2014696263741589
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.02426173	1.1996796302520718
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.02419026	1.1961456240961172
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.02397413	1.1854585560887498
STICKLER SYNDROME, TYPE III	0.02396044	1.1847816210911981
GAPO SYNDROME	0.02396027	1.1847732150320611
KOOLEN-DE VRIES SYNDROME; KDVS	0.02393685	1.1836151567674402
CHARLIE M SYNDROME	0.02378706	1.176208429719721
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02378706	1.176208429719721
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.02378706	1.176208429719721
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.02376821	1.175276346103662
16P11.2P12.2 MICRODELETION SYNDROME	0.023745759999999998	1.1741662518235279
DOUBLE OUTLET RIGHT VENTRICLE	0.02371642	1.1727154649113167
RESTRICTIVE DERMOPATHY, LETHAL	0.02371642	1.1727154649113167
TRISOMY 9P	0.023627469999999998	1.1683171180864644
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02358802	1.1663664178926432
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02352959	1.163477205919893
DISTAL TRISOMY 17Q	0.0234458	1.1593340077135483
SHORT RIB-POLYDACTYLY SYNDROME	0.0234458	1.1593340077135483
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0234458	1.1593340077135483
RENAL AGENESIS, BILATERAL	0.0234458	1.1593340077135483
TRIPLOIDY	0.0234458	1.1593340077135483
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.02336852	1.155512712124739
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0233225	1.153237142468981
JACOBSEN SYNDROME	0.023272960000000002	1.1507875179416827
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	1.1499390004429253
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.0232558	1.1499390004429253
CINCA SYNDROME; CINCA	0.0232558	1.1499390004429253
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	1.1499390004429253
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	1.1499390004429253
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	1.1499390004429253
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	1.1499390004429253
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	1.1499390004429253
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	1.1499390004429253
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.0232558	1.1499390004429253
USHER SYNDROME, TYPE IV; USH4	0.0232558	1.1499390004429253
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	1.1499390004429253
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	1.1499390004429253
PELIZAEUS-MERZBACHER DISEASE	0.02314673	1.1445457717955207
FAMILIAL TUMORAL CALCINOSIS	0.02312204	1.1433249153244067
HEART-HAND SYNDROME TYPE 2	0.02312204	1.1433249153244067
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.02279794	1.1272990108169911
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02279794	1.1272990108169911
CHILDHOOD APRAXIA OF SPEECH	0.0227273	1.1238060460085868
BENCZE SYNDROME	0.0227273	1.1238060460085868
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0227273	1.1238060460085868
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0227273	1.1238060460085868
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.022686500000000002	1.1217885918157375
SPINOCEREBELLAR ATAXIA 14	0.022686500000000002	1.1217885918157375
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.022686500000000002	1.1217885918157375
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.022686500000000002	1.1217885918157375
BARAITSER-WINTER SYNDROME 2; BRWS2	0.02259002	1.1170179060185284
CARTILAGE-HAIR HYPOPLASIA	0.02256348	1.1157055718450424
FREEMAN-SHELDON SYNDROME	0.02256106	1.1155859091208586
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02249288	1.1122145849329055
DISTAL MONOSOMY 7Q36	0.02245668	1.1104245888108184
PENTALOGY OF CANTRELL	0.02245668	1.1104245888108184
ANKYLOBLEPHARON FILIFORME ADNATUM-CLEFT PALATE SYNDROME	0.02245668	1.1104245888108184
VACTERL/VATER ASSOCIATION	0.02245668	1.1104245888108184
HEMIMELIA	0.02245668	1.1104245888108184
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.02245668	1.1104245888108184
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.02245668	1.1104245888108184
CONGENITAL LARYNGOMALACIA	0.02245668	1.1104245888108184
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.02245668	1.1104245888108184
CLEFT PALATE	0.02245668	1.1104245888108184
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.02245668	1.1104245888108184
ISOTRETINOIN-LIKE SYNDROME	0.02245668	1.1104245888108184
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.022398249999999998	1.1075353768380682
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.02216814	1.09615703408521
CADASIL	0.02194691	1.085217784303737
CRI-DU-CHAT SYNDROME	0.02184893	1.0803729273964966
RAMOS-ARROYO SYNDROME	0.02182242	1.079062076645211
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02180357	1.0781299930291521
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.02171723	1.073860703935754
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0216333	1.0697105830924731
METACHROMATIC LEUKODYSTROPHY	0.02162928	1.0695118045175893
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0216009	1.0681084871157982
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.021587960000000003	1.0674686376732625
TRISOMY 4P	0.021587960000000003	1.0674686376732625
GYRATE ATROPHY OF CHOROID AND RETINA	0.02151745	1.0639821010277275
SIMPSON-GOLABI-BEHMEL SYNDROME	0.02146515	1.0613960016579715
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.02131499	1.0539709790697782
CUTIS LAXA	0.021308320000000002	1.0536411648671729
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.021308320000000002	1.0536411648671729
%608572 BURN-MCKEOWN SYNDROME	0.02130801	1.0536258361710995
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.021192350000000002	1.0479067491136247
MYOCLONIC EPILEPSY OF INFANCY	0.021097880000000003	1.0432354526038574
MYOCLONIC-ASTASTIC EPILEPSY	0.021097880000000003	1.0432354526038574
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.021097880000000003	1.0432354526038574
ADIPOSIS DOLOROSA	0.02108361	1.0425298381104267
JUBERG-HAYWARD SYNDROME	0.02107257	1.041983938740597
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.02102507	1.0396351869229412
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02098912	1.0378575526525258
MANITOBA OCULOTRICHOANAL SYNDROME	0.02098912	1.0378575526525258
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	1.030152657742481
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	1.030152657742481
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	1.030152657742481
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	1.030152657742481
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	1.030152657742481
PUPIL, EGG-SHAPED	0.0208333	1.030152657742481
HYPERCALCEMIA, INFANTILE, 1	0.0208333	1.030152657742481
DERMOIDS OF CORNEA	0.0208333	1.030152657742481
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	1.030152657742481
MYELINATED OPTIC NERVE FIBERS	0.0208333	1.030152657742481
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	1.030152657742481
CLEFT LIP-RETINOPATHY SYNDROME	0.0208333	1.030152657742481
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	1.030152657742481
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	1.030152657742481
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	1.030152657742481
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	1.030152657742481
POLYARTERITIS NODOSA	0.0208333	1.030152657742481
UNIQUE GREEN PHENOMENON	0.0208333	1.030152657742481
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	1.030152657742481
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	1.030152657742481
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	1.030152657742481
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	1.030152657742481
AUTOSOMAL RECESSIVE AMELIA	0.0208333	1.030152657742481
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	1.030152657742481
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	1.030152657742481
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	1.030152657742481
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	1.030152657742481
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	1.030152657742481
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	1.030152657742481
GAUCHER DISEASE, TYPE I	0.0208333	1.030152657742481
PREPAPILLARY VASCULAR LOOPS	0.0208333	1.030152657742481
IMINOGLYCINURIA	0.0208333	1.030152657742481
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	1.030152657742481
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	1.030152657742481
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	1.030152657742481
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	1.030152657742481
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	1.030152657742481
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	1.030152657742481
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	1.030152657742481
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	1.030152657742481
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	1.030152657742481
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.0208333	1.030152657742481
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.020820130000000003	1.0295014353964071
SPINOCEREBELLAR ATAXIA TYPE 17	0.020820130000000003	1.0295014353964071
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.020820130000000003	1.0295014353964071
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.02059884	1.0185592187705323
ENDOCARDIAL FIBROELASTOSIS	0.02059884	1.0185592187705323
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.020595210000000003	1.018379724684257
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.020488259999999998	1.0130913245390296
MONOSOMY 18P	0.02033416	1.0054714791684876
LATERAL MENINGOCELE SYNDROME	0.02032459	1.0049982674864884
ACRO-RENAL-MANDIBULAR SYNDROME	0.02032355	1.0049468421835333
MONOSOMY 9Q22.3	0.02032355	1.0049468421835333
TONNE-KALSCHEUER SYNDROME; TOKAS	0.02017484	0.9975935183350366
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.02009595	0.9936926124214608
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.02008345	0.9930745198378671
JOUBERT SYNDROME	0.02008345	0.9930745198378671
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.020045510000000002	0.9911984852281439
FEINGOLD SYNDROME	0.02002226	0.9900488330226596
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.9889481337497961
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.9889481337497961
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.9889481337497961
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.9889481337497961
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.9889481337497961
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.9889481337497961
TRICHODENTOOSSEOUS SYNDROME	0.02	0.9889481337497961
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.9889481337497961
HAIR WHORL	0.02	0.9889481337497961
NEVUS COMEDONICUS SYNDROME	0.02	0.9889481337497961
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.9889481337497961
DARIER DISEASE	0.02	0.9889481337497961
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.9889481337497961
CATATRICHY	0.02	0.9889481337497961
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.9889481337497961
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.9889481337497961
DISSECTING CELLULITIS OF THE SCALP	0.02	0.9889481337497961
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.9889481337497961
VAN BOGAERT-HOZAY SYNDROME	0.02	0.9889481337497961
JUVENILE HYALINE FIBROMATOSIS	0.02	0.9889481337497961
KNOBLOCH SYNDROME	0.02	0.9889481337497961
HAIRY NOSE TIP	0.02	0.9889481337497961
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.9889481337497961
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.9889481337497961
WERNER SYNDROME; WRN	0.02	0.9889481337497961
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.9889481337497961
MIDPHALANGEAL HAIR	0.02	0.9889481337497961
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.9889481337497961
RINGED HAIR	0.02	0.9889481337497961
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.01990296	0.9841497574048421
HOLOPROSENCEPHALY 5; HPE5	0.01950762	0.9646012196450098
MCDONOUGH SYNDROME	0.019503270000000003	0.9643861234259193
JACKSON-WEISS SYNDROME	0.01950327	0.9643861234259192
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01945577	0.9620373716082634
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.019427250000000004	0.9606271315695364
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.01941023	0.9597855367077153
AICARDI SYNDROME; AIC	0.019270429999999998	0.952872789252804
CRANIOFRONTONASAL SYNDROME; CFNS	0.01909098	0.9439994521227341
MELAS	0.019006469999999998	0.9398206517835741
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.01891384	0.9352403385021122
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.01891384	0.9352403385021122
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01881282	0.9302451614785419
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.9275764849396181
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01875425	0.9273490268688557
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0186271	0.9210617891085413
NEUROFERRITINOPATHY	0.01857678	0.9185735956040268
HUNTINGTON DISEASE	0.01857678	0.9185735956040268
SERKAL SYNDROME	0.0185185	0.9156918007422798
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0185185	0.9156918007422798
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0185185	0.9156918007422798
INIENCEPHALY	0.0185185	0.9156918007422798
BOWEN-CONRADI SYNDROME	0.0185185	0.9156918007422798
KAPUR-TORIELLO SYNDROME	0.0185185	0.9156918007422798
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.0185185	0.9156918007422798
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.0185185	0.9156918007422798
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0185185	0.9156918007422798
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.0185185	0.9156918007422798
CAUDAL REGRESSION SEQUENCE	0.0185185	0.9156918007422798
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.0185185	0.9156918007422798
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01851415	0.9154767045231892
6P22 MICRODELETION SYNDROME	0.01846665	0.9131279527055336
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.01845296	0.9124510177079819
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.0182633	0.9030728225556324
AARSKOG-SCOTT SYNDROME	0.01813273	0.8966164746644469
CORNELIA DE LANGE SYNDROME	0.01809347	0.8946751694778962
APERT SYNDROME	0.018080870000000002	0.8940521321536338
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.01807702	0.8938617596378867
HUNTINGTON DISEASE-LIKE 1	0.01803757	0.8919110594440653
ACERULOPLASMINEMIA	0.01803757	0.8919110594440653
PROGRESSIVE SUPRANUCLEAR PALSY	0.01803757	0.8919110594440653
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.01801859	0.8909725476651368
MOEBIUS SYNDROME; MBS	0.017995289999999997	0.8898204230893181
22Q11.2 MICRODUPLICATION SYNDROME	0.01795172	0.8876659995799445
DYSOSTOSIS, STANESCU TYPE	0.01793832	0.887003404330332
WHITE FORELOCK WITH MALFORMATIONS	0.01793832	0.887003404330332
TEMTAMY SYNDROME	0.01793832	0.887003404330332
TREACHER-COLLINS SYNDROME	0.01777251	0.8788045298274794
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.01765026	0.8727595843599337
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.01763657	0.872082649362382
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.01763657	0.872082649362382
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.01763657	0.872082649362382
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0176308	0.8717973378257952
WIEDEMANN-STEINER SYNDROME; WDSTS	0.01757575	0.8690752580876488
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.01754773	0.8676897417522654
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.017542710000000003	0.8674415157706943
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.017542710000000003	0.8674415157706943
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.017542710000000003	0.8674415157706943
SHORT SYNDROME	0.01750903	0.8657761271134594
ISOLATED CEREBELLAR AGENESIS	0.01731894	0.8563766695762347
HISTIDINEMIA	0.01731894	0.8563766695762347
ARGININEMIA	0.01731894	0.8563766695762347
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.01731894	0.8563766695762347
HISTIDINEMIA	0.01731894	0.8563766695762347
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.01728394	0.8546460103421725
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.0172824	0.8545698613358738
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.8525425176616866
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.8525425176616866
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.8525425176616866
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.8525425176616866
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.8525425176616866
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.8525425176616866
TRANSSEXUALITY	0.0172414	0.8525425176616866
MOTION SICKNESS	0.0172414	0.8525425176616866
PALMOMENTAL REFLEX	0.0172414	0.8525425176616866
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.8525425176616866
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.8525425176616866
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.8525425176616866
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.8525425176616866
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.8525425176616866
SICKLE CELL ANEMIA	0.0172414	0.8525425176616866
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.8525425176616866
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.8525425176616866
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.8525425176616866
JUMPING FRENCHMAN OF MAINE	0.0172414	0.8525425176616866
ERYTHERMALGIA, PRIMARY	0.0172414	0.8525425176616866
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.8525425176616866
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.8525425176616866
DIASTEMATOMYELIA	0.0172414	0.8525425176616866
CARDIAC ARRHYTHMIA	0.0172414	0.8525425176616866
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.8525425176616866
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.8525425176616866
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.8525425176616866
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.8525425176616866
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.8525425176616866
269800 SENILE PLAQUE FORMATION	0.0172414	0.8525425176616866
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.8525425176616866
THUMBS, CONGENITAL CLASPED	0.0172414	0.8525425176616866
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.8525425176616866
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.8525425176616866
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.8525425176616866
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.8525425176616866
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.8525425176616866
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.8525425176616866
RHEUMATOID ARTHRITIS	0.0172414	0.8525425176616866
CERVICAL RIB	0.0172414	0.8525425176616866
MOSAIC TRISOMY 15	0.0172414	0.8525425176616866
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.8525425176616866
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.8525425176616866
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.8525425176616866
MYOPATHY, CONGENITAL	0.0172414	0.8525425176616866
ALCOHOL DEPENDENCE	0.0172414	0.8525425176616866
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.8525425176616866
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.8525425176616866
WITTEVEEN-KOLK SYNDROME	0.0172307	0.8520134304101306
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.01716091	0.8485624958974107
OPTICOCOCHLEODENTATE DEGENERATION	0.01706215	0.8436790700129543
RING CHROMOSOME 8 SYNDROME	0.0169492	0.8380939854276022
PEHO SYNDROME	0.0169492	0.8380939854276022
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	0.8380939854276022
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0169492	0.8380939854276022
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0169492	0.8380939854276022
GRANT SYNDROME	0.0169492	0.8380939854276022
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0169492	0.8380939854276022
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	0.8380939854276022
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.0169492	0.8380939854276022
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0169492	0.8380939854276022
GAMMA-HEAVY CHAIN DISEASE	0.0169492	0.8380939854276022
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.016857800000000003	0.8335744924563657
RECOMBINANT 8 SYNDROME	0.016838739999999998	0.832632024884902
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.016812309999999997	0.8313251299261516
LENNOX-GASTAUT SYNDROME	0.016787540000000004	0.8301003176625027
MYXEDEMA	0.01677327	0.829394703169072
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.016723509999999997	0.8269342002123025
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.01666025	0.8238061572652521
KNOBLOCH SYNDROME 1; KNO1	0.016552700000000004	0.8184880886760125
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01650699	0.8162278477163273
SHORT SYNDROME	0.01648426	0.8151039081623207
KEIPERT SYNDROME	0.0164794	0.8148635937658195
SOTOS SYNDROME	0.016420470000000003	0.8119496580897257
ATAXIA WITH VITAMIN E DEFICIENCY	0.01635854	0.8088873801935694
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.01635854	0.8088873801935694
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.01635854	0.8088873801935694
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.01635854	0.8088873801935694
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.01635854	0.8088873801935694
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.0162373	0.802892376606778
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.01615814	0.7989781198933964
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.01613281	0.7977256170820023
HUNTINGTON DISEASE-LIKE 2	0.01613281	0.7977256170820023
CREUTZFELDT-JAKOB DISEASE; CJD	0.01613281	0.7977256170820023
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.01613281	0.7977256170820023
ALZHEIMER DISEASE 3; AD	0.01613281	0.7977256170820023
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.01613281	0.7977256170820023
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.01613281	0.7977256170820023
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.01613281	0.7977256170820023
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.01613281	0.7977256170820023
ALZHEIMER DISEASE 4	0.01613281	0.7977256170820023
3MC SYNDROME 2	0.01600054	0.7911852085994481
WOLF-HIRSCHHORN SYNDROME	0.01600054	0.7911852085994481
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.015957449999999998	0.789054519845284
LAMELLAR ICHTHYOSIS	0.015957449999999998	0.789054519845284
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.01588037	0.7852431137378124
ZTTK SYNDROME; ZTTKS	0.01587625	0.78503939042226
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.01580656	0.7815934006502089
BARATELA-SCOTT SYNDROME	0.0156877	0.7757160818913337
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01562836	0.7727818727784982
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0156156	0.7721509238691657
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0156156	0.7721509238691657
3MC SYNDROME 1	0.015567769999999998	0.769785854407303
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0155659	0.7696933877567975
AYME-GRIPP SYNDROME; AYGRP	0.01551781	0.7673154619691961
VAN DER WOUDE SYNDROME	0.015464519999999999	0.7646804096668197
BILATERAL POLYMICROGYRIA	0.015456720000000002	0.7642947198946575
SPINOCEREBELLAR ATAXIA TYPE 27	0.01537764	0.7603844189738107
CITRULLINEMIA TYPE II	0.01537764	0.7603844189738107
MANGANESE POISONING	0.01537764	0.7603844189738107
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.01535023	0.7590290655565065
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01532351	0.7577078308498169
PALLISTER-KILLIAN SYNDROME	0.01496473	0.7399670902784793
FAMILIAL COLORECTAL CANCER TYPE X	0.01494864	0.7391714815048774
BEHÇET DISEASE	0.01494864	0.7391714815048774
CHOREOACANTHOCYTOSIS	0.01494864	0.7391714815048774
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.01494864	0.7391714815048774
LYNCH SYNDROME	0.01494864	0.7391714815048774
3C SYNDROME	0.0149292	0.7382102239188728
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.014870770000000002	0.7353210119461228
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.014809580000000001	0.7322953251309152
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0148038	0.7320095191202615
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.014794400000000001	0.7315447134973991
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.014760740000000001	0.7298803137882982
PYCNODYSOSTOSIS	0.014760740000000001	0.7298803137882982
RECESSIVE X-LINKED ICHTHYOSIS	0.01468198	0.7259858360375915
HEMIFACIAL MICROSOMIA	0.01451746	0.7178507486893656
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.01451746	0.7178507486893656
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.014499720000000002	0.7169735516947298
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.014486510000000001	0.7163203514523879
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.01448309	0.7161512413215168
ACROCALLOSAL SYNDROME; ACLS	0.01443559	0.7138024895038609
MENTAL RETARDATION, X-LINKED 102	0.01441612	0.7128397484956553
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.014383260000000002	0.7112149067119047
FRASER SYNDROME	0.014344079999999999	0.7092775573178887
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.014309349999999998	0.7075602488836321
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014266440000000002	0.705438460662672
ABETAL34V AMYLOIDOSIS	0.014266440000000002	0.705438460662672
SPINOCEREBELLAR ATAXIA TYPE 12	0.014266440000000002	0.705438460662672
ADULT POLYGLUCOSAN BODY DISEASE	0.014266440000000002	0.705438460662672
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.014266440000000002	0.705438460662672
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.014238240000000001	0.7040440437940848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.014220990000000001	0.7031910760287257
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014218340000000003	0.7030600404010039
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.014212569999999999	0.7027747288644168
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0142099	0.7026427042885612
BRITTLE CORNEA SYNDROME	0.01415435	0.6998959008470712
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.01406486	0.6954708524226078
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.01406168	0.6953136096693415
CRIGLER-NAJJAR SYNDROME TYPE 1	0.01406051	0.6952557562035172
PRIMARY PROGRESSIVE FREEZING GAIT	0.014041520000000002	0.6943167499505218
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.014041520000000002	0.6943167499505218
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.014041520000000002	0.6943167499505218
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.014041520000000002	0.6943167499505218
ACROOSTEOLYSIS DOMINANT TYPE	0.01403461	0.6939750683703112
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.01400498	0.6925099417101609
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.01400282	0.6924031353117158
OROFACIODIGITAL SYNDROME VI	0.01400282	0.6924031353117158
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01400282	0.6924031353117158
PETERS PLUS SYNDROME	0.01400282	0.6924031353117158
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01399763	0.6921465032710078
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.013952960000000002	0.6899376876142778
15Q26 OVERGROWTH SYNDROME	0.013820460000000001	0.6833859062281854
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.01378294	0.6815306395292706
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.013780299999999999	0.6814000983756157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01377219	0.6809990799073801
MONOSOMY X	0.013759740000000001	0.680383459694121
MOSAIC MONOSOMY X	0.013759740000000001	0.680383459694121
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.013759740000000001	0.680383459694121
TURNER SYNDROME	0.013759740000000001	0.680383459694121
WORSTER-DROUGHT SYNDROME	0.01370041	0.677449745055352
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.01368738	0.6768054453462142
ELSAHY-WATERS SYNDROME; ESWS	0.01368738	0.6768054453462142
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.01368738	0.6768054453462142
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01367279	0.6760840076826438
POPLITEAL PTERYGIUM SYNDROME	0.01365384	0.6751469793259157
SIALURIA	0.01359206	0.6720921185407627
RICHARDS-RUNDLE SYNDROME	0.013565650000000002	0.6707862125301461
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.013565650000000002	0.6707862125301461
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.013565650000000002	0.6707862125301461
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013551960000000002	0.6701092775325944
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.013551960000000002	0.6701092775325944
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.013551960000000002	0.6701092775325944
DE SANCTIS-CACCHIONE SYNDROME	0.013551960000000002	0.6701092775325944
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0135353	0.6692854837371807
REFSUM DISEASE	0.013514020000000002	0.668233242922871
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.01350571	0.6678223349732979
WEAVER SYNDROME	0.013470860000000001	0.6660990928502389
KLEEFSTRA SYNDROME	0.01346101	0.6656120358943671
ASPARTYLGLUCOSAMINURIA	0.01340553	0.6628686937713452
OTOFACIOCERVICAL SYNDROME	0.013401380000000001	0.6626634870335921
ALOPECIA ANTIBODY DEFICIENCY	0.013401380000000001	0.6626634870335921
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01338088	0.6616498151964985
16P13.11 MICRODELETION SYNDROME	0.0133729	0.6612552248911324
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01333314	0.6592891960012378
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.013305820000000001	0.6579382928505356
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.013305820000000001	0.6579382928505356
LOEYS-DIETZ SYNDROME 5	0.013287690000000001	0.6570418113672913
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.01327643	0.6564850335679902
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.01325755	0.6555514665297304
ZIMMERMANN-LABAND SYNDROME	0.0132265	0.6540161245520839
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01318326	0.6518780186869167
COCKAYNE SYNDROME A; CSA	0.013133240000000001	0.6494046594044085
3Q29 MICRODUPLICATION SYNDROME	0.01308336	0.6469382227588366
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.01308227	0.6468843250855472
SIMOSA CRANIOFACIAL SYNDROME	0.01307574	0.6465614335198779
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.013046780000000001	0.6451294366222082
GABRIELE-DE VRIES SYNDROME	0.013039340000000002	0.6447615479164533
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0130137	0.643493716408986
KAPUR-TORIELLO SYNDROME	0.0130137	0.643493716408986
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0130137	0.643493716408986
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.012946889999999999	0.6401901351681948
ROBERTS SYNDROME; RBS	0.01291814	0.6387685222259295
CHROMOSOME 10Q26 DELETION SYNDROME	0.01290667	0.638201360471224
CEREBROTENDINOUS XANTHOMATOSIS	0.01285735	0.635762614373397
COFFIN-LOWRY SYNDROME	0.012844940000000001	0.6351489720564053
COFFIN-SIRIS SYNDROME	0.01284326	0.6350659004131702
KABUKI SYNDROME 1	0.01284326	0.6350659004131702
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.01281694	0.6337644446691555
22Q11.2 DELETION SYNDROME	0.012801510000000002	0.6330014711839677
JOHNSON NEUROECTODERMAL SYNDROME	0.0127873	0.6322988235349383
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.012738639999999999	0.6298927127255249
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012734480000000001	0.6296870115137051
SAY SYNDROME	0.012734480000000001	0.6296870115137051
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.01270879	0.6284167076359035
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.012680259999999999	0.6270059731231094
PHELAN-MCDERMID SYNDROME	0.012680259999999999	0.6270059731231094
POLYVALVULAR HEART DISEASE SYNDROME	0.012676050000000001	0.6267977995409552
ADAMS-OLIVER SYNDROME 1; AOS1	0.01266383	0.6261935522312339
BOHRING-OPITZ SYNDROME	0.012630539999999999	0.6245474480626073
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	0.6244490477232993
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.01261486	0.6237721127257476
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01261486	0.6237721127257476
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.01261486	0.6237721127257476
ADULT SYNDROME	0.01260411	0.6232405531038571
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.01259216	0.6226496565939416
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01257821	0.6219598652706511
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0125579	0.6209555884408282
H SYNDROME	0.0125579	0.6209555884408282
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01254618	0.6203760648344508
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.01254618	0.6203760648344508
MACHADO-JOSEPH DISEASE TYPE 3	0.01254306	0.6202217889255858
MACHADO-JOSEPH DISEASE TYPE 1	0.01254306	0.6202217889255858
MACHADO-JOSEPH DISEASE TYPE 2	0.01254306	0.6202217889255858
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.01252067	0.6191146614898528
DISTAL MONOSOMY 19P13.3	0.012486009999999999	0.6174008143740645
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012456710000000001	0.6159520053581211
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01242564	0.6144156744323407
SPINOCEREBELLAR ATAXIA TYPE 21	0.01242157	0.6142144234871227
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.01242157	0.6142144234871227
MONOAMINE OXIDASE A DEFICIENCY	0.01242157	0.6142144234871227
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.01239888	0.6130924618293835
ACROCRANIOFACIAL DYSOSTOSIS	0.01234063	0.6102121503898372
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.6066420476270005
ANGELMAN SYNDROME	0.01226843	0.6066420476270005
MARSHALL SYNDROME	0.012253739999999999	0.6059156652227612
3MC SYNDROME 3	0.012230850000000001	0.6047838140836848
PETERS-PLUS SYNDROME; PTRPLS	0.01223085	0.6047838140836846
CHARGE SYNDROME	0.01223085	0.6047838140836846
DISTAL MONOSOMY 15Q	0.01220755	0.603631689507866
SPINOCEREBELLAR ATAXIA TYPE 28	0.01220325	0.60341906565911
WERNICKE-KORSAKOFF SYNDROME	0.01220325	0.60341906565911
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.01220325	0.60341906565911
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01219665	0.6030927127749725
MUSCLE-EYE-BRAIN DISEASE	0.01219665	0.6030927127749725
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.01219665	0.6030927127749725
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.01219665	0.6030927127749725
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.01219479	0.6030007405985338
SEVERE COMBINED IMMUNODEFICIENCY	0.0121811	0.602323805600982
ERYTHROKERATODERMIA VARIABILIS	0.01215692	0.6011281673072786
WALDENSTRÖM MACROGLOBULINEMIA	0.01215575	0.6010703138414542
CRIGLER-NAJJAR SYNDROME	0.01215575	0.6010703138414542
4Q21 MICRODELETION SYNDROME	0.01214912	0.6007424775351161
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.012135030000000002	0.6000457635748895
8Q21.11 MICRODELETION SYNDROME	0.01204941	0.5958120766143065
METACHROMATIC LEUKODYSTROPHY	0.012048200000000002	0.5957522452522147
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.012048200000000002	0.5957522452522147
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.012048200000000002	0.5957522452522147
LINEAR VERRUCOUS NEVUS SYNDROME	0.012048200000000002	0.5957522452522147
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.012048200000000002	0.5957522452522147
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.012048200000000002	0.5957522452522147
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012048200000000002	0.5957522452522147
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.012048200000000002	0.5957522452522147
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.012048200000000002	0.5957522452522147
KURU, SUSCEPTIBILITY TO	0.012048200000000002	0.5957522452522147
MELANOSIS, NEUROCUTANEOUS; NCMS	0.012048200000000002	0.5957522452522147
SNEDDON SYNDROME	0.012048200000000002	0.5957522452522147
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.012048200000000002	0.5957522452522147
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.012048200000000002	0.5957522452522147
EARLY-ONSET LAFORA BODY DISEASE	0.012048200000000002	0.5957522452522147
ENCEPHALITIS LETHARGICA	0.012048200000000002	0.5957522452522147
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.012048200000000002	0.5957522452522147
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.012048200000000002	0.5957522452522147
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.012048200000000002	0.5957522452522147
SPINOCEREBELLAR ATAXIA TYPE 7	0.012048200000000002	0.5957522452522147
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012048200000000002	0.5957522452522147
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.012048200000000002	0.5957522452522147
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.012048200000000002	0.5957522452522147
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.012048200000000002	0.5957522452522147
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012048200000000002	0.5957522452522147
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.012048200000000002	0.5957522452522147
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012048200000000002	0.5957522452522147
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.012048200000000002	0.5957522452522147
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.012048200000000002	0.5957522452522147
SIALIDOSIS TYPE 1	0.01201541	0.5941308647869318
AURICULOCONDYLAR SYNDROME	0.012010970000000001	0.5939113183012394
AICARDI-GOUTIÈRES SYNDROME	0.01201026	0.5938762106424913
BARDET-BIEDL SYNDROME 1; BBS1	0.011969220000000001	0.5918468890720366
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01188233	0.5875504039049606
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01188233	0.5875504039049606
BARDET-BIEDL SYNDROME	0.011869510000000002	0.5869164881512272
COHEN SYNDROME	0.011855820000000001	0.5862395531536754
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.011840640000000001	0.5854889415201593
DIGEORGE SYNDROME; DGS	0.01182245	0.5845894931925137
1P36 DELETION SYNDROME	0.01181927	0.5844322504392475
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01172569	0.5798049621214323
MEESTER-LOEYS SYNDROME; MRLS	0.01172274	0.5796590922717042
GAPO SYNDROME; GAPOS	0.01166646	0.5768761922233323
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.011615720000000001	0.5743672308080091
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.01154256	0.5707496585347522
LOEYS-DIETZ SYNDROME 3; LDS3	0.01154107	0.5706759818987879
ADRENOLEUKODYSTROPHY	0.01151646	0.5694590812202087
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.01150077	0.5686832514092821
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0114723	0.5672754837408892
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.01140842	0.5641167834016924
ACROCRANIOFACIAL DYSOSTOSIS	0.01135151	0.5613027314871073
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011341180000000001	0.5607919397760256
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.01133771	0.5606203572748201
WOLFRAM SYNDROME	0.01130861	0.559181437740214
KOOLEN-DE VRIES SYNDROME	0.01128794	0.5581593598439836
KERATODERMA HEREDITARIUM MUTILANS	0.01128128	0.5578300401154449
20Q11.2 MICRODELETION SYNDROME	0.0112785	0.5576925763248537
COFFIN-SIRIS SYNDROME 1; CSS1	0.01125017	0.556291731293397
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.011234290000000001	0.5555065064751998
NAIL-PATELLA SYNDROME	0.01122804	0.555197460183403
ACROCARDIOFACIAL SYNDROME	0.011113089999999999	0.549513480784676
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.011113089999999999	0.549513480784676
FRYNS SYNDROME; FRNS	0.011113089999999999	0.549513480784676
BOHRING-OPITZ SYNDROME	0.011113089999999999	0.549513480784676
MOWAT-WILSON SYNDROME	0.011113089999999999	0.549513480784676
BASAL CELL NEVUS SYNDROME	0.011113089999999999	0.549513480784676
HYPOPLASMINOGENEMIA	0.0111111	0.5494150804453679
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.5494150804453679
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.5494150804453679
DERMAL RIDGES, PATTERNLESS	0.0111111	0.5494150804453679
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.5494150804453679
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.5494150804453679
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.5494150804453679
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.5494150804453679
KYRLE DISEASE	0.0111111	0.5494150804453679
SYRINGOMAS, MULTIPLE	0.0111111	0.5494150804453679
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.5494150804453679
CURRY-JONES SYNDROME	0.0111111	0.5494150804453679
TRICHILEMMAL CYST 1	0.0111111	0.5494150804453679
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.5494150804453679
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.5494150804453679
PRENATAL BOWING	0.0111111	0.5494150804453679
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.5494150804453679
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.5494150804453679
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.5494150804453679
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.5494150804453679
GLOMUVENOUS MALFORMATIONS	0.0111111	0.5494150804453679
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.5494150804453679
131600 EPIDERMOID CYSTS	0.0111111	0.5494150804453679
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.5494150804453679
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.5494150804453679
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.5494150804453679
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.5494150804453679
FUTCHER LINE	0.0111111	0.5494150804453679
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.5494150804453679
ACROMIAL DIMPLES	0.0111111	0.5494150804453679
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.5494150804453679
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.5494150804453679
CAROTENEMIA, FAMILIAL	0.0111111	0.5494150804453679
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	0.5494150804453679
PILONIDAL SINUS	0.0111111	0.5494150804453679
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.5494150804453679
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.5494150804453679
CAMOS SYNDROME	0.0111111	0.5494150804453679
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.5494150804453679
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.5494150804453679
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.5494150804453679
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.5494150804453679
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.5494150804453679
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.5494150804453679
GM1 GANGLIOSIDOSIS	0.0111111	0.5494150804453679
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.5494150804453679
LENTIGINES	0.0111111	0.5494150804453679
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.5494150804453679
PSEUDOATROPHODERMA COLLI	0.0111111	0.5494150804453679
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	0.5494150804453679
LICHEN PLANUS, FAMILIAL	0.0111111	0.5494150804453679
PIGMENTED PURPURIC ERUPTION	0.0111111	0.5494150804453679
PARANA HARD-SKIN SYNDROME	0.0111111	0.5494150804453679
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.5494150804453679
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.011031359999999999	0.5454721442361075
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.011031359999999999	0.5454721442361075
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.01099646	0.543746429742714
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.01099517	0.5436826425880873
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010982249999999999	0.5430437820936848
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010954440000000001	0.5416686497137059
THOMAS SYNDROME	0.010953500000000001	0.5416221691514196
CHROMOSOME 15Q25 DELETION SYNDROME	0.010953500000000001	0.5416221691514196
DIAMOND-BLACKFAN ANEMIA 1	0.0109535	0.5416221691514196
CEREBROFACIOTHORACIC DYSPLASIA	0.0109535	0.5416221691514196
GIANT CELL ARTERITIS	0.01092382	0.5401545701209349
MECKEL SYNDROME 12; MKS12	0.01089321	0.5386409850022308
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.01089321	0.5386409850022308
19P13.12 MICRODELETION SYNDROME	0.01087539	0.5377598322150597
PHENYLKETONURIA	0.01087431	0.5377064290158372
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.01086263	0.5371288833057274
TEMPLE SYNDROME	0.01083333	0.5356800742897839
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.01083333	0.5356800742897839
TEMPLE SYNDROME	0.01083333	0.5356800742897839
KLEEFSTRA SYNDROME 2; KLEFS2	0.01083333	0.5356800742897839
TETRASOMY X	0.010811600000000001	0.5346055821424648
GALLOWAY-MOWAT SYNDROME	0.0108116	0.5346055821424647
DISTAL MONOSOMY 9P	0.01074998	0.5315586329423815
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.010733620000000001	0.5307496733689743
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.01072872	0.5305073810762057
LATERAL MENINGOCELE SYNDROME	0.01071725	0.5299402193215
VASCULAR EHLERS-DANLOS SYNDROME	0.01070821	0.5294932147650452
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.01067734	0.5279667733206024
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.01067734	0.5279667733206024
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.01067734	0.5279667733206024
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.5279346325062555
MENTAL RETARDATION, X-LINKED 90	0.01067669	0.5279346325062555
9Q33.3Q34.11 MICRODELETION SYNDROME	0.01067669	0.5279346325062555
LANDAU-KLEFFNER SYNDROME	0.01067669	0.5279346325062555
HOLMES-GANG SYNDROME	0.01065846	0.5270332062823425
DESANTO-SHINAWI SYNDROME	0.01065443	0.5268339332333919
VICI SYNDROME; VICIS	0.010652209999999999	0.5267241599905457
STICKLER SYNDROME	0.010652209999999999	0.5267241599905457
ACRODERMATITIS ENTEROPATHICA	0.01063947	0.5260942000293471
TRICHODYSPLASIA-XERODERMA SYNDROME	0.01063947	0.5260942000293471
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01063947	0.5260942000293471
JUVENILE DERMATOMYOSITIS	0.01063947	0.5260942000293471
OMENN SYNDROME	0.01063947	0.5260942000293471
190360 TRICHODYSPLASIA-XERODERMA	0.01063947	0.5260942000293471
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.01063947	0.5260942000293471
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.01063947	0.5260942000293471
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.01063947	0.5260942000293471
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.01063947	0.5260942000293471
SÉZARY SYNDROME	0.01063947	0.5260942000293471
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.0106383	0.5260363465635227
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0106383	0.5260363465635227
OBESITY DUE TO SIM1 DEFICIENCY	0.0106383	0.5260363465635227
POSTERIOR CORTICAL ATROPHY	0.0106383	0.5260363465635227
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.5260363465635227
PITUICYTOMA	0.0106383	0.5260363465635227
SPINOCEREBELLAR ATAXIA TYPE 1	0.0106383	0.5260363465635227
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0106383	0.5260363465635227
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.5260363465635227
GLIOBLASTOMA	0.0106383	0.5260363465635227
LYME DISEASE	0.0106383	0.5260363465635227
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0106383	0.5260363465635227
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.01059039	0.5236673213091251
MONOSOMY 9P	0.01059039	0.5236673213091251
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010576980000000001	0.523004231585446
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.010567130000000001	0.5225171746295741
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.01055252	0.5217947480178698
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.010551950000000001	0.521766562996058
SAETHRE-CHOTZEN SYNDROME	0.01053558	0.5209571089485837
FLOATING-HARBOR SYNDROME	0.01051165	0.5197738325065522
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01048318	0.5183660648381593
RETT SYNDROME	0.01048318	0.5183660648381593
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.01048318	0.5183660648381593
CEDNIK SYNDROME	0.010470769999999999	0.5177524225211675
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.01044602	0.5165285992056522
STICKLER SYNDROME, TYPE II	0.01043233	0.5158516642081005
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.01043233	0.5158516642081005
2Q33.1 DELETION SYNDROME	0.010395310000000001	0.5140211212125297
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.010395310000000001	0.5140211212125297
LOCKED-IN SYNDROME	0.01028938	0.5087831574221239
INFANTILE REFSUM DISEASE	0.01027569	0.508106222424572
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01027569	0.508106222424572
HUNTINGTON DISEASE-LIKE 1	0.01023385	0.5060373429287675
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01023385	0.5060373429287675
KUFOR-RAKEB SYNDROME	0.01023385	0.5060373429287675
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.01023385	0.5060373429287675
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010200480000000001	0.504387282967606
PITT-HOPKINS SYNDROME	0.010200480000000001	0.504387282967606
LATHOSTEROLOSIS	0.01018901	0.5038201212129004
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.01018756	0.5037484224732036
COFFIN-SIRIS SYNDROME 6; CSS6	0.01018756	0.5037484224732036
MEIER-GORLIN SYNDROME 6; MGORS6	0.01018756	0.5037484224732036
NEURALGIC AMYOTROPHY	0.010170390000000001	0.5028994105003795
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.010140600000000001	0.5014263722551591
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.010140600000000001	0.5014263722551591
CHROMOSOME 16P13.2 DELETION SYNDROME	0.010140600000000001	0.5014263722551591
ZECHI-CEIDE SYNDROME	0.01012397	0.5006040618819461
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01012397	0.5006040618819461
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.010111960000000001	0.5000101985276294
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.010111960000000001	0.5000101985276294
TRISOMY XQ28	0.010111960000000001	0.5000101985276294
GLASS SYNDROME	0.01007253	0.49806048728194163
2Q32Q33 MICRODELETION SYNDROME	0.01007253	0.49806048728194163
CAMURATI-ENGELMANN DISEASE	0.01006446	0.49766144670997364
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.01006446	0.49766144670997364
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.01006446	0.49766144670997364
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.01006446	0.49766144670997364
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.01006446	0.49766144670997364
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.01005077	0.49698451171242186
CONGENITAL RUBELLA SYNDROME	0.01005077	0.49698451171242186
VON HIPPEL-LINDAU DISEASE	0.01005077	0.49698451171242186
ALBINISM-DEAFNESS SYNDROME	0.01005077	0.49698451171242186
PENDRED SYNDROME	0.01005077	0.49698451171242186
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.01005077	0.49698451171242186
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01005077	0.49698451171242186
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01004224	0.49656272533337753
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.010040890000000002	0.4964959713343496
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.010040890000000002	0.4964959713343496
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.010040890000000002	0.4964959713343496
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0100388	0.4963926262543726
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.01001279	0.49510649920643096
IMMUNODEFICIENCY 23; IMD23	0.01000777	0.49485827322485976
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00999901	0.4944251139422773
OGDEN SYNDROME; OGDNS	0.00994253	0.49163232441256793
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00991997	0.49051679091769823
OROFACIODIGITAL SYNDROME III	0.00991769	0.4904040508304507
LOEYS-DIETZ SYNDROME	0.00991769	0.4904040508304507
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00991769	0.4904040508304507
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00991769	0.4904040508304507
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00991769	0.4904040508304507
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00990643	0.4898472730311496
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00988265	0.488671413700121
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00984775	0.4869456992067277
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00984775	0.4869456992067277
NON-DISTAL TRISOMY 13Q	0.00982248	0.4856961632397348
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00982248	0.4856961632397348
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00980485	0.4848244054598344
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00980485	0.4848244054598344
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00980485	0.4848244054598344
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0098044	0.484802154126825
DK1-CDG	0.00978461	0.4838235899484795
PITT-HOPKINS-LIKE SYNDROME	0.009753290000000001	0.48227489717102745
16P13.2 MICRODELETION SYNDROME	0.009753290000000001	0.48227489717102745
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.009739600000000001	0.4815979621734757
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00972813	0.48103080041877017
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00972428	0.48084042790302334
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00972428	0.48084042790302334
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00972428	0.48084042790302334
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00972428	0.48084042790302334
15Q14 MICRODELETION SYNDROME	0.00970098	0.47968830332720475
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00967678	0.4784916760853675
HARDIKAR SYNDROME	0.00967678	0.4784916760853675
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00967678	0.4784916760853675
FOCAL DERMAL HYPOPLASIA	0.00967159	0.47823504404465955
MULTIPLE CARBOXYLASE DEFICIENCY	0.00967159	0.47823504404465955
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00967159	0.47823504404465955
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00966934	0.47812378737961264
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00966934	0.47812378737961264
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00966934	0.47812378737961264
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.009664559999999999	0.47788742877564633
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.009664559999999999	0.47788742877564633
CENTRAL CONGENITAL HYPOTHYROIDISM	0.009663109999999999	0.4778157300359495
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.009663090000000001	0.47781474108781585
DYSTONIA, JUVENILE-ONSET	0.009663090000000001	0.47781474108781585
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00966309	0.4778147410878158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00963147	0.4762512140883574
PRIMROSE SYNDROME; PRIMS	0.00962679	0.4760198002250599
14Q12 MICRODELETION SYNDROME	0.009611890000000001	0.4752830338654164
19Q13.11 MICRODELETION SYNDROME	0.00955718	0.4725777662455437
ABLEPHARON MACROSTOMIA SYNDROME	0.00955718	0.4725777662455437
KABUKI SYNDROME	0.00954646	0.4720476900458539
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00954284	0.47186869043364515
FUMARASE DEFICIENCY; FMRD	0.00953613	0.47153689833477214
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00953266	0.4713653158335665
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.009524930000000001	0.47098308737987227
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.009524930000000001	0.47098308737987227
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00948971	0.46924154971633886
CANAVAN DISEASE	0.00947743	0.46863433556221645
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00946374	0.46795740056466467
FABRY DISEASE	0.00946374	0.46795740056466467
SMITH-LEMLI-OPITZ SYNDROME	0.009450900000000002	0.4673224958627974
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.009438269999999999	0.4666979751163343
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009438269999999999	0.4666979751163343
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.009438269999999999	0.4666979751163343
ZUNICH NEUROECTODERMAL SYNDROME	0.00943151	0.46636371064712695
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009371790000000001	0.4634107115197501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009371790000000001	0.4634107115197501
DISTAL MONOSOMY 3P	0.00934454	0.46206326968751593
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00932429	0.4610619597020943
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00932429	0.4610619597020943
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00932429	0.4610619597020943
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.009316479999999999	0.46067577545586486
CRANIOMETAPHYSEAL DYSPLASIA	0.00931189	0.4604488118591694
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00931189	0.4604488118591694
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0093106	0.46038502470454257
SALT-AND-PEPPER SYNDROME	0.0093106	0.46038502470454257
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00926211	0.45798731995426617
EEC SYNDROME	0.00926211	0.45798731995426617
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00924155	0.4569706812727713
SHPRINTZEN-GOLDBERG SYNDROME	0.00921349	0.4555831870411204
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.00921349	0.4555831870411204
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.009198169999999999	0.454825652770668
DOWN SYNDROME	0.00916471	0.4531711425429046
FRONTOMETAPHYSEAL DYSPLASIA	0.0091523	0.4525575002259129
7Q11.23 MICRODUPLICATION SYNDROME	0.00915067	0.4524769009530123
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00914845	0.4523671277101661
ROBERTS SYNDROME	0.009148449999999999	0.452367127710166
HARTSFIELD SYNDROME; HRTFDS	0.009148449999999999	0.452367127710166
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.009148449999999999	0.452367127710166
MECKEL SYNDROME, TYPE 1; MKS1	0.009148449999999999	0.452367127710166
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.009148449999999999	0.452367127710166
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00914326	0.452110495669458
VELO-FACIAL-SKELETAL SYNDROME	0.009126599999999999	0.45128670187404435
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009126599999999999	0.45128670187404435
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00909002	0.4494779157374161
SYNDROMIC DIARRHEA	0.00908873	0.4494141285827892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.009049680000000001	0.4474832073516427
RING CHROMOSOME 1 SYNDROME	0.00898428	0.44424934695428087
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00896701	0.44339539024078783
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00892857	0.4414946319277208
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.00892857	0.4414946319277208
UVULA, BIFID	0.00892857	0.4414946319277208
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00892857	0.4414946319277208
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.4414946319277208
CLEFT PALATE, X-LINKED	0.00892857	0.4414946319277208
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.00892857	0.4414946319277208
ACRO-RENAL-OCULAR SYNDROME	0.0089122	0.4406851778802466
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00888957	0.4395661830669087
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.008795960000000002	0.43493741132689284
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00879596	0.4349374113268928
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00879596	0.4349374113268928
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.43374919014419244
BREATH-HOLDING SPELLS	0.00877193	0.43374919014419244
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.43374919014419244
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.43374919014419244
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.43374919014419244
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.43374919014419244
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.43374919014419244
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.43374919014419244
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.43374919014419244
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.43374919014419244
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.43374919014419244
LESCH-NYHAN SYNDROME	0.00877193	0.43374919014419244
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00877193	0.43374919014419244
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.43374919014419244
CAFFEY DISEASE	0.00877193	0.43374919014419244
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00877193	0.43374919014419244
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.43374919014419244
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.43374919014419244
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00877193	0.43374919014419244
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.43374919014419244
DIENCEPHALIC SYNDROME	0.00877193	0.43374919014419244
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.43374919014419244
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.43374919014419244
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.43374919014419244
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.43374919014419244
MILROY DISEASE	0.00877193	0.43374919014419244
RHEUMATIC FEVER	0.00877193	0.43374919014419244
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.43374919014419244
NANCE-HORAN SYNDROME	0.00877193	0.43374919014419244
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.43374919014419244
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.43374919014419244
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.43374919014419244
FAMILIAL DYSAUTONOMIA	0.00877193	0.43374919014419244
HAMAMY SYNDROME; HMMS	0.00876786	0.43354793919897433
2P15P16.1 MICRODELETION SYNDROME	0.00875685	0.43300352325134506
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00875685	0.43300352325134506
CHAND SYNDROME	0.00874747	0.4325397065766164
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00872691	0.4315230678951215
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00867941	0.4291743160774659
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00866572	0.42849738107991414
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00866572	0.42849738107991414
BARBER-SAY SYNDROME; BBRSAY	0.00864154	0.4273017427862106
PROLIDASE DEFICIENCY	0.00864154	0.4273017427862106
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00860874	0.42567986784686096
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00860197	0.4253451089035866
KEARNS-SAYRE SYNDROME; KSS	0.00856322	0.4234290218944464
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00856322	0.4234290218944464
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00856322	0.4234290218944464
TOLUENE EMBRYOPATHY	0.00854701	0.4226274794320422
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00854701	0.4226274794320422
FRAGILE X SYNDROME	0.00854701	0.4226274794320422
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.4226274794320422
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00854701	0.4226274794320422
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.4226274794320422
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00854701	0.4226274794320422
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.4226274794320422
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00854701	0.4226274794320422
WHIM SYNDROME	0.00854701	0.4226274794320422
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00854701	0.4226274794320422
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00854701	0.4226274794320422
CENTRAL BILATERAL MACROGYRIA	0.00854701	0.4226274794320422
ATAXIA-PANCYTOPENIA SYNDROME	0.00854701	0.4226274794320422
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00854701	0.4226274794320422
BETA-UREIDOPROPIONASE DEFICIENCY	0.00854701	0.4226274794320422
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00854701	0.4226274794320422
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00854701	0.4226274794320422
TYROSINEMIA TYPE 2	0.00854701	0.4226274794320422
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.4226274794320422
PYRIDOXINE-DEPENDENT EPILEPSY	0.00854701	0.4226274794320422
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.4226274794320422
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00854701	0.4226274794320422
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.4226274794320422
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00854701	0.4226274794320422
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00854701	0.4226274794320422
TAKAYASU ARTERITIS	0.00854701	0.4226274794320422
FLOATING-HARBOR SYNDROME	0.00850401	0.4205012409444801
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.008449149999999999	0.41778855621360433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.008449149999999999	0.41778855621360433
LUSCAN-LUMISH SYNDROME; LLS	0.008449149999999999	0.41778855621360433
3P25.3 MICRODELETION SYNDROME	0.00842869	0.4167768622727785
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00838898	0.41481330575321823
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008383950000000001	0.41456458529758017
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00838251	0.41449338103195005
CORNELIA DE LANGE SYNDROME 3	0.00835542	0.41315385078478606
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00834857	0.4128151360489767
RETINITIS PIGMENTOSA	0.00832277	0.41153939295643954
TREACHER COLLINS SYNDROME 3; TCS3	0.0082828	0.40956298011114056
TREACHER COLLINS SYNDROME 2; TCS2	0.0082828	0.40956298011114056
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.008235840000000001	0.40724092989309607
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.008235840000000001	0.40724092989309607
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.008235840000000001	0.40724092989309607
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008235840000000001	0.40724092989309607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008235840000000001	0.40724092989309607
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.40724092989309607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008235840000000001	0.40724092989309607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.008235840000000001	0.40724092989309607
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00822852	0.40687897487614355
COHEN-GIBSON SYNDROME; COGIS	0.00822852	0.40687897487614355
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008214309999999999	0.4061763272271143
COFFIN-SIRIS SYNDROME 8; CSS8	0.008209049999999999	0.4059162338679381
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008209049999999999	0.4059162338679381
NOONAN SYNDROME 6; NS6	0.00816733	0.40385328806093607
ACROOTOOCULAR SYNDROME	0.00816318	0.40364808132318303
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.00815933	0.40345770880743614
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00815933	0.40345770880743614
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00815933	0.40345770880743614
CATEL-MANZKE SYNDROME; CATMANS	0.00815933	0.40345770880743614
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00815933	0.40345770880743614
NIJMEGEN BREAKAGE SYNDROME	0.00815933	0.40345770880743614
MECKEL SYNDROME, TYPE 6; MKS6	0.00815933	0.40345770880743614
PARIETAL FORAMINA	0.00815933	0.40345770880743614
KYPHOMELIC DYSPLASIA	0.00815933	0.40345770880743614
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00815933	0.40345770880743614
MECKEL SYNDROME, TYPE 5	0.00815933	0.40345770880743614
HOLZGREVE SYNDROME	0.00815933	0.40345770880743614
CULLER-JONES SYNDROME; CJS	0.00815933	0.40345770880743614
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00815933	0.40345770880743614
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00815933	0.40345770880743614
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00815933	0.40345770880743614
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00815933	0.40345770880743614
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00815933	0.40345770880743614
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00815933	0.40345770880743614
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00815933	0.40345770880743614
GENITOPALATOCARDIAC SYNDROME	0.00815933	0.40345770880743614
AICARDI SYNDROME	0.00815933	0.40345770880743614
VAN DER WOUDE SYNDROME	0.00815933	0.40345770880743614
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00815933	0.40345770880743614
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00815933	0.40345770880743614
THORACOABDOMINAL SYNDROME	0.00815933	0.40345770880743614
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00815933	0.40345770880743614
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00815414	0.4032010767667281
PACHYONYCHIA CONGENITA	0.00815414	0.4032010767667281
HIDROTIC ECTODERMAL DYSPLASIA	0.00815414	0.4032010767667281
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008137479999999999	0.4023772829713145
SCLEROSTEOSIS 1; SOST1	0.00812085	0.4015549725981016
9P13 MICRODELETION SYNDROME	0.00809961	0.4005047096800593
JUNG SYNDROME	0.00809961	0.4005047096800593
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.008077599999999999	0.39941637225886756
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00806097	0.3985940618856547
OKAMOTO SYNDROME	0.00804685	0.3978958645032273
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00803973	0.3975437989676124
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00803973	0.3975437989676124
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00803973	0.3975437989676124
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00799935	0.3955471126855715
DEAFNESS-CRANIOFACIAL SYNDROME	0.00798659	0.3949161637762392
ABRUZZO-ERICKSON SYNDROME	0.00798151	0.39466497095026676
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00798151	0.39466497095026676
BRANCHIOOTIC SYNDROME	0.00798151	0.39466497095026676
CHROMOSOME 1P35 DELETION SYNDROME	0.007967710000000001	0.3939825967379794
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00795998	0.393600368284285
DRAVET SYNDROME	0.00795998	0.393600368284285
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00795998	0.393600368284285
NIEMANN-PICK DISEASE TYPE C	0.00795998	0.393600368284285
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00795998	0.393600368284285
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007954020000000001	0.3933056617404277
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.007954020000000001	0.3933056617404277
HALLERMANN-STREIFF SYNDROME; HSS	0.00794002	0.3926133980468028
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00794002	0.3926133980468028
HUNTER-MACDONALD SYNDROME	0.00792308	0.3917757589775167
CODAS SYNDROME	0.00792308	0.3917757589775167
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00791302	0.3912783180662406
PIERPONT SYNDROME	0.007907830000000001	0.39102168602553256
OTOPALATODIGITAL SYNDROME TYPE 1	0.00789964	0.39061671176476187
OPITZ G/BBB SYNDROME	0.007885950000000001	0.38993977676721026
6Q25 MICRODELETION SYNDROME	0.007885950000000001	0.38993977676721026
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00785562	0.38844003692237866
RUBINSTEIN-TAYBI SYNDROME	0.00784121	0.3877274997920119
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.007827	0.3870248521429827
HENNEKAM SYNDROME	0.00780813	0.3860917795787897
AICARDI-GOUTIERES SYNDROME 7	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.007806840000000001	0.38602799242416286
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.007806840000000001	0.38602799242416286
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.007806840000000001	0.38602799242416286
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.007806840000000001	0.38602799242416286
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.007806840000000001	0.38602799242416286
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.007806840000000001	0.38602799242416286
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.007806840000000001	0.38602799242416286
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.007806840000000001	0.38602799242416286
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0077962199999999995	0.3855028609651417
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0077962199999999995	0.3855028609651417
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0077962199999999995	0.3855028609651417
WILLIAMS SYNDROME	0.00777874	0.3846385202962444
RICHARDS-RUNDLE SYNDROME; RRNS	0.00776055	0.38373907196859897
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00773779	0.3826136489923917
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00773255	0.38235454458134926
HSD10 DISEASE	0.00773255	0.38235454458134926
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00771886	0.38167760958379754
POPOV-CHANG SYNDROME; POPCHAS	0.00769992	0.38074107570113647
BETA-THALASSEMIA MAJOR	0.00769029	0.38026489717473594
BUSCHKE-OLLENDORFF SYNDROME	0.00769029	0.38026489717473594
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00769029	0.38026489717473594
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00769029	0.38026489717473594
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00769029	0.38026489717473594
FUCOSIDOSIS	0.00769029	0.38026489717473594
JUVENILE PAGET DISEASE	0.00769029	0.38026489717473594
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00765242	0.37839232388348065
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00765242	0.37839232388348065
ALG11-CDG	0.00765242	0.37839232388348065
PLAGUE	0.00765242	0.37839232388348065
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00765242	0.37839232388348065
XFE PROGEROID SYNDROME; XFEPS	0.00765242	0.37839232388348065
FONTAINE PROGEROID SYNDROME; FPS	0.00764854	0.3782004679455332
BRESEK SYNDROME	0.00764533	0.3780417417700664
ALPORT SYNDROME	0.00763873	0.377715388885929
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00763873	0.377715388885929
SHEEHAN SYNDROME	0.00763873	0.377715388885929
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00763873	0.377715388885929
48,XYYY SYNDROME	0.00763322	0.37744293367508086
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00763322	0.37744293367508086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00763322	0.37744293367508086
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00763322	0.37744293367508086
RENPENNING SYNDROME	0.007631639999999999	0.37736480677251466
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0075732099999999995	0.3744755947997646
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00752507	0.3720951966418289
TRISOMY 17P	0.00749995	0.37085307778583915
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00748626	0.37017614278828737
OROFACIODIGITAL SYNDROME TYPE 6	0.0074668700000000005	0.369217357572617
BALLER-GEROLD SYNDROME	0.0074668700000000005	0.369217357572617
LARSEN-LIKE SYNDROME	0.0074668700000000005	0.369217357572617
LARSEN SYNDROME	0.0074668700000000005	0.369217357572617
RING CHROMOSOME 13 SYNDROME	0.0074582599999999995	0.3687916154010376
FRONTONASAL DYSPLASIA 2; FND2	0.0074582599999999995	0.3687916154010376
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00741933	0.36686662785869373
CROUZON DISEASE	0.0074084400000000005	0.36632814559986693
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00739927	0.3658747128805427
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00739274	0.36555182131487335
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00739274	0.36555182131487335
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00739274	0.36555182131487335
MUENKE SYNDROME	0.007380330000000001	0.36493817899788167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00737905	0.36487488631732157
MEND SYNDROME	0.00735184	0.363529422381355
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00734725	0.36330245878465944
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0072661900000000005	0.35929425199857157
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0072394	0.3579695559734137
20Q11.2 MICRODUPLICATION SYNDROME	0.0072394	0.3579695559734137
HYPERTRYPTOPHANEMIA; HYPTRP	0.00723222	0.35761452359339746
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0071919	0.3556208041557579
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00717923	0.3549943055130274
NON-DISTAL MONOSOMY 10Q	0.00717923	0.3549943055130274
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00716196	0.35414034879953443
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00716196	0.35414034879953443
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00716196	0.35414034879953443
FOIX-CHAVANY-MARIE SYNDROME	0.0071461400000000005	0.3533580908257384
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00712409	0.3522677755082792
ZELLWEGER SYNDROME	0.00711804	0.35196861869781987
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00705946	0.34907198961406677
MACHADO-JOSEPH DISEASE; MJD	0.00705946	0.34907198961406677
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00705816	0.349007707985373
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.007019640000000001	0.34710299387977095
NARP SYNDROME	0.00701196	0.346723237796411
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00701196	0.346723237796411
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00701196	0.346723237796411
DEMENTIA, FAMILIAL DANISH	0.00701196	0.346723237796411
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00701196	0.346723237796411
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00701196	0.346723237796411
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00701196	0.346723237796411
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00699827	0.34604630279885923
MYOPATHY AND DIABETES MELLITUS	0.00699827	0.34604630279885923
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.0069649	0.3443962428376977
MONOSOMY 22Q13.3	0.0069518	0.3437484818100916
19P13.3 MICRODUPLICATION SYNDROME	0.00692493	0.3424198299923987
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00691052	0.341707292862032
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0068665	0.33953061801964873
TRISOMY 5P	0.0068644100000000005	0.33942727293967184
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0068384000000000006	0.3381411458917303
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0068384000000000006	0.3381411458917303
CRANIODIAPHYSEAL DYSPLASIA	0.00681901	0.33718236067605983
HENNEKAM-BEEMER SYNDROME	0.00681901	0.33718236067605983
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00681901	0.33718236067605983
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006819	0.337181866201993
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.006819	0.337181866201993
DYSOSTEOSCLEROSIS	0.006816910000000001	0.33707852112201614
ISOLATED KLIPPEL-FEIL SYNDROME	0.00679047	0.33577113168919887
PRIMARY CILIARY DYSKINESIA	0.00675913	0.3342214499636129
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.3328819197164488
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.3328819197164488
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00671835	0.3322049847188971
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00671835	0.3322049847188971
COWCHOCK SYNDROME; COWCK	0.00667085	0.32985623290124133
AL KAISSI SYNDROME; ALKAS	0.006663570000000001	0.32949625578055647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.006663570000000001	0.32949625578055647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.006663570000000001	0.32949625578055647
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00665942	0.3292910490428033
PHAVER SYNDROME	0.00665942	0.3292910490428033
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00665942	0.3292910490428033
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00665942	0.3292910490428033
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00665942	0.3292910490428033
DUANE RETRACTION SYNDROME	0.0066567300000000005	0.329158035518814
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.0066441	0.328533514772351
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0066441	0.328533514772351
HYPERPROLINEMIA, TYPE I	0.0066441	0.328533514772351
ADENYLOSUCCINASE DEFICIENCY	0.0066441	0.328533514772351
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.0066441	0.328533514772351
CK SYNDROME	0.0066441	0.328533514772351
11P15.4 MICRODUPLICATION SYNDROME	0.0066441	0.328533514772351
FRAXE INTELLECTUAL DISABILITY	0.0066441	0.328533514772351
1P21.3 MICRODELETION SYNDROME	0.0066441	0.328533514772351
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.0066441	0.328533514772351
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0066441	0.328533514772351
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0066441	0.328533514772351
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0066441	0.328533514772351
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0066441	0.328533514772351
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0066441	0.328533514772351
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0066441	0.328533514772351
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.0066441	0.328533514772351
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00663733	0.3281987558290767
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00662364	0.3275218208315249
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00661054	0.3268740598039188
PONTINE TEGMENTAL CAP DYSPLASIA	0.00656521	0.3246326088587749
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00654439	0.32360311385154134
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00654439	0.32360311385154134
DUPLICATION/INVERSION 15Q11	0.00654439	0.32360311385154134
ALG13-CDG	0.00654352	0.3235600946077233
NAXOS DISEASE	0.00653595	0.32318577773909896
PALLISTER-HALL SYNDROME	0.00653595	0.32318577773909896
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.00653595	0.32318577773909896
ELLIS-VAN CREVELD SYNDROME	0.00653595	0.32318577773909896
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00653595	0.32318577773909896
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00653595	0.32318577773909896
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00653595	0.32318577773909896
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0065108300000000004	0.3219436588831092
DIAMOND-BLACKFAN ANEMIA 10	0.00647775	0.32030793866988705
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00647775	0.32030793866988705
CEREBROCOSTOMANDIBULAR SYNDROME	0.00647775	0.32030793866988705
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.00646914	0.31988219649830774
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00646914	0.31988219649830774
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.006450260000000001	0.318948629460048
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.006450260000000001	0.318948629460048
HALL-RIGGS SYNDROME	0.006450260000000001	0.318948629460048
NOONAN SYNDROME 7; NS7	0.0064438099999999995	0.31862969368691363
NON-DISTAL TRISOMY 10Q	0.0064438099999999995	0.31862969368691363
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.006423470000000001	0.31762393343489015
RHYNS SYNDROME; RHYNS	0.00641932	0.317418726697137
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00640926	0.3169212857858609
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.006382189999999999	0.3155827444868305
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.31506997487948124
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.3143930398819295
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00635813	0.3143930398819295
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00635813	0.3143930398819295
RAMON SYNDROME	0.00635813	0.3143930398819295
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0063237599999999995	0.3126935325140805
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0063237599999999995	0.3126935325140805
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0063237599999999995	0.3126935325140805
HYPERTELORISM, TEEBI TYPE; TBHS	0.0063237599999999995	0.3126935325140805
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0063237599999999995	0.3126935325140805
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0063237599999999995	0.3126935325140805
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.006322309999999999	0.3126218337743836
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00630955	0.3119908848650513
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00630429	0.31173079150587507
JOUBERT SYNDROME 1	0.00630429	0.31173079150587507
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.006290670000000001	0.31105731782679147
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00629067	0.31105731782679147
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00629067	0.31105731782679147
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.00629067	0.31105731782679147
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00629067	0.31105731782679147
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.00629067	0.31105731782679147
15Q24 MICRODELETION SYNDROME	0.0062762600000000005	0.3103447806964248
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00626388	0.30973262180163363
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0062638799999999994	0.3097326218016336
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0062638799999999994	0.3097326218016336
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0062638799999999994	0.3097326218016336
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0062638799999999994	0.3097326218016336
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00626257	0.309667845698873
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.006262139999999999	0.3096465833139973
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00625679	0.3093820396882193
FRIED SYNDROME	0.00625679	0.3093820396882193
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00625679	0.3093820396882193
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0062431	0.30870510469066753
CHROMOSOME 2Q37 DELETION SYNDROME	0.0062431	0.30870510469066753
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0062163800000000005	0.3073838699839779
COFFIN-SIRIS SYNDROME 7; CSS7	0.0062163800000000005	0.3073838699839779
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.0062151	0.3073205773034179
RING CHROMOSOME 22 SYNDROME	0.0062151	0.3073205773034179
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.0062151	0.3073205773034179
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0062151	0.3073205773034179
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0062151	0.3073205773034179
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.0062151	0.3073205773034179
ASPARTYLGLUCOSAMINURIA; AGU	0.0062151	0.3073205773034179
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0062151	0.3073205773034179
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0062151	0.3073205773034179
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0062151	0.3073205773034179
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0062151	0.3073205773034179
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0062151	0.3073205773034179
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00620269	0.3067069349864261
FG SYNDROME TYPE 1	0.00620269	0.3067069349864261
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.3052309298968045
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.3052309298968045
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.3052309298968045
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.3052309298968045
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.3052309298968045
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.3052309298968045
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.3052309298968045
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.3052309298968045
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.3052309298968045
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00617284	0.3052309298968045
PRIMARY HYPEROXALURIA TYPE 1	0.00617284	0.3052309298968045
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.3052309298968045
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00617284	0.3052309298968045
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.3052309298968045
IRIDOGONIODYSGENESIS, TYPE 2	0.00617284	0.3052309298968045
TEETH, FUSED	0.00617284	0.3052309298968045
DENS EVAGINATUS	0.00617284	0.3052309298968045
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.3052309298968045
CORNEODERMATOOSSEOUS SYNDROME	0.00617284	0.3052309298968045
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.3052309298968045
BARDET-BIEDL SYNDROME 4; BBS4	0.00617284	0.3052309298968045
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.3052309298968045
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.3052309298968045
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.3052309298968045
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00617284	0.3052309298968045
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.3052309298968045
BANGSTAD SYNDROME	0.00617284	0.3052309298968045
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.3052309298968045
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.3052309298968045
SPLIT LOWER LIP	0.00617284	0.3052309298968045
TOOTH SIZE	0.00617284	0.3052309298968045
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00617284	0.3052309298968045
HYPOPHOSPHATASIA, INFANTILE	0.00617284	0.3052309298968045
17Q21.31 MICRODUPLICATION SYNDROME	0.00617284	0.3052309298968045
ISOLATED HEMIHYPERPLASIA	0.00617284	0.3052309298968045
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.3052309298968045
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00617284	0.3052309298968045
STÜVE-WIEDEMANN SYNDROME	0.00617284	0.3052309298968045
MOLAR I REINCLUSION	0.00617284	0.3052309298968045
HYPOPHOSPHATASIA	0.00617284	0.3052309298968045
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.3052309298968045
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.3052309298968045
JABERI-ELAHI SYNDROME; JABELS	0.00617284	0.3052309298968045
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.3052309298968045
INCISORS, FUSED MANDIBULAR	0.00617284	0.3052309298968045
MOSAIC TRISOMY 14	0.006142089999999999	0.30371042214116417
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.006142089999999999	0.30371042214116417
TEEBI-SHALTOUT SYNDROME; TBSH	0.006142089999999999	0.30371042214116417
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.00613497	0.30335835660554933
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00613497	0.30335835660554933
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00613497	0.30335835660554933
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.00613497	0.30335835660554933
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00613497	0.30335835660554933
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00613497	0.30335835660554933
HELIX SYNDROME; HELIX	0.00613497	0.30335835660554933
PEELING SKIN SYNDROME	0.00613497	0.30335835660554933
TANGIER DISEASE	0.00613497	0.30335835660554933
CONGENITAL LETHAL ERYTHRODERMA	0.00613497	0.30335835660554933
RABSON-MENDENHALL SYNDROME	0.00613497	0.30335835660554933
HURIEZ SYNDROME	0.00613497	0.30335835660554933
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00613497	0.30335835660554933
KERATOSIS PILARIS ATROPHICANS	0.00613497	0.30335835660554933
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00613497	0.30335835660554933
NETHERTON SYNDROME	0.00613497	0.30335835660554933
SPINOCEREBELLAR ATAXIA TYPE 34	0.00613497	0.30335835660554933
DERMATITIS, ATOPIC	0.00613497	0.30335835660554933
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.00613497	0.30335835660554933
ATOPIC KERATOCONJUNCTIVITIS	0.00613497	0.30335835660554933
DERMOODONTODYSPLASIA	0.00613497	0.30335835660554933
COMPLEX REGIONAL PAIN SYNDROME	0.00613497	0.30335835660554933
CRANIOECTODERMAL DYSPLASIA 3	0.00613497	0.30335835660554933
TOOTH AGENESIS, SELECTIVE, 4	0.00613497	0.30335835660554933
257960 OCULOTRICHODYSPLASIA; OTD	0.00613497	0.30335835660554933
IMMUNODEFICIENCY 55; IMD55	0.00613497	0.30335835660554933
XERODERMA PIGMENTOSUM VARIANT	0.00613497	0.30335835660554933
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.00613497	0.30335835660554933
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00613497	0.30335835660554933
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00613497	0.30335835660554933
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.00613497	0.30335835660554933
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.00613497	0.30335835660554933
ACUTE ADRENAL INSUFFICIENCY	0.00613497	0.30335835660554933
AICARDI-GOUTIERES SYNDROME 5	0.00613497	0.30335835660554933
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00613497	0.30335835660554933
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00613497	0.30335835660554933
SJÖGREN-LARSSON SYNDROME	0.00613497	0.30335835660554933
BLAU SYNDROME	0.00613497	0.30335835660554933
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00613497	0.30335835660554933
ADDISON DISEASE	0.00613497	0.30335835660554933
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00613497	0.30335835660554933
ORAL EROSIVE LICHEN	0.00613497	0.30335835660554933
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00613497	0.30335835660554933
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00613497	0.30335835660554933
TANGIER DISEASE; TGD	0.00613497	0.30335835660554933
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00613497	0.30335835660554933
ACQUIRED ICHTHYOSIS	0.00613497	0.30335835660554933
OCULOCEREBROCUTANEOUS SYNDROME	0.00612788	0.303007774492135
PARC SYNDROME	0.00612788	0.303007774492135
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006109	0.3020742074538752
TARP SYNDROME	0.00609459	0.30136167032350847
SWEENEY-COX SYNDROME; SWCOS	0.00609459	0.30136167032350847
THYMOMA	0.00606945	0.30011856251938496
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00606945	0.30011856251938496
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00606945	0.30011856251938496
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00605057	0.29918499548112515
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00605057	0.29918499548112515
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0060361600000000005	0.2984724583507585
MICROTRIPLICATION 11Q24.1	0.00603471	0.2984007596110616
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00602247	0.2977955233532067
BIOTINIDASE DEFICIENCY	0.00602195	0.2977698107017292
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00602195	0.2977698107017292
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00602195	0.2977698107017292
DYSKERATOSIS CONGENITA	0.00602195	0.2977698107017292
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00602195	0.2977698107017292
KEUTEL SYNDROME	0.00602195	0.2977698107017292
PILI TORTI	0.00602195	0.2977698107017292
KID SYNDROME	0.00600826	0.2970928757041775
JOHANSON-BLIZZARD SYNDROME	0.00600826	0.2970928757041775
BJÖRNSTAD SYNDROME	0.00600826	0.2970928757041775
MOYNAHAN SYNDROME	0.00600826	0.2970928757041775
WOODHOUSE-SAKATI SYNDROME	0.00600826	0.2970928757041775
CHANARIN-DORFMAN SYNDROME	0.00600826	0.2970928757041775
RELAPSING POLYCHONDRITIS	0.00600826	0.2970928757041775
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00600826	0.2970928757041775
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00600826	0.2970928757041775
X-LINKED AGAMMAGLOBULINEMIA	0.00600826	0.2970928757041775
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00600826	0.2970928757041775
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00600826	0.2970928757041775
2Q31.1 MICRODELETION SYNDROME	0.0059825	0.2958191105079077
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0059825	0.2958191105079077
OTOPALATODIGITAL SYNDROME TYPE 2	0.005934999999999999	0.2934703586902519
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005934999999999999	0.2934703586902519
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00593372	0.29340706600969196
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00593372	0.29340706600969196
14Q22Q23 MICRODELETION SYNDROME	0.005876569999999999	0.2905811467175019
CENANI-LENZ SYNDROME	0.005876569999999999	0.2905811467175019
ALEXANDER DISEASE	0.00587529	0.2905178540369419
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00587529	0.2905178540369419
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00587529	0.2905178540369419
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00587529	0.2905178540369419
NOONAN SYNDROME 11; NS11	0.00586288	0.2899042117199502
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00584349	0.2889454265042798
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00584349	0.2889454265042798
CROUZON SYNDROME	0.00584349	0.2889454265042798
MARSHALL-SMITH SYNDROME	0.00584349	0.2889454265042798
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00584349	0.2889454265042798
DYSOSTEOSCLEROSIS	0.00582779	0.28816910221928616
ATYPICAL RETT SYNDROME	0.00582779	0.28816910221928616
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00582779	0.28816910221928616
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00582779	0.28816910221928616
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00582779	0.28816910221928616
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00582779	0.28816910221928616
GAUCHER DISEASE	0.00582779	0.28816910221928616
CANAVAN DISEASE	0.00582779	0.28816910221928616
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00582779	0.28816910221928616
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00582779	0.28816910221928616
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0058141	0.2874921672217345
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0058141	0.2874921672217345
NORRIE DISEASE	0.0058141	0.2874921672217345
TRIPLE A SYNDROME	0.0058141	0.2874921672217345
MUCOPOLYSACCHARIDOSIS TYPE 1	0.0058141	0.2874921672217345
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057284599999999995	0.2832574913130178
FANCONI ANEMIA	0.0056949	0.2815980363445857
CHIME SYNDROME	0.005694899999999999	0.28159803634458563
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005694899999999999	0.28159803634458563
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.005694899999999999	0.28159803634458563
LAMB-SHAFFER SYNDROME	0.00567445	0.2805868368778265
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00567445	0.2805868368778265
CLASSICAL EHLERS-DANLOS SYNDROME	0.00561428	0.27761158641744027
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.0055544	0.27465067570499335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0055544	0.27465067570499335
SPINOCEREBELLAR ATAXIA TYPE 29	0.0055544	0.27465067570499335
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0055544	0.27465067570499335
DYSTONIA 16; DYT16	0.0055544	0.27465067570499335
HYPERLYSINEMIA, TYPE I	0.0055544	0.27465067570499335
DUCHENNE MUSCULAR DYSTROPHY	0.0055544	0.27465067570499335
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.0055544	0.27465067570499335
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0055544	0.27465067570499335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0055544	0.27465067570499335
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0055544	0.27465067570499335
PERRY SYNDROME	0.00549451	0.2716892705184796
AREGENERATIVE ANEMIA	0.00549451	0.2716892705184796
SEMANTIC DEMENTIA	0.00549451	0.2716892705184796
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.00549451	0.2716892705184796
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.00549451	0.2716892705184796
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00549451	0.2716892705184796
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00549451	0.2716892705184796
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00549451	0.2716892705184796
HUNTINGTON DISEASE-LIKE 2	0.00549451	0.2716892705184796
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00549451	0.2716892705184796
WAISMAN SYNDROME; WSMN	0.00549451	0.2716892705184796
MAST SYNDROME	0.00549451	0.2716892705184796
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00549451	0.2716892705184796
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00549451	0.2716892705184796
HUNTINGTON DISEASE; HD	0.00549451	0.2716892705184796
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00549451	0.2716892705184796
PRESENILE DEMENTIA, KRAEPELIN TYPE	0.00549451	0.2716892705184796
GAUCHER DISEASE TYPE 3	0.00549451	0.2716892705184796
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.00549451	0.2716892705184796
AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	0.00549451	0.2716892705184796
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.00549451	0.2716892705184796
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00549451	0.2716892705184796
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00549451	0.2716892705184796
GANGLIOCYTOMA	0.00549451	0.2716892705184796
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00549451	0.2716892705184796
NIEMANN-PICK DISEASE, TYPE C2	0.00549451	0.2716892705184796
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.00549451	0.2716892705184796
SPINOCEREBELLAR ATAXIA TYPE 2	0.00549451	0.2716892705184796
LEBER OPTIC ATROPHY AND DYSTONIA	0.00549451	0.2716892705184796
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00549451	0.2716892705184796
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00549451	0.2716892705184796
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00549451	0.2716892705184796
ACERULOPLASMINEMIA	0.00549451	0.2716892705184796
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.00549451	0.2716892705184796
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00549451	0.2716892705184796
HYDROCEPHALUS, NORMAL-PRESSURE	0.00549451	0.2716892705184796
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00549451	0.2716892705184796
PARKINSON DISEASE, LATE-ONSET; PD	0.00549451	0.2716892705184796
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00549451	0.2716892705184796
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.00549451	0.2716892705184796
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.00549451	0.2716892705184796
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.00549451	0.2716892705184796
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.00549451	0.2716892705184796
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00549451	0.2716892705184796
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00549451	0.2716892705184796
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.00549451	0.2716892705184796
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00549451	0.2716892705184796
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00549451	0.2716892705184796
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00549451	0.2716892705184796
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00549451	0.2716892705184796
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00549451	0.2716892705184796
DEMENTIA, LEWY BODY; DLB	0.00549451	0.2716892705184796
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00549451	0.2716892705184796
PRIMARY DYSTONIA, DYT4 TYPE	0.00549451	0.2716892705184796
KUFOR-RAKEB SYNDROME	0.00549451	0.2716892705184796
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00549451	0.2716892705184796
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00549451	0.2716892705184796
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00549451	0.2716892705184796
UNVERRICHT-LUNDBORG DISEASE	0.00549451	0.2716892705184796
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00549451	0.2716892705184796
MEGALOBLASTIC ANEMIA 1	0.00549451	0.2716892705184796
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00549451	0.2716892705184796
WILSON DISEASE	0.00549451	0.2716892705184796
AMYLOIDOSIS VI	0.00549451	0.2716892705184796
ALZHEIMER DISEASE 2	0.00549451	0.2716892705184796
ALZHEIMER DISEASE	0.00549451	0.2716892705184796
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00549451	0.2716892705184796
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00549451	0.2716892705184796
GM2-GANGLIOSIDOSIS, AB VARIANT	0.00549451	0.2716892705184796
EARLY-ONSET ALZHEIMER DISEASE WITH CEREBRAL AMYLOID ANGIOPATHY	0.00549451	0.2716892705184796
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00549451	0.2716892705184796
SPINOCEREBELLAR ATAXIA 12	0.00549451	0.2716892705184796
LAFORA DISEASE	0.00549451	0.2716892705184796
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.00549451	0.2716892705184796
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.00549451	0.2716892705184796
JUVENILE HUNTINGTON DISEASE	0.00549451	0.2716892705184796
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.005493619999999999	0.2716452623265277
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.005493619999999999	0.2716452623265277
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005461140000000001	0.27003921055731805
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005461140000000001	0.27003921055731805
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.005461140000000001	0.27003921055731805
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005461140000000001	0.27003921055731805
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005461140000000001	0.27003921055731805
SECKEL SYNDROME	0.00545469	0.2697202747841837
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00543435	0.2687145145321602
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00543435	0.2687145145321602
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005401260000000001	0.2670782998448712
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00538685	0.26636576271450446
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00538685	0.26636576271450446
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00538685	0.26636576271450446
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00537316	0.2656888277169527
COG5-CDG	0.00537316	0.2656888277169527
HELSMOORTEL-VAN DER AA SYNDROME	0.00533464	0.26378411361135057
SCARF SYNDROME	0.00533464	0.26378411361135057
GOLDBERG-SHPRINTZEN SYNDROME	0.00533464	0.26378411361135057
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00533319	0.2637124148716537
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00527476	0.26082320289890365
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00527476	0.26082320289890365
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00527302	0.26073716441126743
ISOTRETINOIN SYNDROME	0.00527302	0.26073716441126743
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00527302	0.26073716441126743
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00521459	0.25784795243851744
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00521459	0.25784795243851744
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00521459	0.25784795243851744
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.00521459	0.25784795243851744
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00521459	0.25784795243851744
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00521459	0.25784795243851744
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00516709	0.2554992006208617
DISTAL TRISOMY 14Q	0.00516709	0.2554992006208617
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00516709	0.2554992006208617
CYCLIC VOMITING SYNDROME	0.00516709	0.2554992006208617
COWDEN SYNDROME	0.00516709	0.2554992006208617
CONGENITAL TOXOPLASMOSIS	0.00516709	0.2554992006208617
THANATOPHORIC DYSPLASIA TYPE 2	0.00516709	0.2554992006208617
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00516709	0.2554992006208617
BARDET-BIEDL SYNDROME 16; BBS16	0.00516709	0.2554992006208617
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0051534	0.25482226562330995
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.0051534	0.25482226562330995
USHER SYNDROME	0.0051534	0.25482226562330995
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0051534	0.25482226562330995
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0051534	0.25482226562330995
SUSAC SYNDROME	0.0051534	0.25482226562330995
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0051534	0.25482226562330995
MERRF	0.0051534	0.25482226562330995
VOGT-KOYANAGI-HARADA DISEASE	0.0051534	0.25482226562330995
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.0051534	0.25482226562330995
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.0051534	0.25482226562330995
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00511988	0.25316478855114527
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00510547	0.25245225142077854
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00510547	0.25245225142077854
ALLAN-HERNDON-DUDLEY SYNDROME	0.00506145	0.2502755765783953
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.00506145	0.2502755765783953
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00506145	0.2502755765783953
COFFIN-SIRIS SYNDROME 5	0.00506145	0.2502755765783953
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00506145	0.2502755765783953
HADZISELIMOVIC SYNDROME	0.00506145	0.2502755765783953
OHDO SYNDROME	0.00504704	0.24956303944802852
DEAFNESS, X-LINKED 7; DFNX7	0.00504704	0.24956303944802852
EMANUEL SYNDROME	0.00504559	0.24949134070833168
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0050139500000000005	0.24792682476073952
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0050139500000000005	0.24792682476073952
TRANSKETOLASE DEFICIENCY	0.0050139500000000005	0.24792682476073952
YOU-HOOVER-FONG SYNDROME; YHFS	0.0050139500000000005	0.24792682476073952
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0050139500000000005	0.24792682476073952
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0050139500000000005	0.24792682476073952
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0050139500000000005	0.24792682476073952
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0050139500000000005	0.24792682476073952
OPTIC ATROPHY 11; OPA11	0.0050139500000000005	0.24792682476073952
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00500026	0.24724988976318776
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00500026	0.24724988976318776
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00500026	0.24724988976318776
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00500026	0.24724988976318776
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00500026	0.24724988976318776
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00500026	0.24724988976318776
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00500026	0.24724988976318776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00500026	0.24724988976318776
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00500026	0.24724988976318776
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00500026	0.24724988976318776
CAREY-FINEMAN-ZITER SYNDROME	0.00499338	0.24690969160517784
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00499338	0.24690969160517784
AU-KLINE SYNDROME; AUKS	0.00499338	0.24690969160517784
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00498716	0.24660212873558163
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00497347	0.24592519373802987
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00494588	0.24456093978752202
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00493219	0.24388400478997033
MESOMELIA-SYNOSTOSES SYNDROME	0.00488745	0.24167172781477203
LATHOSTEROLOSIS	0.00488745	0.24167172781477203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00485852	0.24024121433930293
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00485852	0.24024121433930293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00485852	0.24024121433930293
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00485852	0.24024121433930293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.00485852	0.24024121433930293
49,XXXYY SYNDROME	0.00485852	0.24024121433930293
CHROMOSOME 9P DELETION SYNDROME	0.00485852	0.24024121433930293
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00485852	0.24024121433930293
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00485437	0.2400360076015499
PARAGANGLIOMAS 1	0.00485437	0.2400360076015499
OTOSCLEROSIS	0.00485437	0.2400360076015499
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.2400360076015499
ACHONDROPLASIA	0.00485437	0.2400360076015499
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.2400360076015499
NON-FUNCTIONING PARAGANGLIOMA	0.00485437	0.2400360076015499
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00485437	0.2400360076015499
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00485437	0.2400360076015499
OTOFACIOCERVICAL SYNDROME	0.00485437	0.2400360076015499
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00485437	0.2400360076015499
COOPER-JABS SYNDROME	0.00485437	0.2400360076015499
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.2400360076015499
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00485437	0.2400360076015499
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00485437	0.2400360076015499
2Q37 MICRODELETION SYNDROME	0.00485437	0.2400360076015499
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.2400360076015499
TURNPENNY-FRY SYNDROME; TPFS	0.00485437	0.2400360076015499
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.2400360076015499
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.2400360076015499
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.2400360076015499
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00485437	0.2400360076015499
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00485437	0.2400360076015499
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.2400360076015499
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.2400360076015499
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00485437	0.2400360076015499
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00485437	0.2400360076015499
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00485437	0.2400360076015499
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00485437	0.2400360076015499
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.2400360076015499
MULTIPLE SYNOSTOSES SYNDROME	0.00485437	0.2400360076015499
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00485437	0.2400360076015499
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004826260000000001	0.23864604099956455
RING CHROMOSOME 10 SYNDROME	0.0047588100000000005	0.23531081341849336
MAN1B1-CDG	0.0047588100000000005	0.23531081341849336
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0047588100000000005	0.23531081341849336
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0047588100000000005	0.23531081341849336
FRANK-TER HAAR SYNDROME	0.0047588100000000005	0.23531081341849336
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0047588100000000005	0.23531081341849336
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0047588100000000005	0.23531081341849336
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0047588100000000005	0.23531081341849336
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.0047588100000000005	0.23531081341849336
MONOSOMY 5P	0.0047588100000000005	0.23531081341849336
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0047588100000000005	0.23531081341849336
COG1-CDG	0.0047588100000000005	0.23531081341849336
20P12.3 MICRODELETION SYNDROME	0.0047588100000000005	0.23531081341849336
HEREDITARY OROTIC ACIDURIA	0.0047588100000000005	0.23531081341849336
CRANIOFACIAL DYSSYNOSTOSIS	0.0047588100000000005	0.23531081341849336
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0047588100000000005	0.23531081341849336
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0047588100000000005	0.23531081341849336
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.0047588100000000005	0.23531081341849336
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00473934	0.2343480724102879
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.00473934	0.2343480724102879
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00473934	0.2343480724102879
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00473934	0.2343480724102879
SPINOCEREBELLAR ATAXIA TYPE 10	0.00473934	0.2343480724102879
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.2343480724102879
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00473934	0.2343480724102879
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00473934	0.2343480724102879
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.00473934	0.2343480724102879
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.00473934	0.2343480724102879
16P13.11 MICRODUPLICATION SYNDROME	0.00473934	0.2343480724102879
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00473934	0.2343480724102879
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00473934	0.2343480724102879
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00473934	0.2343480724102879
BRUNNER SYNDROME; BRNRS	0.00473934	0.2343480724102879
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00473934	0.2343480724102879
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00473934	0.2343480724102879
JAWAD SYNDROME	0.00473934	0.2343480724102879
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	0.2343480724102879
MENTAL RETARDATION, X-LINKED 99	0.00473934	0.2343480724102879
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00473934	0.2343480724102879
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00473934	0.2343480724102879
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.2343480724102879
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.00473934	0.2343480724102879
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00473934	0.2343480724102879
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00473934	0.2343480724102879
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00473934	0.2343480724102879
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00473934	0.2343480724102879
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00473934	0.2343480724102879
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.2343480724102879
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00473934	0.2343480724102879
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00473934	0.2343480724102879
WILSON DISEASE	0.00473934	0.2343480724102879
GLYCINE ENCEPHALOPATHY; GCE	0.00473934	0.2343480724102879
KNIEST DYSPLASIA	0.00470578	0.23268861744185576
MOEBIUS SYNDROME	0.00470578	0.23268861744185576
20Q13.33 MICRODELETION SYNDROME	0.0046989300000000005	0.23234990270604647
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0046989300000000005	0.23234990270604647
20P13 MICRODELETION SYNDROME	0.0046989300000000005	0.23234990270604647
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0046989300000000005	0.23234990270604647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0046989300000000005	0.23234990270604647
SHUKLA-VERNON SYNDROME; SHUVER	0.0046989300000000005	0.23234990270604647
DISTAL TRISOMY 5Q	0.0046989300000000005	0.23234990270604647
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0046989300000000005	0.23234990270604647
WRINKLY SKIN SYNDROME	0.0046989300000000005	0.23234990270604647
CDAGS SYNDROME	0.00469209	0.23201168244430403
KALLMANN SYNDROME	0.00469209	0.23201168244430403
DISTAL MONOSOMY 13Q	0.0046387600000000005	0.2293746522456602
TRISOMY X	0.0046387600000000005	0.2293746522456602
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00457714	0.2263277030455771
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00457714	0.2263277030455771
TARP SYNDROME; TARPS	0.00457714	0.2263277030455771
FACIOCARDIORENAL SYNDROME	0.00457714	0.2263277030455771
STROMME SYNDROME; STROMS	0.00457714	0.2263277030455771
TRISOMY 12P	0.00457714	0.2263277030455771
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00457714	0.2263277030455771
MONOSOMY 13Q14	0.0045187100000000004	0.22343849107282704
PFEIFFER SYNDROME	0.0045187100000000004	0.22343849107282704
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00451726	0.2233667923331302
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.00451726	0.2233667923331302
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0045045	0.22273584342379782
CUTANEOUS MASTOCYTOSIS	0.0045045	0.22273584342379782
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0045045	0.22273584342379782
CHRONIC GRAFT VERSUS HOST DISEASE	0.0045045	0.22273584342379782
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.22273584342379782
ALOPECIA, ANDROGENETIC, 1	0.0045045	0.22273584342379782
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0045045	0.22273584342379782
ADAMS-OLIVER SYNDROME	0.0045045	0.22273584342379782
KERION CELSI	0.0045045	0.22273584342379782
MARIE UNNA HEREDITARY HYPOTRICHOSIS	0.0045045	0.22273584342379782
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0045045	0.22273584342379782
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0045045	0.22273584342379782
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0045045	0.22273584342379782
PORPHYRIA CUTANEA TARDA	0.0045045	0.22273584342379782
SARCOIDOSIS	0.0045045	0.22273584342379782
HYPOTRICHOSIS SIMPLEX	0.0045045	0.22273584342379782
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0045045	0.22273584342379782
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0045045	0.22273584342379782
ATYPICAL WERNER SYNDROME	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0045045	0.22273584342379782
LICHEN PLANOPILARIS	0.0045045	0.22273584342379782
HYPOGONADISM, PRIMARY, AND PARTIAL ALOPECIA	0.0045045	0.22273584342379782
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.0045045	0.22273584342379782
LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA	0.0045045	0.22273584342379782
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.0045045	0.22273584342379782
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0045045	0.22273584342379782
HEMOCHROMATOSIS, TYPE 1	0.0045045	0.22273584342379782
THUMB DEFORMITY AND ALOPECIA	0.0045045	0.22273584342379782
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0045045	0.22273584342379782
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.0045045	0.22273584342379782
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0045045	0.22273584342379782
MONILETHRIX; MNLIX	0.0045045	0.22273584342379782
KIKUCHI-FUJIMOTO DISEASE	0.0045045	0.22273584342379782
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0045045	0.22273584342379782
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0045045	0.22273584342379782
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0045045	0.22273584342379782
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.0045045	0.22273584342379782
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0045045	0.22273584342379782
GRAHAM LITTLE-PICCARDI-LASSUEUR SYNDROME	0.0045045	0.22273584342379782
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0045045	0.22273584342379782
MIXED CONNECTIVE TISSUE DISEASE	0.0045045	0.22273584342379782
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.0045045	0.22273584342379782
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0045045	0.22273584342379782
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.0045045	0.22273584342379782
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0045045	0.22273584342379782
MANDIBULOACRAL DYSPLASIA	0.0045045	0.22273584342379782
T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	0.0045045	0.22273584342379782
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0045045	0.22273584342379782
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0045045	0.22273584342379782
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0045045	0.22273584342379782
COLCHICINE POISONING	0.0045045	0.22273584342379782
BATHING SUIT ICHTHYOSIS	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0045045	0.22273584342379782
ALPHA-HEAVY CHAIN DISEASE	0.0045045	0.22273584342379782
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.22273584342379782
HYPOTRICHOSIS 5; HYPT5	0.0045045	0.22273584342379782
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0045045	0.22273584342379782
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0045045	0.22273584342379782
CENTRIFUGAL LIPODYSTROPHY	0.0045045	0.22273584342379782
TRICHOTILLOMANIA; TTM	0.0045045	0.22273584342379782
PSEUDOPROGERIA SYNDROME	0.0045045	0.22273584342379782
OLIVER-MCFARLANE SYNDROME	0.0045045	0.22273584342379782
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0045045	0.22273584342379782
LINEAR NEVUS SEBACEUS SYNDROME	0.0045045	0.22273584342379782
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.0045045	0.22273584342379782
HALLERMANN-STREIFF SYNDROME	0.0045045	0.22273584342379782
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.0045045	0.22273584342379782
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0045045	0.22273584342379782
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0045045	0.22273584342379782
HYPOTRICHOSIS 11; HYPT11	0.0045045	0.22273584342379782
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0045045	0.22273584342379782
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0045045	0.22273584342379782
ULERYTHEMA OPHRYOGENESIS	0.0045045	0.22273584342379782
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0045045	0.22273584342379782
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0045045	0.22273584342379782
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0045045	0.22273584342379782
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0045045	0.22273584342379782
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0045045	0.22273584342379782
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0045045	0.22273584342379782
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0045045	0.22273584342379782
PSEUDOPELADE OF BROCQ	0.0045045	0.22273584342379782
ALOPECIA, CONGENITAL	0.0045045	0.22273584342379782
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0045045	0.22273584342379782
INSULIN-RESISTANCE SYNDROME TYPE B	0.0045045	0.22273584342379782
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004485620000000001	0.22180227638553804
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004485620000000001	0.22180227638553804
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004485620000000001	0.22180227638553804
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004485620000000001	0.22180227638553804
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004485620000000001	0.22180227638553804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004485620000000001	0.22180227638553804
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.004485620000000001	0.22180227638553804
IMMUNODEFICIENCY 49; IMD49	0.004485620000000001	0.22180227638553804
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004485620000000001	0.22180227638553804
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004485620000000001	0.22180227638553804
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00447121	0.22108973925517122
AXENFELD-RIEGER SYNDROME	0.00447121	0.22108973925517122
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00447121	0.22108973925517122
ACRODYSOSTOSIS	0.00447121	0.22108973925517122
BARBER-SAY SYNDROME	0.00447121	0.22108973925517122
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00445883	0.22047758036038015
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00445883	0.22047758036038015
VERVERI-BRADY SYNDROME; VERBRAS	0.00445883	0.22047758036038015
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00445883	0.22047758036038015
SHASHI-PENA SYNDROME; SHAPNS	0.00445883	0.22047758036038015
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0044575199999999995	0.22041280425761953
STEEL SYNDROME; STLS	0.0044575199999999995	0.22041280425761953
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0044575199999999995	0.22041280425761953
2Q24 MICRODELETION SYNDROME	0.00441755	0.21843639141232057
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00441755	0.21843639141232057
ANTLEY-BIXLER SYNDROME	0.00441755	0.21843639141232057
TRISOMY 1Q	0.00441755	0.21843639141232057
RITSCHER-SCHINZEL SYNDROME 1	0.00441755	0.21843639141232057
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00441133	0.2181288285427244
GENITOPATELLAR SYNDROME	0.00441133	0.2181288285427244
8P23.1 DUPLICATION SYNDROME	0.00441133	0.2181288285427244
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0043976399999999995	0.21745189354517264
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0043976399999999995	0.21745189354517264
NOONAN SYNDROME 9; NS9	0.00435912	0.21554717943957055
JOUBERT SYNDROME 14	0.00435912	0.21554717943957055
PROTEUS SYNDROME	0.00435912	0.21554717943957055
NOONAN SYNDROME 4; NS4	0.00435912	0.21554717943957055
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00435912	0.21554717943957055
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00435912	0.21554717943957055
LEGIUS SYNDROME	0.00435912	0.21554717943957055
NEUROFACIODIGITORENAL SYNDROME	0.00435912	0.21554717943957055
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00435912	0.21554717943957055
NOONAN SYNDROME 2; NS2	0.00435912	0.21554717943957055
NOONAN SYNDROME 5; NS5	0.00435912	0.21554717943957055
FRIAS SYNDROME	0.00435912	0.21554717943957055
NOONAN SYNDROME 8; NS8	0.00435912	0.21554717943957055
NOONAN SYNDROME 10; NS10	0.00435912	0.21554717943957055
MESOMELIA-SYNOSTOSES SYNDROME	0.00435912	0.21554717943957055
COSTELLO SYNDROME; CSTLO	0.00435912	0.21554717943957055
CAT-EYE SYNDROME	0.00431162	0.21319842762191477
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00431162	0.21319842762191477
XP22.13P22.2 DUPLICATION SYNDROME	0.00431162	0.21319842762191477
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00431162	0.21319842762191477
17P11.2 MICRODUPLICATION SYNDROME	0.00431162	0.21319842762191477
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00431162	0.21319842762191477
POTOCKI-LUPSKI SYNDROME	0.00431162	0.21319842762191477
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00431034	0.2131351349413548
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00431034	0.2131351349413548
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.2131351349413548
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.00431034	0.2131351349413548
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00431034	0.2131351349413548
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.2131351349413548
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.2131351349413548
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00431034	0.2131351349413548
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00431034	0.2131351349413548
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00431034	0.2131351349413548
CHÉDIAK-HIGASHI SYNDROME	0.00431034	0.2131351349413548
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00431034	0.2131351349413548
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00431034	0.2131351349413548
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.00431034	0.2131351349413548
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.2131351349413548
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00431034	0.2131351349413548
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00431034	0.2131351349413548
PANDAS	0.00431034	0.2131351349413548
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.2131351349413548
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00431034	0.2131351349413548
WHIPPLE DISEASE	0.00431034	0.2131351349413548
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00431034	0.2131351349413548
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.00431034	0.2131351349413548
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.2131351349413548
OPTIC PATHWAY GLIOMA	0.00431034	0.2131351349413548
SCHINDLER DISEASE, TYPE I	0.00431034	0.2131351349413548
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.2131351349413548
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00431034	0.2131351349413548
COG8-CDG	0.00431034	0.2131351349413548
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.2131351349413548
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00431034	0.2131351349413548
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00431034	0.2131351349413548
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00431034	0.2131351349413548
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00431034	0.2131351349413548
ALPERS-HUTTENLOCHER SYNDROME	0.00431034	0.2131351349413548
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00431034	0.2131351349413548
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00431034	0.2131351349413548
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00431034	0.2131351349413548
CARNOSINASE DEFICIENCY	0.00431034	0.2131351349413548
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00431034	0.2131351349413548
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.2131351349413548
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.2131351349413548
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00431034	0.2131351349413548
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00431034	0.2131351349413548
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00431034	0.2131351349413548
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00431034	0.2131351349413548
AICARDI-GOUTIERES SYNDROME 6	0.00431034	0.2131351349413548
ALEXANDER DISEASE	0.00431034	0.2131351349413548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00431034	0.2131351349413548
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00431034	0.2131351349413548
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00431034	0.2131351349413548
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00431034	0.2131351349413548
RETT SYNDROME, CONGENITAL VARIANT	0.00431034	0.2131351349413548
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00429793	0.212521492624363
DONNAI-BARROW SYNDROME	0.00429793	0.212521492624363
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00429793	0.212521492624363
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00417745	0.20656406906665428
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00417745	0.20656406906665428
MARDEN-WALKER SYNDROME	0.00417745	0.20656406906665428
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00417745	0.20656406906665428
SCHWARTZ-JAMPEL SYNDROME	0.00417745	0.20656406906665428
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00412995	0.2042153172489985
MOSAIC TRISOMY 8	0.00412995	0.2042153172489985
CAMPOMELIC DYSPLASIA	0.00412995	0.2042153172489985
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00412995	0.2042153172489985
CAMPOMELIC DYSPLASIA	0.00412995	0.2042153172489985
CLEIDOCRANIAL DYSPLASIA; CCD	0.00412995	0.2042153172489985
PFEIFFER SYNDROME TYPE 3	0.00412995	0.2042153172489985
DIASTROPHIC DWARFISM	0.00412995	0.2042153172489985
CLEIDOCRANIAL DYSPLASIA	0.00412995	0.2042153172489985
DUPLICATION OF THE PITUITARY GLAND	0.00412995	0.2042153172489985
SIFRIM-HITZ-WEISS SYNDROME	0.00407152	0.2013261052762485
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00407152	0.2013261052762485
CRANIOSYNOSTOSIS 6; CRS6	0.00405783	0.20064917027869675
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0038694000000000003	0.19133179543657305
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0038694000000000003	0.19133179543657305
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0038694000000000003	0.19133179543657305
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0038694000000000003	0.19133179543657305
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0038694000000000003	0.19133179543657305
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0038694000000000003	0.19133179543657305
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0038694000000000003	0.19133179543657305
FILIPPI SYNDROME	0.00376969	0.18640139451576343
NEONATAL MARFAN SYNDROME	0.00376969	0.18640139451576343
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00376969	0.18640139451576343
8P23.1 MICRODELETION SYNDROME	0.00376969	0.18640139451576343
POTOCKI-SHAFFER SYNDROME	0.00376969	0.18640139451576343
JOUBERT SYNDROME 10	0.00376969	0.18640139451576343
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00376969	0.18640139451576343
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00370981	0.18344048380331654
SOTOS SYNDROME 2	0.00370981	0.18344048380331654
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00370981	0.18344048380331654
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00370981	0.18344048380331654
15Q11Q13 MICRODUPLICATION SYNDROME	0.00370981	0.18344048380331654
MAXILLOFACIAL DYSOSTOSIS	0.00370981	0.18344048380331654
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.00370981	0.18344048380331654
MEIER-GORLIN SYNDROME 3; MGORS3	0.00370981	0.18344048380331654
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00370981	0.18344048380331654
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00370981	0.18344048380331654
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00370981	0.18344048380331654
3Q27.3 MICRODELETION SYNDROME	0.00370981	0.18344048380331654
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00370981	0.18344048380331654
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.18046523334293027
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.18046523334293027
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.18046523334293027
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00364964	0.18046523334293027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00364964	0.18046523334293027
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00364964	0.18046523334293027
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00364964	0.18046523334293027
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00364964	0.18046523334293027
BARDET-BIEDL SYNDROME 8; BBS8	0.00364964	0.18046523334293027
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00364964	0.18046523334293027
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.18046523334293027
BARDET-BIEDL SYNDROME 12; BBS12	0.00364964	0.18046523334293027
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00364964	0.18046523334293027
BARDET-BIEDL SYNDROME 17; BBS17	0.00364964	0.18046523334293027
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00364964	0.18046523334293027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.18046523334293027
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.18046523334293027
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00364964	0.18046523334293027
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.00364964	0.18046523334293027
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00364964	0.18046523334293027
ALG2-CDG	0.00364964	0.18046523334293027
ALG9-CDG	0.00364964	0.18046523334293027
ALG12-CDG	0.00364964	0.18046523334293027
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293027
JOUBERT SYNDROME 31; JBTS31	0.00364964	0.18046523334293027
CONGENITAL SHORT BOWEL SYNDROME	0.00364964	0.18046523334293027
MPDU1-CDG	0.00364964	0.18046523334293027
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.18046523334293027
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00364964	0.18046523334293027
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00364964	0.18046523334293027
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00364964	0.18046523334293027
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.18046523334293027
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00364964	0.18046523334293027
DYSTONIA 28, CHILDHOOD-ONSET	0.00364964	0.18046523334293027
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00364964	0.18046523334293027
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00364964	0.18046523334293027
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00364964	0.18046523334293027
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.18046523334293027
EPISODIC ATAXIA TYPE 7	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA 42	0.00364964	0.18046523334293027
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00364964	0.18046523334293027
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00364964	0.18046523334293027
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.18046523334293027
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00364964	0.18046523334293027
GALACTOSEMIA	0.00364964	0.18046523334293027
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00364964	0.18046523334293027
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00364964	0.18046523334293027
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00364964	0.18046523334293027
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00364964	0.18046523334293027
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00364964	0.18046523334293027
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.18046523334293027
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.18046523334293027
DYSTONIA-APHONIA SYNDROME	0.00364964	0.18046523334293027
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.00364964	0.18046523334293027
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.18046523334293027
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00364964	0.18046523334293027
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA TYPE 14	0.00364964	0.18046523334293027
LYSINURIC PROTEIN INTOLERANCE	0.00364964	0.18046523334293027
LEIGH SYNDROME	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA 1	0.00364964	0.18046523334293027
LYMPHANGIOLEIOMYOMATOSIS	0.00364964	0.18046523334293027
ONDINE SYNDROME	0.00364964	0.18046523334293027
MALARIA	0.00364964	0.18046523334293027
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00364964	0.18046523334293027
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.18046523334293027
PRUNE BELLY SYNDROME	0.00364964	0.18046523334293027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00364964	0.18046523334293027
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.18046523334293027
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00364964	0.18046523334293027
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.18046523334293027
PAPILLOMA OF CHOROID PLEXUS	0.00364964	0.18046523334293027
ALPHA-THALASSEMIA	0.00364964	0.18046523334293027
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00364964	0.18046523334293027
REACTIVE ARTHRITIS	0.00364964	0.18046523334293027
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00364964	0.18046523334293027
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00364964	0.18046523334293027
SECKEL SYNDROME 4	0.00364964	0.18046523334293027
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.18046523334293027
DISTAL TRISOMY 18Q	0.00364964	0.18046523334293027
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.18046523334293027
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00364964	0.18046523334293027
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00364964	0.18046523334293027
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00364964	0.18046523334293027
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00364964	0.18046523334293027
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00364964	0.18046523334293027
JOUBERT SYNDROME 4	0.00364964	0.18046523334293027
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00364964	0.18046523334293027
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00364964	0.18046523334293027
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00364964	0.18046523334293027
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.18046523334293027
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.00364964	0.18046523334293027
ATAXIA-TELANGIECTASIA	0.00364964	0.18046523334293027
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00364964	0.18046523334293027
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00364964	0.18046523334293027
BENIGN FAMILIAL NEONATAL EPILEPSY	0.00364964	0.18046523334293027
CRISPONI SYNDROME	0.00364964	0.18046523334293027
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00364964	0.18046523334293027
ISOLATED ECTOPIA LENTIS	0.00364964	0.18046523334293027
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.18046523334293027
FACIOCARDIORENAL SYNDROME	0.00358802	0.17741828414284713
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00358802	0.17741828414284713
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00358802	0.17741828414284713
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00358802	0.17741828414284713
JOUBERT SYNDROME 3; JBTS3	0.00352959	0.1745290721700971
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00352959	0.1745290721700971
608028 THAI SYMPHALANGISM SYNDROME	0.00352959	0.1745290721700971
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00352959	0.1745290721700971
PERLMAN SYNDROME	0.00352959	0.1745290721700971
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00352959	0.1745290721700971
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00352959	0.1745290721700971
17Q12 MICRODUPLICATION SYNDROME	0.00352814	0.17445737343040024
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0034965000000000005	0.1728928574828081
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0034965000000000005	0.1728928574828081
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0034965000000000005	0.1728928574828081
OLIVER SYNDROME	0.0034965000000000005	0.1728928574828081
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0034965000000000005	0.1728928574828081
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0034965000000000005	0.1728928574828081
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.1728928574828081
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0034965000000000005	0.1728928574828081
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.0034965000000000005	0.1728928574828081
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0034965000000000005	0.1728928574828081
JOUBERT SYNDROME 24	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.1728928574828081
PEHO-LIKE SYNDROME; PEHOL	0.0034965000000000005	0.1728928574828081
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0034965000000000005	0.1728928574828081
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0034965000000000005	0.1728928574828081
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0034965000000000005	0.1728928574828081
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0034965000000000005	0.1728928574828081
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.1728928574828081
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0034965000000000005	0.1728928574828081
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0034965000000000005	0.1728928574828081
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0034965000000000005	0.1728928574828081
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.1728928574828081
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0034965000000000005	0.1728928574828081
LISSENCEPHALY 8; LIS8	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0034965000000000005	0.1728928574828081
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0034965000000000005	0.1728928574828081
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0034965000000000005	0.1728928574828081
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0034965000000000005	0.1728928574828081
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0034965000000000005	0.1728928574828081
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0034965000000000005	0.1728928574828081
XQ28 (MECP2) DUPLICATION	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0034965000000000005	0.1728928574828081
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED 103	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.1728928574828081
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0034965000000000005	0.1728928574828081
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0034965000000000005	0.1728928574828081
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034965000000000005	0.1728928574828081
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.1728928574828081
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0034965000000000005	0.1728928574828081
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.1728928574828081
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0034965000000000005	0.1728928574828081
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0034965000000000005	0.1728928574828081
AL-RAQAD SYNDROME; ARS	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0034965000000000005	0.1728928574828081
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0034965000000000005	0.1728928574828081
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.1728928574828081
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0034965000000000005	0.1728928574828081
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0034965000000000005	0.1728928574828081
SCHAAF-YANG SYNDROME; SHFYNG	0.0034965000000000005	0.1728928574828081
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0034965000000000005	0.1728928574828081
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0034965000000000005	0.1728928574828081
COG4-CDG	0.0034965000000000005	0.1728928574828081
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0034965000000000005	0.1728928574828081
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0034965000000000005	0.1728928574828081
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.1728928574828081
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0034965000000000005	0.1728928574828081
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0034965000000000005	0.1728928574828081
ANGELMAN SYNDROME	0.0034965000000000005	0.1728928574828081
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0034965000000000005	0.1728928574828081
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0034965000000000005	0.1728928574828081
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0034965000000000005	0.1728928574828081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0034965000000000005	0.1728928574828081
INFANTILE DYSTONIA-PARKINSONISM	0.0034965000000000005	0.1728928574828081
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.1728928574828081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0034965000000000005	0.1728928574828081
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0034965000000000005	0.1728928574828081
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0034965000000000005	0.1728928574828081
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.1728928574828081
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0034965000000000005	0.1728928574828081
ZIMMERMANN-LABAND SYNDROME 1	0.00348209	0.17218032035244138
PIEBALDISM	0.00348209	0.17218032035244138
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00348209	0.17218032035244138
WAARDENBURG-SHAH SYNDROME	0.00348209	0.17218032035244138
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00348209	0.17218032035244138
FEINGOLD SYNDROME 1; FGLDS1	0.00348209	0.17218032035244138
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00348209	0.17218032035244138
HURLER SYNDROME	0.00348209	0.17218032035244138
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00346971	0.17156816145765022
CHROMOSOME 5Q12 DELETION SYNDROME	0.00346971	0.17156816145765022
WIEACKER-WOLFF SYNDROME	0.00346971	0.17156816145765022
JOUBERT SYNDROME 30; JBTS30	0.00346971	0.17156816145765022
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00346971	0.17156816145765022
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00346971	0.17156816145765022
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00346971	0.17156816145765022
9Q21.13 MICRODELETION SYNDROME	0.00346971	0.17156816145765022
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00346971	0.17156816145765022
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00346971	0.17156816145765022
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00346971	0.17156816145765022
1Q21.1 MICRODELETION SYNDROME	0.0034684	0.17150338535488963
COFS SYNDROME	0.0034684	0.17150338535488963
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.0034684	0.17150338535488963
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0034684	0.17150338535488963
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0034684	0.17150338535488963
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0034684	0.17150338535488963
8Q12 MICRODUPLICATION SYNDROME	0.0034684	0.17150338535488963
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0034684	0.17150338535488963
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0034684	0.17150338535488963
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00342843	0.16952697250959067
MARFAN SYNDROME	0.00342843	0.16952697250959067
LOWRY-MACLEAN SYNDROME	0.00342843	0.16952697250959067
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00342843	0.16952697250959067
SECKEL SYNDROME 1; SCKL1	0.00342843	0.16952697250959067
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00342843	0.16952697250959067
16Q24.3 MICRODELETION SYNDROME	0.00342221	0.1692194096399945
13Q12.3 MICRODELETION SYNDROME	0.00342221	0.1692194096399945
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00342221	0.1692194096399945
SIALIDOSIS TYPE 2	0.00342221	0.1692194096399945
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00342221	0.1692194096399945
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00342221	0.1692194096399945
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00342221	0.1692194096399945
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00342221	0.1692194096399945
GALACTOSE EPIMERASE DEFICIENCY	0.00340852	0.16854247464244274
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00340852	0.16854247464244274
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00340852	0.16854247464244274
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00340852	0.16854247464244274
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00340852	0.16854247464244274
2P15-16.1 MICRODELETION SYNDROME	0.00337	0.16663776053684062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00337	0.16663776053684062
SCARF SYNDROME	0.00337	0.16663776053684062
RUVALCABA SYNDROME	0.00337	0.16663776053684062
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00337	0.16663776053684062
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00337	0.16663776053684062
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00337	0.16663776053684062
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00337	0.16663776053684062
DISTAL TRISOMY 15Q	0.00337	0.16663776053684062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00337	0.16663776053684062
PROTEUS SYNDROME	0.00337	0.16663776053684062
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0033225	0.16428900871918484
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0033225	0.16428900871918484
THANATOPHORIC DYSPLASIA	0.0033225	0.16428900871918484
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0033225	0.16428900871918484
WAARDENBURG SYNDROME TYPE 3	0.0033225	0.16428900871918484
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0033225	0.16428900871918484
GENITOPATELLAR SYNDROME; GTPTS	0.0033225	0.16428900871918484
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0033225	0.16428900871918484
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0033225	0.16428900871918484
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00330881	0.16361207372163314
CONGENITAL HYDROCEPHALUS	0.00330881	0.16361207372163314
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00330881	0.16361207372163314
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00330881	0.16361207372163314
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00330881	0.16361207372163314
MECKEL SYNDROME, TYPE 10; MKS10	0.00318833	0.15765465016392435
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00318833	0.15765465016392435
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00318833	0.15765465016392435
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00318833	0.15765465016392435
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00318833	0.15765465016392435
TYSHCHENKO SYNDROME	0.00318833	0.15765465016392435
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00318833	0.15765465016392435
JOUBERT SYNDROME WITH RENAL DEFECT	0.00318833	0.15765465016392435
AASE-SMITH SYNDROME I	0.00318833	0.15765465016392435
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00314083	0.15530589834626857
CHARGE-LIKE SYNDROME, X-LINKED	0.00314083	0.15530589834626857
MEIER-GORLIN SYNDROME 7	0.00314083	0.15530589834626857
MEIER-GORLIN SYNDROME 1; MGORS1	0.00314083	0.15530589834626857
TIBIAL HEMIMELIA	0.00314083	0.15530589834626857
RAPADILINO SYNDROME	0.00314083	0.15530589834626857
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00314083	0.15530589834626857
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00314083	0.15530589834626857
DIABETIC EMBRYOPATHY	0.00314083	0.15530589834626857
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00314083	0.15530589834626857
GORDON SYNDROME	0.00314083	0.15530589834626857
BOR SYNDROME	0.00314083	0.15530589834626857
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00314083	0.15530589834626857
STICKLER SYNDROME TYPE 2	0.00312714	0.15462896334871684
STICKLER SYNDROME TYPE 1	0.00312714	0.15462896334871684
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00312714	0.15462896334871684
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00312714	0.15462896334871684
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00312714	0.15462896334871684
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00312714	0.15462896334871684
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00312714	0.15462896334871684
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00312714	0.15462896334871684
SPINOCEREBELLAR ATAXIA TYPE 36	0.0030824	0.15241668637351855
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0030824	0.15241668637351855
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0030824	0.15241668637351855
RHYNS SYNDROME	0.0030824	0.15241668637351855
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0030824	0.15241668637351855
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0030824	0.15241668637351855
MYASTHENIA GRAVIS	0.0030824	0.15241668637351855
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0030824	0.15241668637351855
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0030824	0.15241668637351855
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00306871	0.15173975137596682
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00306871	0.15173975137596682
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00306871	0.15173975137596682
WAARDENBURG SYNDROME TYPE 2	0.00306871	0.15173975137596682
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00306871	0.15173975137596682
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00306871	0.15173975137596682
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00306871	0.15173975137596682
JOUBERT SYNDROME 21	0.00306871	0.15173975137596682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00306871	0.15173975137596682
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00306871	0.15173975137596682
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00306871	0.15173975137596682
CONGENITAL MYASTHENIC SYNDROME	0.00306871	0.15173975137596682
CODAS SYNDROME	0.00306871	0.15173975137596682
ISOLATED COMPLEX I DEFICIENCY	0.00306871	0.15173975137596682
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00306871	0.15173975137596682
LEIGH SYNDROME; LS	0.00306871	0.15173975137596682
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00306871	0.15173975137596682
REFSUM DISEASE	0.00306871	0.15173975137596682
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00306871	0.15173975137596682
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00306871	0.15173975137596682
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.14939099955831106
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.14939099955831106
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.14939099955831106
CHROMOSOME 18P DELETION SYNDROME	0.00295376	0.14605577197723987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00295376	0.14605577197723987
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00295376	0.14605577197723987
TETRASOMY 5P	0.00295376	0.14605577197723987
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00295376	0.14605577197723987
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00295376	0.14605577197723987
GORLIN SYNDROME	0.00295376	0.14605577197723987
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00295376	0.14605577197723987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00295376	0.14605577197723987
600736 VELOFACIOSKELETAL SYNDROME	0.00295376	0.14605577197723987
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00295376	0.14605577197723987
OROFACIODIGITAL SYNDROME XV; OFD15	0.00295376	0.14605577197723987
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00295376	0.14605577197723987
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00295376	0.14605577197723987
PENTASOMY X	0.00295376	0.14605577197723987
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00295376	0.14605577197723987
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00295376	0.14605577197723987
3Q13 MICRODELETION SYNDROME	0.00295376	0.14605577197723987
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00295376	0.14605577197723987
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00295376	0.14605577197723987
CHROMOSOME 16Q22 DELETION SYNDROME	0.00295376	0.14605577197723987
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00295376	0.14605577197723987
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00295376	0.14605577197723987
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00295376	0.14605577197723987
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00295376	0.14605577197723987
DIAMOND-BLACKFAN ANEMIA 8	0.00295376	0.14605577197723987
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00295376	0.14605577197723987
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00295376	0.14605577197723987
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00295376	0.14605577197723987
RING CHROMOSOME 6 SYNDROME	0.00295376	0.14605577197723987
ROIFMAN-CHITAYAT SYNDROME	0.00295376	0.14605577197723987
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00295376	0.14605577197723987
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00295376	0.14605577197723987
6Q TERMINAL DELETION SYNDROME	0.0028938799999999997	0.14309486126479296
XQ12-Q13.3 DUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479296
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0028938799999999997	0.14309486126479296
7P22.1 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479296
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.14309486126479296
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0028938799999999997	0.14309486126479296
SAY-BARBER-MILLER SYNDROME	0.0028938799999999997	0.14309486126479296
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.0028938799999999997	0.14309486126479296
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0028938799999999997	0.14309486126479296
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0028938799999999997	0.14309486126479296
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.0028938799999999997	0.14309486126479296
12Q14 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479296
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0028938799999999997	0.14309486126479296
6Q16 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479296
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0028938799999999997	0.14309486126479296
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028938799999999997	0.14309486126479296
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0028938799999999997	0.14309486126479296
47,XYY SYNDROME	0.0028938799999999997	0.14309486126479296
1Q44 MICRODELETION SYNDROME	0.0028938799999999997	0.14309486126479296
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0028938799999999997	0.14309486126479296
CHITAYAT SYNDROME	0.0028938799999999997	0.14309486126479296
PMM2-CDG	0.0028938799999999997	0.14309486126479296
49,XYYYY SYNDROME	0.0028938799999999997	0.14309486126479296
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028938799999999997	0.14309486126479296
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0027941700000000003	0.1381644603439834
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0027941700000000003	0.1381644603439834
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027941700000000003	0.1381644603439834
FRANK-TER HAAR SYNDROME; FTHS	0.0027941700000000003	0.1381644603439834
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027941700000000003	0.1381644603439834
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0027941700000000003	0.1381644603439834
17P13.3 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.1381644603439834
AUTISM, SUSCEPTIBILITY TO, 18	0.0027941700000000003	0.1381644603439834
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.0027941700000000003	0.1381644603439834
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0027941700000000003	0.1381644603439834
19P13.13 MICRODELETION SYNDROME	0.0027941700000000003	0.1381644603439834
ARTERIAL TORTUOSITY SYNDROME	0.0027941700000000003	0.1381644603439834
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0027941700000000003	0.1381644603439834
XIA-GIBBS SYNDROME	0.0027941700000000003	0.1381644603439834
MONOSOMY 13Q34	0.0027941700000000003	0.1381644603439834
JUVENILE POLYPOSIS OF INFANCY	0.0027941700000000003	0.1381644603439834
WEAVER SYNDROME	0.0027941700000000003	0.1381644603439834
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0027941700000000003	0.1381644603439834
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.0027941700000000003	0.1381644603439834
JUVENILE POLYPOSIS SYNDROME	0.0027941700000000003	0.1381644603439834
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0027941700000000003	0.1381644603439834
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0027941700000000003	0.1381644603439834
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0027941700000000003	0.1381644603439834
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0027941700000000003	0.1381644603439834
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0027941700000000003	0.1381644603439834
ATKIN-FLAITZ SYNDROME	0.0027941700000000003	0.1381644603439834
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0027941700000000003	0.1381644603439834
COLE-CARPENTER SYNDROME 2; CLCRP2	0.0027941700000000003	0.1381644603439834
SMITH-KINGSMORE SYNDROME; SKS	0.0027941700000000003	0.1381644603439834
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0027941700000000003	0.1381644603439834
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.0027941700000000003	0.1381644603439834
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0027941700000000003	0.1381644603439834
ALAGILLE SYNDROME	0.0027941700000000003	0.1381644603439834
RING CHROMOSOME 14 SYNDROME	0.0027941700000000003	0.1381644603439834
NOONAN SYNDROME 3; NS3	0.0027941700000000003	0.1381644603439834
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.0027941700000000003	0.1381644603439834
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027941700000000003	0.1381644603439834
TEMTAMY SYNDROME; TEMTYS	0.0027941700000000003	0.1381644603439834
MOMO SYNDROME	0.0027941700000000003	0.1381644603439834
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0027941700000000003	0.1381644603439834
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.1381644603439834
CEREBROOCULONASAL SYNDROME	0.0026125000000000002	0.12918134997106712
MELNICK-NEEDLES SYNDROME	0.0026125000000000002	0.12918134997106712
OROFACIODIGITAL SYNDROME IV; OFD4	0.0026125000000000002	0.12918134997106712
PFEIFFER SYNDROME TYPE 2	0.0026125000000000002	0.12918134997106712
ACALVARIA	0.0026125000000000002	0.12918134997106712
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0026125000000000002	0.12918134997106712
DIAPHANOSPONDYLODYSOSTOSIS	0.0026125000000000002	0.12918134997106712
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0026125000000000002	0.12918134997106712
CRANE-HEISE SYNDROME	0.0026125000000000002	0.12918134997106712
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.0026125000000000002	0.12918134997106712
MECKEL SYNDROME	0.0026125000000000002	0.12918134997106712
KNIEST-LIKE DYSPLASIA, LETHAL	0.0026125000000000002	0.12918134997106712
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.0026125000000000002	0.12918134997106712
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0026125000000000002	0.12918134997106712
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0026125000000000002	0.12918134997106712
NEMALINE MYOPATHY 2; NEM2	0.0026125000000000002	0.12918134997106712
48,XXYY SYNDROME	0.0026125000000000002	0.12918134997106712
49,XXXXY SYNDROME	0.0026125000000000002	0.12918134997106712
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0026125000000000002	0.12918134997106712
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0026125000000000002	0.12918134997106712
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0026125000000000002	0.12918134997106712
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0026125000000000002	0.12918134997106712
ATELOSTEOGENESIS TYPE I	0.0026125000000000002	0.12918134997106712
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0026125000000000002	0.12918134997106712
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.0026125000000000002	0.12918134997106712
MOSAIC TRISOMY 9	0.0026125000000000002	0.12918134997106712
FETAL AKINESIA DEFORMATION SEQUENCE	0.0026125000000000002	0.12918134997106712
CATEL-MANZKE SYNDROME	0.0026125000000000002	0.12918134997106712
NEU-LAXOVA SYNDROME 2; NLS2	0.0026125000000000002	0.12918134997106712
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0025540700000000003	0.1262921379983171
TETRASOMY 12P	0.0025540700000000003	0.1262921379983171
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0025540700000000003	0.1262921379983171
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0025540700000000003	0.1262921379983171
MCDONOUGH SYNDROME	0.0025540700000000003	0.1262921379983171
CHAR SYNDROME	0.0025540700000000003	0.1262921379983171
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0025540700000000003	0.1262921379983171
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0025540700000000003	0.1262921379983171
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.0025540700000000003	0.1262921379983171
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0025540700000000003	0.1262921379983171
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.0025540700000000003	0.1262921379983171
JACOBSEN SYNDROME	0.0025540700000000003	0.1262921379983171
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0025540700000000003	0.1262921379983171
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.0025540700000000003	0.1262921379983171
COACH SYNDROME	0.0025540700000000003	0.1262921379983171
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.0025540700000000003	0.1262921379983171
ASCHER SYNDROME	0.0025540700000000003	0.1262921379983171
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0025540700000000003	0.1262921379983171
SCLEROSTEOSIS 2; SOST2	0.00250657	0.12394338618066131
MELNICK-NEEDLES SYNDROME	0.00250657	0.12394338618066131
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00250657	0.12394338618066131
CHOPS SYNDROME; CHOPS	0.00250657	0.12394338618066131
YUNIS-VARON SYNDROME	0.00250657	0.12394338618066131
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00250657	0.12394338618066131
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00250657	0.12394338618066131
YUNIS-VARON SYNDROME	0.00250657	0.12394338618066131
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00250657	0.12394338618066131
PFEIFFER SYNDROME TYPE 1	0.00250657	0.12394338618066131
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00250657	0.12394338618066131
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00250657	0.12394338618066131
ALPHA-MANNOSIDOSIS	0.00250657	0.12394338618066131
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00250657	0.12394338618066131
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00250657	0.12394338618066131
PELVISCAPULAR DYSPLASIA	0.00250657	0.12394338618066131
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00250657	0.12394338618066131
ISOLATED BRACHYCEPHALY	0.00250657	0.12394338618066131
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0024928800000000003	0.12326645118310958
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0024928800000000003	0.12326645118310958
ACROCALLOSAL SYNDROME	0.0024928800000000003	0.12326645118310958
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.0024928800000000003	0.12326645118310958
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.0024928800000000003	0.12326645118310958
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.0024928800000000003	0.12326645118310958
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0024928800000000003	0.12326645118310958
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0024928800000000003	0.12326645118310958
KEIPERT SYNDROME; KPTS	0.0024928800000000003	0.12326645118310958
VICI SYNDROME	0.0024928800000000003	0.12326645118310958
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0024928800000000003	0.12326645118310958
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0024928800000000003	0.12326645118310958
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0024928800000000003	0.12326645118310958
DUANE-RADIAL RAY SYNDROME; DRRS	0.0024928800000000003	0.12326645118310958
NASODIGITOACOUSTIC SYNDROME	0.0024928800000000003	0.12326645118310958
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0024928800000000003	0.12326645118310958
GLUTAMINE DEFICIENCY, CONGENITAL	0.00196464	0.09714635307450997
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00196464	0.09714635307450997
MEGALENCEPHALY	0.00196464	0.09714635307450997
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00196464	0.09714635307450997
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00196464	0.09714635307450997
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.09714635307450997
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00196464	0.09714635307450997
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00196464	0.09714635307450997
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00196464	0.09714635307450997
MICRO SYNDROME	0.00196464	0.09714635307450997
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00196464	0.09714635307450997
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.09714635307450997
TRISOMY 18P	0.00196464	0.09714635307450997
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.09714635307450997
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00196464	0.09714635307450997
TRISOMY 18-LIKE SYNDROME	0.00196464	0.09714635307450997
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00196464	0.09714635307450997
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00196464	0.09714635307450997
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00196464	0.09714635307450997
OMODYSPLASIA 1; OMOD1	0.00196464	0.09714635307450997
BOOMERANG DYSPLASIA	0.00196464	0.09714635307450997
MULTIPLE METAPHYSEAL DYSPLASIA	0.00196464	0.09714635307450997
CARPENTER-WAZIRI SYNDROME	0.00196464	0.09714635307450997
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.09714635307450997
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.09714635307450997
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00196464	0.09714635307450997
SHELDON-HALL SYNDROME	0.00196464	0.09714635307450997
OCULOECTODERMAL SYNDROME; OES	0.00196464	0.09714635307450997
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.09714635307450997
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.09714635307450997
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00196464	0.09714635307450997
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00196464	0.09714635307450997
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00196464	0.09714635307450997
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00196464	0.09714635307450997
C SYNDROME	0.00196464	0.09714635307450997
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.09714635307450997
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.09714635307450997
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00196464	0.09714635307450997
FILIPPI SYNDROME; FLPIS	0.00196464	0.09714635307450997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.09714635307450997
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00196464	0.09714635307450997
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00196464	0.09714635307450997
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00196464	0.09714635307450997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00196464	0.09714635307450997
FAMILIAL BENIGN COPPER DEFICIENCY	0.00196464	0.09714635307450997
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00196464	0.09714635307450997
MIETENS SYNDROME	0.00196464	0.09714635307450997
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00196464	0.09714635307450997
8Q24.3 MICRODELETION SYNDROME	0.00196464	0.09714635307450997
MULIBREY NANISM	0.00196464	0.09714635307450997
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.09714635307450997
LISSENCEPHALY, X-LINKED, 2	0.00196464	0.09714635307450997
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00196464	0.09714635307450997
BEEMER LETHAL MALFORMATION SYNDROME	0.00196464	0.09714635307450997
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00196464	0.09714635307450997
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00196464	0.09714635307450997
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00196464	0.09714635307450997
LIG4 SYNDROME	0.00196464	0.09714635307450997
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00196464	0.09714635307450997
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.09714635307450997
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.09714635307450997
CRANIOECTODERMAL DYSPLASIA 1	0.00196464	0.09714635307450997
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00196464	0.09714635307450997
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00196464	0.09714635307450997
ISOLATED TRIGONOCEPHALY	0.00196464	0.09714635307450997
ALAZAMI SYNDROME; ALAZS	0.00196464	0.09714635307450997
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.09714635307450997
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.09714635307450997
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.09418544236206307
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.09418544236206307
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.09418544236206307
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00190476	0.09418544236206307
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.09418544236206307
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.09418544236206307
SAUL-WILSON SYNDROME; SWILS	0.00190476	0.09418544236206307
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.09418544236206307
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00190476	0.09418544236206307
MILD CANAVAN DISEASE	0.00190476	0.09418544236206307
PARTINGTON SYNDROME	0.00190476	0.09418544236206307
SALLA DISEASE	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.09418544236206307
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.09418544236206307
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00190476	0.09418544236206307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00190476	0.09418544236206307
FG SYNDROME 2; FGS2	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.09418544236206307
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.09418544236206307
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	0.09418544236206307
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.09418544236206307
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.09418544236206307
EPISODIC ATAXIA TYPE 1	0.00190476	0.09418544236206307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00190476	0.09418544236206307
CRANIOSYNOSTOSIS 7	0.00190476	0.09418544236206307
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.09418544236206307
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.09418544236206307
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.09418544236206307
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00190476	0.09418544236206307
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206307
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.09418544236206307
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.09418544236206307
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00190476	0.09418544236206307
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.09418544236206307
MENTAL RETARDATION, X-LINKED 9	0.00190476	0.09418544236206307
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	0.09418544236206307
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00190476	0.09418544236206307
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.09418544236206307
EPIDERMAL NEVUS SYNDROME	0.00190476	0.09418544236206307
LIG4 SYNDROME	0.00190476	0.09418544236206307
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.09418544236206307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.00190476	0.09418544236206307
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.09418544236206307
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.09418544236206307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00190476	0.09418544236206307
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.09418544236206307
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	0.09418544236206307
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00190476	0.09418544236206307
MASA SYNDROME	0.00190476	0.09418544236206307
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	0.09418544236206307
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00190476	0.09418544236206307
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	0.09418544236206307
XQ25 DUPLICATION SYNDROME	0.00190476	0.09418544236206307
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	0.09418544236206307
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00190476	0.09418544236206307
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206307
HAREL-YOON SYNDROME; HAYOS	0.00190476	0.09418544236206307
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.09418544236206307
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.09418544236206307
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00190476	0.09418544236206307
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.09418544236206307
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	0.09418544236206307
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00190476	0.09418544236206307
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206307
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	0.09418544236206307
PRADER-WILLI SYNDROME	0.00190476	0.09418544236206307
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.09418544236206307
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.09418544236206307
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.09418544236206307
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00190476	0.09418544236206307
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00190476	0.09418544236206307
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.09418544236206307
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.09418544236206307
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.09418544236206307
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.09418544236206307
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206307
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.09418544236206307
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.09418544236206307
5Q14.3 MICRODELETION SYNDROME	0.00190476	0.09418544236206307
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	0.09418544236206307
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09418544236206307
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.09418544236206307
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00190476	0.09418544236206307
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00190476	0.09418544236206307
TENORIO SYNDROME; TNORS	0.00190476	0.09418544236206307
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.09418544236206307
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.09418544236206307
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00190476	0.09418544236206307
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	0.09418544236206307
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.09418544236206307
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.09418544236206307
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.09418544236206307
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.09418544236206307
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.09418544236206307
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	0.09418544236206307
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.09418544236206307
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	0.09418544236206307
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.09418544236206307
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.09418544236206307
2Q23.1 MICRODELETION SYNDROME	0.00190476	0.09418544236206307
AUTISM	0.00190476	0.09418544236206307
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.09418544236206307
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	0.09418544236206307
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00190476	0.09418544236206307
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00190476	0.09418544236206307
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.09418544236206307
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00190476	0.09418544236206307
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	0.09418544236206307
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00190476	0.09418544236206307
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.09418544236206307
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	0.09418544236206307
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.09418544236206307
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00190476	0.09418544236206307
PRADER-WILLI SYNDROME; PWS	0.00190476	0.09418544236206307
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09418544236206307
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	0.09418544236206307
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.09418544236206307
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	0.09418544236206307
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.09418544236206307
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00190476	0.09418544236206307
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	0.09418544236206307
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	0.09418544236206307
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	0.09418544236206307
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00190476	0.09418544236206307
MICROTIA	0.00190476	0.09418544236206307
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.09418544236206307
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.09418544236206307
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	0.09418544236206307
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.09418544236206307
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00190476	0.09418544236206307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00190476	0.09418544236206307
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.09418544236206307
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.09418544236206307
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.09418544236206307
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00190476	0.09418544236206307
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.09418544236206307
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	0.09418544236206307
COFFIN-SIRIS SYNDROME 2; CSS2	0.00190476	0.09418544236206307
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00180505	0.08925504144125347
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00180505	0.08925504144125347
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00180505	0.08925504144125347
TETRASOMY 18P	0.00180505	0.08925504144125347
COHEN SYNDROME	0.00180505	0.08925504144125347
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00180505	0.08925504144125347
OGDEN SYNDROME	0.00180505	0.08925504144125347
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.08925504144125347
MALAN OVERGROWTH SYNDROME	0.00180505	0.08925504144125347
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.08925504144125347
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.08925504144125347
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.00180505	0.08925504144125347
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00180505	0.08925504144125347
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00180505	0.08925504144125347
MARTSOLF SYNDROME	0.00180505	0.08925504144125347
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.08925504144125347
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00180505	0.08925504144125347
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.08925504144125347
ROIFMAN SYNDROME; RFMN	0.00180505	0.08925504144125347
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.08925504144125347
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00180505	0.08925504144125347
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00180505	0.08925504144125347
PROTEUS-LIKE SYNDROME	0.00180505	0.08925504144125347
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00180505	0.08925504144125347
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.08925504144125347
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.08925504144125347
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00180505	0.08925504144125347
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00180505	0.08925504144125347
OCCIPITAL HORN SYNDROME	0.00180505	0.08925504144125347
GABA-TRANSAMINASE DEFICIENCY	0.00180505	0.08925504144125347
ACRORENAL-MANDIBULAR SYNDROME	0.00180505	0.08925504144125347
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00180505	0.08925504144125347
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00180505	0.08925504144125347
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00180505	0.08925504144125347
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00180505	0.08925504144125347
RUVALCABA SYNDROME	0.00180505	0.08925504144125347
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.08925504144125347
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00180505	0.08925504144125347
611961 STEVENSON-CAREY SYNDROME	0.00180505	0.08925504144125347
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00180505	0.08925504144125347
MEVALONIC ACIDURIA; MEVA	0.00180505	0.08925504144125347
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00180505	0.08925504144125347
MARFAN SYNDROME; MFS	0.00180505	0.08925504144125347
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.08925504144125347
CLARK-BARAITSER SYNDROME	0.00180505	0.08925504144125347
COLE-CARPENTER SYNDROME	0.00180505	0.08925504144125347
GMS SYNDROME	0.00180505	0.08925504144125347
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00180505	0.08925504144125347
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.08925504144125347
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.00180505	0.08925504144125347
MEVALONIC ACIDURIA	0.00180505	0.08925504144125347
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00180505	0.08925504144125347
SECKEL SYNDROME 5; SCKL5	0.00180505	0.08925504144125347
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00180505	0.08925504144125347
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00180505	0.08925504144125347
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.08925504144125347
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.08925504144125347
RETINOBLASTOMA; RB1	0.00162338	0.0802719310683372
MICROPHTHALMIA, SYNDROMIC 4	0.00162338	0.0802719310683372
ISOLATED PIERRE ROBIN SYNDROME	0.00162338	0.0802719310683372
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.0802719310683372
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00162338	0.0802719310683372
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.0802719310683372
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00162338	0.0802719310683372
ACRORENAL SYNDROME	0.00162338	0.0802719310683372
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.0802719310683372
WEAVER-WILLIAMS SYNDROME	0.00162338	0.0802719310683372
BLACKFAN-DIAMOND ANEMIA	0.00162338	0.0802719310683372
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00162338	0.0802719310683372
FAMILIAL VISCERAL MYOPATHY	0.00162338	0.0802719310683372
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00162338	0.0802719310683372
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00162338	0.0802719310683372
ADDUCTED THUMBS SYNDROME	0.00162338	0.0802719310683372
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00162338	0.0802719310683372
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00162338	0.0802719310683372
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00162338	0.0802719310683372
OCULO-PALATO-CEREBRAL SYNDROME	0.00162338	0.0802719310683372
ACROPECTOROVERTEBRAL DYSPLASIA	0.00162338	0.0802719310683372
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00162338	0.0802719310683372
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00162338	0.0802719310683372
XYLT1-CDG	0.00162338	0.0802719310683372
FEMORAL-FACIAL SYNDROME	0.00162338	0.0802719310683372
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.00162338	0.0802719310683372
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00162338	0.0802719310683372
METATROPIC DYSPLASIA	0.00162338	0.0802719310683372
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00162338	0.0802719310683372
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00162338	0.0802719310683372
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00162338	0.0802719310683372
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00162338	0.0802719310683372
RETINOBLASTOMA	0.00162338	0.0802719310683372
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00162338	0.0802719310683372
MAXILLONASAL DYSPLASIA	0.00162338	0.0802719310683372
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00162338	0.0802719310683372
PRIMARY PULMONARY HYPOPLASIA	0.00162338	0.0802719310683372
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00162338	0.0802719310683372
HISTIOCYTOID CARDIOMYOPATHY	0.00162338	0.0802719310683372
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00162338	0.0802719310683372
LETHAL KNIEST-LIKE DYSPLASIA	0.00162338	0.0802719310683372
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00162338	0.0802719310683372
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00162338	0.0802719310683372
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.0802719310683372
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.0802719310683372
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00162338	0.0802719310683372
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00162338	0.0802719310683372
LYMPHEDEMA, HEREDITARY, II	0.00162338	0.0802719310683372
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00162338	0.0802719310683372
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00162338	0.0802719310683372
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.0802719310683372
ATELOSTEOGENESIS, TYPE II	0.00162338	0.0802719310683372
OCULOPALATOCEREBRAL SYNDROME	0.00162338	0.0802719310683372
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00162338	0.0802719310683372
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00162338	0.0802719310683372
FIBROCHONDROGENESIS 1; FBCG1	0.00162338	0.0802719310683372
SPRENGEL DEFORMITY	0.00162338	0.0802719310683372
MESOMELIC LIMB SHORTENING AND BOWING	0.00162338	0.0802719310683372
MECKEL SYNDROME, TYPE 4; MKS4	0.00162338	0.0802719310683372
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00162338	0.0802719310683372
HOLZGREVE SYNDROME	0.00162338	0.0802719310683372
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00162338	0.0802719310683372
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00162338	0.0802719310683372
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00162338	0.0802719310683372
ATELOSTEOGENESIS, TYPE I; AO1	0.00162338	0.0802719310683372
OROFACIODIGITAL SYNDROME XI; OFD11	0.00162338	0.0802719310683372
OROFACIODIGITAL SYNDROME X	0.00162338	0.0802719310683372
ISOLATED DANDY-WALKER MALFORMATION	0.00162338	0.0802719310683372
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00162338	0.0802719310683372
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.0802719310683372
PALATOPHARYNGEAL INCOMPETENCE	0.00162338	0.0802719310683372
AASE-SMITH SYNDROME	0.00162338	0.0802719310683372
MEGAEPIPHYSEAL DWARFISM	0.00162338	0.0802719310683372
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00162338	0.0802719310683372
PELVIS-SHOULDER DYSPLASIA	0.00162338	0.0802719310683372
PHOCOMELIA, SCHINZEL TYPE	0.00162338	0.0802719310683372
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00162338	0.0802719310683372
LOWRY-MACLEAN SYNDROME	0.00162338	0.0802719310683372
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00162338	0.0802719310683372
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00162338	0.0802719310683372
MICROFORM HOLOPROSENCEPHALY	0.00162338	0.0802719310683372
C SYNDROME	0.00162338	0.0802719310683372
MCKUSICK-KAUFMAN SYNDROME	0.00162338	0.0802719310683372
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00162338	0.0802719310683372
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00162338	0.0802719310683372
PIERRE ROBIN SYNDROME	0.00162338	0.0802719310683372
260150 PALANT CLEFT PALATE SYNDROME	0.00162338	0.0802719310683372
OROFACIODIGITAL SYNDROME TYPE 14	0.00162338	0.0802719310683372
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00162338	0.0802719310683372
TETRAPLOIDY	0.00162338	0.0802719310683372
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00162338	0.0802719310683372
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00162338	0.0802719310683372
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00162338	0.0802719310683372
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00162338	0.0802719310683372
CAMPOMELIA, CUMMING TYPE	0.00162338	0.0802719310683372
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00162338	0.0802719310683372
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.07738271909558717
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558717
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.00156495	0.07738271909558717
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558717
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00156495	0.07738271909558717
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00156495	0.07738271909558717
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.00156495	0.07738271909558717
PURPURA SIMPLEX	0.00156495	0.07738271909558717
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558717
MALIGNANT ATROPHIC PAPULOSIS	0.00156495	0.07738271909558717
INFANTILE SIALIC ACID STORAGE DISEASE	0.00156495	0.07738271909558717
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00156495	0.07738271909558717
X-LINKED CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558717
GOOD SYNDROME	0.00156495	0.07738271909558717
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00156495	0.07738271909558717
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00156495	0.07738271909558717
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558717
CLUSTER HEADACHE, FAMILIAL	0.00156495	0.07738271909558717
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558717
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.07738271909558717
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00156495	0.07738271909558717
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00156495	0.07738271909558717
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00156495	0.07738271909558717
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558717
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.07738271909558717
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00156495	0.07738271909558717
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00156495	0.07738271909558717
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00156495	0.07738271909558717
MYASTHENIA GRAVIS; MG	0.00156495	0.07738271909558717
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00156495	0.07738271909558717
PRADER-WILLI-LIKE SYNDROME	0.00156495	0.07738271909558717
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.07738271909558717
ARIMA SYNDROME	0.00156495	0.07738271909558717
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00156495	0.07738271909558717
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00156495	0.07738271909558717
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00156495	0.07738271909558717
TYPICAL NEMALINE MYOPATHY	0.00156495	0.07738271909558717
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558717
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00156495	0.07738271909558717
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00156495	0.07738271909558717
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00156495	0.07738271909558717
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.07738271909558717
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00156495	0.07738271909558717
CENTRONUCLEAR MYOPATHY	0.00156495	0.07738271909558717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00156495	0.07738271909558717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00156495	0.07738271909558717
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00156495	0.07738271909558717
JOUBERT SYNDROME 7	0.00156495	0.07738271909558717
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00156495	0.07738271909558717
SALIH MYOPATHY; SALMY	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00156495	0.07738271909558717
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00156495	0.07738271909558717
FACIOCARDIOMELIC SYNDROME	0.00156495	0.07738271909558717
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00156495	0.07738271909558717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00156495	0.07738271909558717
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00156495	0.07738271909558717
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00156495	0.07738271909558717
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00156495	0.07738271909558717
PROLACTINOMA	0.00156495	0.07738271909558717
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00156495	0.07738271909558717
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00156495	0.07738271909558717
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00156495	0.07738271909558717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00156495	0.07738271909558717
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00156495	0.07738271909558717
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00156495	0.07738271909558717
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00156495	0.07738271909558717
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00156495	0.07738271909558717
MEIER-GORLIN SYNDROME 8; MGORS8	0.00156495	0.07738271909558717
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00156495	0.07738271909558717
KAWASAKI DISEASE	0.00156495	0.07738271909558717
TUKEL SYNDROME	0.00156495	0.07738271909558717
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.07738271909558717
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.00156495	0.07738271909558717
ISOLATED CONGENITAL ALACRIMA	0.00156495	0.07738271909558717
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00156495	0.07738271909558717
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00156495	0.07738271909558717
TSH-SECRETING PITUITARY ADENOMA	0.00156495	0.07738271909558717
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00156495	0.07738271909558717
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00156495	0.07738271909558717
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00156495	0.07738271909558717
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00156495	0.07738271909558717
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00156495	0.07738271909558717
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00156495	0.07738271909558717
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.07738271909558717
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00156495	0.07738271909558717
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00156495	0.07738271909558717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00156495	0.07738271909558717
FETAL TRIMETHADIONE SYNDROME	0.00156495	0.07738271909558717
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.00156495	0.07738271909558717
PROGRESSIVE HEMIFACIAL ATROPHY	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00156495	0.07738271909558717
INHALATIONAL BOTULISM	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00156495	0.07738271909558717
IATROGENIC BOTULISM	0.00156495	0.07738271909558717
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00156495	0.07738271909558717
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00156495	0.07738271909558717
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00156495	0.07738271909558717
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00156495	0.07738271909558717
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00156495	0.07738271909558717
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00156495	0.07738271909558717
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00156495	0.07738271909558717
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00156495	0.07738271909558717
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00156495	0.07738271909558717
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00156495	0.07738271909558717
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00156495	0.07738271909558717
NON-FUNCTIONING PITUITARY ADENOMA	0.00156495	0.07738271909558717
INFANT BOTULISM	0.00156495	0.07738271909558717
WARBURG MICRO SYNDROME 1	0.00156495	0.07738271909558717
ERDHEIM-CHESTER DISEASE	0.00156495	0.07738271909558717
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00156495	0.07738271909558717
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00156495	0.07738271909558717
THYMIC TUMOR	0.00156495	0.07738271909558717
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00156495	0.07738271909558717
PITUITARY APOPLEXY	0.00156495	0.07738271909558717
ADULT INTESTINAL BOTULISM	0.00156495	0.07738271909558717
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00156495	0.07738271909558717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00156495	0.07738271909558717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00156495	0.07738271909558717
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00156495	0.07738271909558717
WOUND BOTULISM	0.00156495	0.07738271909558717
JOUBERT SYNDROME 35; JBTS35	0.00156495	0.07738271909558717
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00156495	0.07738271909558717
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00156495	0.07738271909558717
FRONTOOCULAR SYNDROME	0.00156495	0.07738271909558717
WIDOW'S PEAK SYNDROME	0.00156495	0.07738271909558717
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00156495	0.07738271909558717
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00156495	0.07738271909558717
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00156495	0.07738271909558717
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.07738271909558717
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00156495	0.07738271909558717
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00156495	0.07738271909558717
THYMIC EPITHELIAL NEOPLASM	0.00156495	0.07738271909558717
PAROXYSMAL HEMICRANIA	0.00156495	0.07738271909558717
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.00156495	0.07738271909558717
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00156495	0.07738271909558717
INTESTINAL BOTULISM	0.00156495	0.07738271909558717
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00156495	0.07738271909558717
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00156495	0.07738271909558717
FOODBORNE BOTULISM	0.00156495	0.07738271909558717
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00156495	0.07738271909558717
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00156495	0.07738271909558717
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00156495	0.07738271909558717
BROOKE-SPIEGLER SYNDROME	0.00151745	0.0750339672779314
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.0750339672779314
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.0750339672779314
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00151745	0.0750339672779314
BETA-MANNOSIDOSIS	0.00151745	0.0750339672779314
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.0750339672779314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00151745	0.0750339672779314
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.0750339672779314
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.0750339672779314
OSTEOGENESIS IMPERFECTA	0.00151745	0.0750339672779314
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.0750339672779314
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.0750339672779314
AUROCEPHALOSYNDACTYLY	0.00151745	0.0750339672779314
RETINAL VENOUS BEADING	0.00151745	0.0750339672779314
NAIL-PATELLA SYNDROME	0.00151745	0.0750339672779314
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.0750339672779314
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.0750339672779314
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00151745	0.0750339672779314
17Q12 MICRODELETION SYNDROME	0.00151745	0.0750339672779314
TUNE DEAFNESS	0.00151745	0.0750339672779314
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00151745	0.0750339672779314
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00151745	0.0750339672779314
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.0750339672779314
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.0750339672779314
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.0750339672779314
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00151745	0.0750339672779314
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.0750339672779314
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00151745	0.0750339672779314
NEUROFIBROMATOSIS, TYPE II	0.00151745	0.0750339672779314
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.0750339672779314
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.0750339672779314
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00151745	0.0750339672779314
LEBER CONGENITAL AMAUROSIS	0.00151745	0.0750339672779314
EAR EXOSTOSES	0.00151745	0.0750339672779314
BRANCHIOOTIC SYNDROME 2	0.00151745	0.0750339672779314
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.0750339672779314
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00151745	0.0750339672779314
COXOAURICULAR SYNDROME	0.00151745	0.0750339672779314
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.0750339672779314
MENIERE DISEASE	0.00151745	0.0750339672779314
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.0750339672779314
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00151745	0.0750339672779314
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.0750339672779314
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.0750339672779314
FETAL METHYLMERCURY SYNDROME	0.00151745	0.0750339672779314
CAMURATI-ENGELMANN DISEASE	0.00151745	0.0750339672779314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00151745	0.0750339672779314
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.0750339672779314
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.0750339672779314
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.0750339672779314
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.0750339672779314
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.0750339672779314
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.0750339672779314
IVIC SYNDROME	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.0750339672779314
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.0750339672779314
IVIC SYNDROME	0.00151745	0.0750339672779314
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.0750339672779314
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.0750339672779314
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.0750339672779314
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.0750339672779314
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.0750339672779314
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00151745	0.0750339672779314
TOWNES-BROCKS SYNDROME	0.00151745	0.0750339672779314
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.0750339672779314
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.0750339672779314
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.0750339672779314
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.0750339672779314
LYMPHEDEMA, HEREDITARY, III	0.00151745	0.0750339672779314
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.0750339672779314
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00151745	0.0750339672779314
LASSA FEVER	0.00151745	0.0750339672779314
GRACILE SYNDROME	0.00151745	0.0750339672779314
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.0750339672779314
WYBURN-MASON SYNDROME	0.00151745	0.0750339672779314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00151745	0.0750339672779314
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.0750339672779314
CRANIOPHARYNGIOMA	0.00151745	0.0750339672779314
RFT1-CDG	0.00151745	0.0750339672779314
46,XX GONADAL DYSGENESIS	0.00151745	0.0750339672779314
CHIARI MALFORMATION TYPE I	0.00151745	0.0750339672779314
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.0750339672779314
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.0750339672779314
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.0750339672779314
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.0750339672779314
XYLOSIDASE DEFICIENCY	0.00151745	0.0750339672779314
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00151745	0.0750339672779314
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.0750339672779314
THALIDOMIDE EMBRYOPATHY	0.00151745	0.0750339672779314
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.0750339672779314
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.0750339672779314
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.0750339672779314
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00151745	0.0750339672779314
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00151745	0.0750339672779314
NATHALIE SYNDROME	0.00151745	0.0750339672779314
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.0750339672779314
COXOAURICULAR SYNDROME	0.00151745	0.0750339672779314
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.0750339672779314
RENAL COLOBOMA SYNDROME	0.00151745	0.0750339672779314
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00151745	0.0750339672779314
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.0750339672779314
MORQUIO SYNDROME A	0.00151745	0.0750339672779314
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00151745	0.0750339672779314
OTOSCLEROSIS 3; OTSC3	0.00151745	0.0750339672779314
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00151745	0.0750339672779314
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.0750339672779314
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00151745	0.0750339672779314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00151745	0.0750339672779314
SEVERE CANAVAN DISEASE	0.00151745	0.0750339672779314
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00151745	0.0750339672779314
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.0750339672779314
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.0750339672779314
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00151745	0.0750339672779314
RETICULAR DYSGENESIS	0.00151745	0.0750339672779314
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.0750339672779314
KEUTEL SYNDROME; KTLS	0.00151745	0.0750339672779314
USHER SYNDROME, TYPE ID	0.00151745	0.0750339672779314
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.00151745	0.0750339672779314
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.0750339672779314
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.0750339672779314
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.0750339672779314
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.00151745	0.0750339672779314
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00151745	0.0750339672779314
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00151745	0.0750339672779314
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.0750339672779314
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.0750339672779314
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.0750339672779314
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.0750339672779314
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00151745	0.0750339672779314
GALACTOSIALIDOSIS	0.00151745	0.0750339672779314
ISOLATED PLAGIOCEPHALY	0.00151745	0.0750339672779314
N SYNDROME	0.00151745	0.0750339672779314
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.0750339672779314
SPASTIC PARAPARESIS AND DEAFNESS	0.00151745	0.0750339672779314
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.0750339672779314
WILDERVANCK SYNDROME	0.00151745	0.0750339672779314
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.0750339672779314
RAMON SYNDROME	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.0750339672779314
VIRAL HEMORRHAGIC FEVER	0.00151745	0.0750339672779314
CARNEY-STRATAKIS SYNDROME	0.00151745	0.0750339672779314
ABCD SYNDROME	0.00151745	0.0750339672779314
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.0750339672779314
FRIEDREICH ATAXIA	0.00151745	0.0750339672779314
TIETZ SYNDROME	0.00151745	0.0750339672779314
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.0750339672779314
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00151745	0.0750339672779314
THANATOPHORIC DYSPLASIA TYPE 1	0.00151745	0.0750339672779314
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.0750339672779314
COFFIN-SIRIS SYNDROME 4; CSS4	0.00151745	0.0750339672779314
COFFIN-SIRIS SYNDROME 3; CSS3	0.00151745	0.0750339672779314
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.0750339672779314
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.0750339672779314
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.0750339672779314
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.0750339672779314
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.0750339672779314
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.0750339672779314
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00151745	0.0750339672779314
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.0750339672779314
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.0750339672779314
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.0750339672779314
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.0750339672779314
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.0750339672779314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00151745	0.0750339672779314
COWDEN SYNDROME 5; CWS5	0.00151745	0.0750339672779314
COWDEN SYNDROME 6; CWS6	0.00151745	0.0750339672779314
LISSENCEPHALY 5; LIS5	0.00151745	0.0750339672779314
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.0750339672779314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00151745	0.0750339672779314
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.0750339672779314
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00151745	0.0750339672779314
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00151745	0.0750339672779314
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.0750339672779314
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.0750339672779314
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.0750339672779314
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.0750339672779314
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.0750339672779314
ANUS, IMPERFORATE	0.00151745	0.0750339672779314
KEARNS-SAYRE SYNDROME	0.00151745	0.0750339672779314
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00151745	0.0750339672779314
GLYCOGEN STORAGE DISEASE II	0.00151745	0.0750339672779314
BRITTLE CORNEA SYNDROME	0.00151745	0.0750339672779314
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.0750339672779314
OTOSCLEROSIS 8; OTSC8	0.00151745	0.0750339672779314
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.0750339672779314
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00151745	0.0750339672779314
SPINOCEREBELLAR ATAXIA TYPE 13	0.00151745	0.0750339672779314
HYDROXYKYNURENINURIA	0.00151745	0.0750339672779314
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00151745	0.0750339672779314
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00151745	0.0750339672779314
PITUITARY CARCINOMA	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.0750339672779314
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.0750339672779314
WARSAW BREAKAGE SYNDROME; WABS	0.00151745	0.0750339672779314
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00151745	0.0750339672779314
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.0750339672779314
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.0750339672779314
SLC39A8-CDG	0.00151745	0.0750339672779314
ARACHNOIDITIS	0.00151745	0.0750339672779314
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.0750339672779314
FANCONI ANEMIA	0.00151745	0.0750339672779314
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.0750339672779314
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00151745	0.0750339672779314
PANHYPOPHYSITIS	0.00150376	0.07435703228037967
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.07435703228037967
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.07435703228037967
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00150376	0.07435703228037967
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.07435703228037967
JUBERG-MARSIDI SYNDROME	0.00150376	0.07435703228037967
HADDAD SYNDROME	0.00150376	0.07435703228037967
HURLER-SCHEIE SYNDROME	0.00150376	0.07435703228037967
ADENOHYPOPHYSITIS	0.00150376	0.07435703228037967
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.07435703228037967
FAMILIAL LONG QT SYNDROME	0.00150376	0.07435703228037967
SCHEIE SYNDROME	0.00150376	0.07435703228037967
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.07435703228037967
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.07435703228037967
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.07435703228037967
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.07435703228037967
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.07435703228037967
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.07435703228037967
INFANTILE LIVER FAILURE SYNDROME 1	0.00150376	0.07435703228037967
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00150376	0.07435703228037967
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00150376	0.07435703228037967
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.07435703228037967
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.07435703228037967
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.07435703228037967
PEROXISOME BIOGENESIS DISORDER 6B	0.00150376	0.07435703228037967
PEROXISOME BIOGENESIS DISORDER 5B	0.00150376	0.07435703228037967
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.07435703228037967
THYROCEREBRORETINAL SYNDROME	0.00150376	0.07435703228037967
USHER SYNDROME, TYPE IIIA	0.00150376	0.07435703228037967
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.07435703228037967
WAARDENBURG-SHAH SYNDROME	0.00150376	0.07435703228037967
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.07435703228037967
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.07435703228037967
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.07435703228037967
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.07435703228037967
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00150376	0.07435703228037967
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.07435703228037967
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.07435703228037967
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.07435703228037967
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.07435703228037967
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037967
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.07435703228037967
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.07435703228037967
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.07435703228037967
IMMUNODEFICIENCY 47	0.00150376	0.07435703228037967
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00150376	0.07435703228037967
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00150376	0.07435703228037967
JOHANSON-BLIZZARD SYNDROME; JBS	0.00150376	0.07435703228037967
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.07435703228037967
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.07435703228037967
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.07435703228037967
NEURAMINIDASE DEFICIENCY	0.00150376	0.07435703228037967
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.07435703228037967
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00150376	0.07435703228037967
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.07435703228037967
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.07435703228037967
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.07435703228037967
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00150376	0.07435703228037967
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00150376	0.07435703228037967
PEROXISOME BIOGENESIS DISORDER 3B	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.07435703228037967
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.07435703228037967
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.07435703228037967
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.07435703228037967
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.07435703228037967
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.07435703228037967
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.07435703228037967
OPTIC ATROPHY 8	0.00150376	0.07435703228037967
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.07435703228037967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00150376	0.07435703228037967
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.07435703228037967
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.07435703228037967
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.07435703228037967
USHER SYNDROME, TYPE IG	0.00150376	0.07435703228037967
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.07435703228037967
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.07435703228037967
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.07435703228037967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00150376	0.07435703228037967
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.07435703228037967
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.07435703228037967
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.07435703228037967
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.07435703228037967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00150376	0.07435703228037967
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.07435703228037967
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.07435703228037967
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00150376	0.07435703228037967
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037967
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.07435703228037967
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.07435703228037967
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.07435703228037967
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.07435703228037967
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.07435703228037967
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037967
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.07435703228037967
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00150376	0.07435703228037967
BRACHYDACTYLY, TYPE B2	0.00150376	0.07435703228037967
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.07435703228037967
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00150376	0.07435703228037967
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.07435703228037967
DEAFNESS, X-LINKED 1	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.07435703228037967
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.07435703228037967
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.07435703228037967
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.07435703228037967
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.07435703228037967
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.07435703228037967
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00150376	0.07435703228037967
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.07435703228037967
DEAFNESS, Y-LINKED 1	0.00150376	0.07435703228037967
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.07435703228037967
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.07435703228037967
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.07435703228037967
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00150376	0.07435703228037967
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.07435703228037967
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.07435703228037967
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.07435703228037967
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.07435703228037967
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.07435703228037967
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.07435703228037967
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
STIFF SKIN SYNDROME	0.00150376	0.07435703228037967
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.07435703228037967
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.07435703228037967
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.07435703228037967
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.07435703228037967
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.07435703228037967
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.07435703228037967
NATHALIE SYNDROME	0.00150376	0.07435703228037967
OTODENTAL DYSPLASIA	0.00150376	0.07435703228037967
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037967
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
WILLIAMS-BEUREN SYNDROME; WBS	0.00150376	0.07435703228037967
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.07435703228037967
WT LIMB-BLOOD SYNDROME	0.00150376	0.07435703228037967
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.07435703228037967
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.07435703228037967
LAURENCE-MOON SYNDROME	0.00150376	0.07435703228037967
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.07435703228037967
USHER SYNDROME TYPE 3	0.00150376	0.07435703228037967
USHER SYNDROME TYPE 2	0.00150376	0.07435703228037967
USHER SYNDROME TYPE 1	0.00150376	0.07435703228037967
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.07435703228037967
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037967
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.07435703228037967
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.07435703228037967
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.07435703228037967
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.07435703228037967
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.07435703228037967
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.07435703228037967
TOWNES-BROCKS SYNDROME 1; TBS1	0.00150376	0.07435703228037967
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00150376	0.07435703228037967
KRABBE DISEASE	0.00150376	0.07435703228037967
FAMILIAL COLD URTICARIA	0.00150376	0.07435703228037967
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037967
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00150376	0.07435703228037967
HIRSCHSPRUNG DISEASE	0.00150376	0.07435703228037967
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.07435703228037967
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.07435703228037967
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.07435703228037967
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.07435703228037967
SLC35A2-CDG	0.00150376	0.07435703228037967
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.07435703228037967
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.07435703228037967
THYROCEREBRORENAL SYNDROME	0.00150376	0.07435703228037967
PAPILLORENAL SYNDROME	0.00150376	0.07435703228037967
PROXIMAL SYMPHALANGISM	0.00150376	0.07435703228037967
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.07435703228037967
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.07435703228037967
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.07435703228037967
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.07435703228037967
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.07435703228037967
MICROPHTHALMIA, SYNDROMIC 3	0.00150376	0.07435703228037967
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.07435703228037967
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.07435703228037967
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.07435703228037967
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.07435703228037967
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.07435703228037967
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.07435703228037967
ERMINE PHENOTYPE	0.00150376	0.07435703228037967
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.07435703228037967
FOUNTAIN SYNDROME	0.00150376	0.07435703228037967
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.07435703228037967
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.07435703228037967
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.07435703228037967
COGAN SYNDROME	0.00150376	0.07435703228037967
CINCA SYNDROME	0.00150376	0.07435703228037967
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00150376	0.07435703228037967
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.07435703228037967
MADRAS MOTOR NEURON DISEASE	0.00150376	0.07435703228037967
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.07435703228037967
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.07435703228037967
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00150376	0.07435703228037967
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.07435703228037967
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.07435703228037967
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.07435703228037967
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.07435703228037967
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.07435703228037967
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.07435703228037967
FETAL IODINE SYNDROME	0.00150376	0.07435703228037967
MYH9-RELATED DISEASE	0.00150376	0.07435703228037967
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.07435703228037967
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.07435703228037967
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.07435703228037967
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.07435703228037967
GEMIGNANI SYNDROME	0.00150376	0.07435703228037967
EAST SYNDROME	0.00150376	0.07435703228037967
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.07435703228037967
BRAIN-LUNG-THYROID SYNDROME	0.00150376	0.07435703228037967
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00098912	0.048909418902729915
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00098912	0.048909418902729915
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00098912	0.048909418902729915
MENTAL RETARDATION, X-LINKED 21	0.00098912	0.048909418902729915
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00098912	0.048909418902729915
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00098912	0.048909418902729915
ALAGILLE SYNDROME 1; ALGS1	0.00098912	0.048909418902729915
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00098912	0.048909418902729915
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00098912	0.048909418902729915
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00098912	0.048909418902729915
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00098912	0.048909418902729915
OPSISMODYSPLASIA; OPSMD	0.00098912	0.048909418902729915
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00098912	0.048909418902729915
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00098912	0.048909418902729915
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00098912	0.048909418902729915
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00098912	0.048909418902729915
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00098912	0.048909418902729915
LAMBOTTE SYNDROME	0.00098912	0.048909418902729915
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.048909418902729915
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00098912	0.048909418902729915
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00098912	0.048909418902729915
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00098912	0.048909418902729915
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00098912	0.048909418902729915
KBG SYNDROME	0.00098912	0.048909418902729915
NEUROFIBROMATOSIS, TYPE I	0.00098912	0.048909418902729915
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00098912	0.048909418902729915
HYPERTELORISM	0.00098912	0.048909418902729915
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00098912	0.048909418902729915
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00098912	0.048909418902729915
ROBINOW-SORAUF SYNDROME	0.00098912	0.048909418902729915
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00098912	0.048909418902729915
WIDOW'S PEAK	0.00098912	0.048909418902729915
GLYCEROL KINASE DEFICIENCY; GKD	0.00098912	0.048909418902729915
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00098912	0.048909418902729915
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00098912	0.048909418902729915
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00098912	0.048909418902729915
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00098912	0.048909418902729915
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00098912	0.048909418902729915
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00098912	0.048909418902729915
GASTROCUTANEOUS SYNDROME	0.00098912	0.048909418902729915
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00098912	0.048909418902729915
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00098912	0.048909418902729915
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00098912	0.048909418902729915
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00098912	0.048909418902729915
X SMALL RINGS	0.00098912	0.048909418902729915
CRANIOSYNOSTOSIS 4; CRS4	0.00098912	0.048909418902729915
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00098912	0.048909418902729915
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00098912	0.048909418902729915
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00098912	0.048909418902729915
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00098912	0.048909418902729915
LAURIN-SANDROW SYNDROME	0.00098912	0.048909418902729915
ICF SYNDROME	0.00098912	0.048909418902729915
GASTROCUTANEOUS SYNDROME	0.00098912	0.048909418902729915
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00098912	0.048909418902729915
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00098912	0.048909418902729915
FRONTAL ENCEPHALOCELE	0.00098912	0.048909418902729915
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00098912	0.048909418902729915
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00098912	0.048909418902729915
THAKKER-DONNAI SYNDROME	0.00098912	0.048909418902729915
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00098912	0.048909418902729915
INTERMEDIATE NEMALINE MYOPATHY	0.00098912	0.048909418902729915
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00098912	0.048909418902729915
SPONDYLO-OCULAR SYNDROME	0.00098912	0.048909418902729915
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00098912	0.048909418902729915
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00098912	0.048909418902729915
DISTAL MONOSOMY 17Q	0.00098912	0.048909418902729915
CURRY-JONES SYNDROME	0.00098912	0.048909418902729915
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00098912	0.048909418902729915
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00098912	0.048909418902729915
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00098912	0.048909418902729915
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00098912	0.048909418902729915
ATKIN-FLAITZ SYNDROME	0.00098912	0.048909418902729915
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.00098912	0.048909418902729915
ISOLATED ARRHINIA	0.00098912	0.048909418902729915
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00098912	0.048909418902729915
1Q21.1 MICRODUPLICATION SYNDROME	0.00098912	0.048909418902729915
8P11.2 DELETION SYNDROME	0.00098912	0.048909418902729915
14Q11.2 MICRODELETION SYNDROME	0.00098912	0.048909418902729915
RHOMBENCEPHALOSYNAPSIS	0.00098912	0.048909418902729915
FAMILIAL INTESTINAL MALROTATION	0.00098912	0.048909418902729915
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00098912	0.048909418902729915
CONO-SPONDYLAR DYSPLASIA	0.00098912	0.048909418902729915
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00098912	0.048909418902729915
DISTAL MONOSOMY 1Q	0.00098912	0.048909418902729915
ROIFMAN SYNDROME	0.00098912	0.048909418902729915
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00098912	0.048909418902729915
SUMMITT SYNDROME	0.00098912	0.048909418902729915
FGFR2-RELATED BENT BONE DYSPLASIA	0.00098912	0.048909418902729915
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00098912	0.048909418902729915
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00098912	0.048909418902729915
RENAL TUBULAR DYSGENESIS	0.00098912	0.048909418902729915
QAZI-MARKOUIZOS SYNDROME	0.00098912	0.048909418902729915
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.00098912	0.048909418902729915
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00098912	0.048909418902729915
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00098912	0.048909418902729915
OCULOTRICHOANAL SYNDROME	0.00098912	0.048909418902729915
BIFID NOSE	0.00098912	0.048909418902729915
OSTEOGLOSPHONIC DYSPLASIA	0.00098912	0.048909418902729915
CHST3-RELATED SKELETAL DYSPLASIA	0.00098912	0.048909418902729915
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00098912	0.048909418902729915
XP21 MICRODELETION SYNDROME	0.00098912	0.048909418902729915
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00098912	0.048909418902729915
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00098912	0.048909418902729915
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00098912	0.048909418902729915
PACHYGYRIA, FRONTOTEMPORAL	0.00098912	0.048909418902729915
CHROMOSOME 4Q21 DELETION SYNDROME	0.00098912	0.048909418902729915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00098912	0.048909418902729915
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00098912	0.048909418902729915
AUTOSOMAL DOMINANT CUTIS LAXA	0.00098912	0.048909418902729915
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00098912	0.048909418902729915
DIAMOND-BLACKFAN ANEMIA 5	0.00098912	0.048909418902729915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00098912	0.048909418902729915
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00098912	0.048909418902729915
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00098912	0.048909418902729915
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00098912	0.048909418902729915
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00098912	0.048909418902729915
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00098912	0.048909418902729915
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00098912	0.048909418902729915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00098912	0.048909418902729915
POSTERIOR URETHRAL VALVE	0.00098912	0.048909418902729915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00098912	0.048909418902729915
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00098912	0.048909418902729915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00098912	0.048909418902729915
JOUBERT SYNDROME 2	0.00098912	0.048909418902729915
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00098912	0.048909418902729915
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00098912	0.048909418902729915
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00098912	0.048909418902729915
AUTOSOMAL DOMINANT OMODYSPLASIA	0.00098912	0.048909418902729915
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00098912	0.048909418902729915
CEREBROOCULONASAL SYNDROME	0.00098912	0.048909418902729915
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00098912	0.048909418902729915
ADAMS-OLIVER SYNDROME 2; AOS2	0.00098912	0.048909418902729915
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00098912	0.048909418902729915
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00098912	0.048909418902729915
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00098912	0.048909418902729915
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00098912	0.048909418902729915
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00098912	0.048909418902729915
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00098912	0.048909418902729915
JOUBERT SYNDROME 32; JBTS32	0.00098912	0.048909418902729915
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00098912	0.048909418902729915
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00098912	0.048909418902729915
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00098912	0.048909418902729915
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00098912	0.048909418902729915
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00098912	0.048909418902729915
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00098912	0.048909418902729915
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00098912	0.048909418902729915
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00098912	0.048909418902729915
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00098912	0.048909418902729915
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00098912	0.048909418902729915
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00098912	0.048909418902729915
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00098912	0.048909418902729915
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00098912	0.048909418902729915
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00098912	0.048909418902729915
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00098912	0.048909418902729915
TRICHOHEPATOENTERIC SYNDROME 2	0.00098912	0.048909418902729915
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00098912	0.048909418902729915
NF1-MICRODELETION SYNDROME	0.00098912	0.048909418902729915
